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Abstract 
New Chiral Carbene Precursors for Catalysis and Chiral Recognition 
 The thesis presents the development and application of new enantiopure chiral carbene 
precursors. Two new different types of chiral carbene precursors were prepared. The first type 
includes enantiopure unsymmetrical N-heterocyclic based zwitterions incorporating 
alkylsulphonate or sulphamidate substituents. To date there have been only a few reports of 
imidazolium salts incorporating anionic substituents such as carboxylate, sulphonate, amide, or 
phosphonate groups. The second type are camphor based monodentate as well as bidentate 
carbene precursors. Camphor is a cheap desirable starting material from the chiral pool, yet only 
a few carbene precursors have been reported so far. The carbene precursors from this source 
were evaluated in asymmetric synthesis. 
The presented thesis is divided into three parts, Introduction, Results and Discussion and 
Experimental. 
 In the Introduction, an overview of the field of organocatalysis is given. Main highlights are 
a brief history, types of organocatalysts, modes of interaction and recent applications. 
 In the first part of the Results and Discussion, the preparation of nucleophilic chiral carbene 
precursors is described. N-Heterocyclic carbene precursors based zwitterions having chiral 
centers in the backbone or side arms were synthesized. Also different types of camphor based 
carbene precursors were prepared from camphor diamine. These include carbene precursors 
with either nitrogen atoms having the same or different substituents. Bidentate camphor carbene 
precursors containing pyridine as another ligating group were also prepared. The last type of 
precursors includes different sterically demanding bulky substituents at the nitrogen atoms. 
  The second part of Results and Discussion deals with the application of carbene precursors 
in different catalytic reactions. The imidazolinium based zwitterions were used in catalysis. The 
first application was the allylation of aldehydes. The optimization of this reaction involved the 
screening of the new ligands with different reaction conditions such as additives, temperature 
and solvents. Other reactions catalyzed with zwitterion ions were the TMSCN and TMSCF3 
addition to aldehydes. The reaction of ketenes and imines, the Staudinger reaction, was also 
catalyzed by imidazolinium based zwitterions. 
 The camphor based carbene precursors were used for the [2+2] cycloaddition reaction of 
ketenes and aldehyde, the Wynberg Reaction. The latter provides access to β-lactones in high 
enantioselectivity in up to 92% and excellent yield in up to 95%. 
 In addition, alkali metal hexamethyldisilazane amides that are commonly used as strong 
bases for deprotonation are reported as Lewis base catalysts for achiral β-lactones. The reaction 
was found to proceed with 0.1 eq. of MHMDS in quantitative yields. 
 Furthermore imidazolinium based zwitterions proved as versatile chiral shift reagents for 
Mosher´s acid, alcohols, cyanohydrins, amino alcohols, nitro alcohols, thiols and carboxylic 
acids. 
 Finally, in the Experimental detailed procedures for the preparation of the described 
compounds and their characterization are given. 
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Abstract 
Neue chirale Carbenvorstufen für die Katalyse und chirale Erkennung 
Die Arbeit behandelt die Entwicklung und Anwendung neuer, enantiomerenreiner chiraler 
Carbenvorstufen. Zwei unterschiedliche Typen wurden dabei synthetisiert. Die erste Art beinhaltet 
enantiomerenreine, unsymmetrische N-heterocyclische Carbene, die auf Zwitterionen mit Alkyl-
sulphonat- bzw. Sulphamidatsubstituenten fußen. Arbeiten über Imidazoliumsalze, die anionische 
Strukturinkremente wie Carboxylat-, Sulphonat-, Amid- oder Phosphonatgruppen enthalten, sind bis 
heute eher selten. Die zweite Gruppe beruht auf Campher-basierenden einzähnigen bzw. zweizähnigen 
Liganden. Obwohl es sich bei Campher um ein kostengünstiges Startmaterial aus dem chiral pool 
handelt, sind bislang nur wenige Artikel mit auf Campher-basierenden Carbenvorstufen veröffentlicht 
worden. Diese Vorläufer wurden in Reaktionen der asymmetrischen Synthese getestet. 
Die vorgelegte Arbeit ist in drei Bereiche gegliedert: Einleitung, Ergebnisse und Auswertung und 
Experimentalteil. 
Die Einleitung gibt dabei einen Überblick über das Feld der Organokatalyse. Hauptpunkte sind dabei ein 
kurzer geschichtlicher Überblick, die verschiedenen Klassen von Organokatalysatoren, unterschiedliche 
Aktivierungsmodi der Katalysatoren und neuere Anwendungen. 
Im ersten Teil von Ergebnisse und Auswertung wird die Darstellung nukleophiler chiraler 
Carbenvorläufer beschrieben. Die synthetisierten zwitterionischen N-heterocyclischen Vorstufen besitzen 
dabei chirale Zentren im Rückgrat oder in Seitenketten. Ausgehend von Campherdiamin wurden 
verschiedene Carbenvorläufer dargestellt, die sowohl unterschiedliche als auch gleiche N-Substituenten 
beinhalten. Zudem wurden zweizähnige Carbenvorstufen mit Pyridin als Ligatorgruppe synthetisiert. Die 
letzte Form der Carbenvorstufen beinhaltet Strukturen mit verschieden sterisch anspruchsvollen 
Substituenten an den Stickstoffatomen. 
Der zweite Teil von Ergebnisse und Auswertung behandelt die Anwendung der dargestellten 
Carbenvorstufen in diversen katalytischen Reaktionen, im Besonderen der Einsatz von auf Imidazolium-
basierenden Zwitterionen, z.B. in der Allylierung von Aldehyden. Die Optimierung dieser Reaktion 
machte ein Screening der dargestellten Liganden mit einer Vielzahl von Reaktionsparametern wie 
unterschiedlichen Additiven, aber auch verschiedene Reaktionstemperaturen und Lösungsmittel, nötig. 
Andere durch Zwitterionen katalysierte Reaktionen waren die TMSCN- und TMSCF3-Addition an 
Aldehyde. Auch die Staudinger-Reaktion, die Reaktion von Iminen mit Ketenen, wurde ebenfalls durch 
Zwitterionen mit Imidazoliumbasis katalysiert. 
Die Campher-basierten Carbenvorstufen wurden in der [2+2]-Cycloaddition von Ketenen mit Aldehyden 
(Wynberg-Reaktion) eingesetzt. Diese ermöglicht den Zugang zu β-Lactonen in hoher 
Enantioselektivität (bis zu 92% ee) und ausgezeichneter Ausbeute bis zu 95%. 
Darüber hinaus konnten Alkalimetallhexamethyldisilazanamide als Lewisbasekatalysatoren in der 
quantitativen Darstellung von β-Lactonen, bereits unter einer Beteiligung von 0.1 eq MHMDS, 
eingesetzt werden. Diese Amide finden normalerweise Anwendung als starke Basen für 
Deprotonierungen.  
Auf Imidazolium-basierende Zwitterionen kristallisierten sich als vielseitige chirale Shiftreagenzien für 
Moshers Säure, Alkohole, Cyanhydrine, Aminoalkohole, Nitroalkohole, Thiole und Carbonsäuren 
heraus. 
Der Experimentalteil gibt abschließend eine genaue Übersicht über die Synthesemethoden der 
dargestellten Chemikalien und deren Charakterisierung. 
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 1. 1.  Introduction 
 Life depends upon chiral recognition. In living systems enantiomers interact in different 
manners. A well known example is the smell of the molecule limonene. Its one enantiomer (R)-
(+)-limonene 1 smells rounded and orangey. In contrast (S)-(–)-limonene 2 smells sharp and 
lemony. Another example is the chiral compound dopa. This is a well known drug for restoring 
nerve function but only its (S)-enantiomer (known as L-dopa 3) is an effective drug. D-Dopa 4 
is biologically ineffective. Therefore, this drug must be administered as a single enantiomer 
(Scheme 1). In conclusion, handedness or chirality being the principle element in nature has an 
important place in science and technology.
1
 
Scheme 1 
 1.2.  Asymmetric Organocatalysis 
 Organocatalysis provides a means of accelerating chemical reactions with a 
substoichiometric amount of organic molecules, which do not contain a metal element.
2 
For 
example the cinchona alkaloid quinidine 5, the amino acid proline 6, the oxazolidinone 7, the 
DMAP analogue 8, the primary amines 9, secondary amines, N-heterocyclic carbenes (NHCs), 
thiazolium salts, peptide-derived compounds and various sugars like the fructose derivative 10 
have been applied as organocatalysts (Scheme 2). Metalloids are usually considered as non-
metallic elements. The metal element in the catalyst structure is not always strictly considered, 
when the metal is not the reaction center such as in metallocenes.
3
 
 Enantiomeric pure compounds have a broad utility as pharmaceuticals because of their 
continually increasing demand for the production of new drugs, which overcome challenges 
associated with the treatment of new and existing diseases. Most of the new drugs need one or 
more non-racemic, asymmetric centers. Single enantiomeric drugs are, however, significantly 
more difficult to synthesize by using conventional asymmetric methodologies.
4
 
Enantiomerically pure compounds have also been utilized in electronic and optical devices. 
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They are components of polymers for novel properties and probes with a biological function. 
All these demands have made asymmetric catalysis as a prominent theme in current research.
5 
Scheme 2 
 1.3.  Historic Overview 
 In the 19
th
 century, there are examples of organic molecules that have been used as 
catalysts. The first organocatalytic reaction was discovered accidentally by Liebig, who found 
that dicyan 11 is transformed into oxamide 12 in the presence of an aqueous solution of 
acetaldehyde (Scheme 3). Subsequently, this efficient reaction found industrial application by 
forming the basis of the Degussa oxamide synthesis (Scheme 3). 
Scheme 3 
 1.3.1.  Discovery of Enzymes 
 There is no doubt that the discovery of enzymes and their functions had an important 
impact on the development of asymmetric catalytic reactions. Pasteur discovered the first 
asymmetric reaction, a decarboxylative kinetic resolution,
6
 and observed that the organism 
Penicillium glauca destroyed more rapidly one of the enantiomers, the D-form of a racemic 
solution of ammonium tartarate. Asymmetric decarboxylation reactions were re-examined 
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under non-enzymatic conditions by Breding during the early 1900s. He had an interdisciplinary 
interest as he found the chemical origin of enzyme activity in living organisms and also worked 
on decarboxylation reactions in the presence of chiral alkaloids, such as nicotine or quinidine 
and established the basic kinetic resolution equation.
7
 These experiments helped him to 
understand the chemical basis of enzyme activity in living organisms.  
 1.3.2.  Organocatalysts 
 It should be noted that the synthetic chemistry community has been revolutionized over 
the past 40 years by the advent of enantioselective catalysis.
8
 Before the last 9 years, it was 
considered that there are only two types for asymmetric catalysis, transition-metal complexes 
and enzymes. The concept of asymmetric catalysis was even synonymous with metal catalysis 
in which metals are coordinated with chiral organic ligands.
9 
There are very rare examples in 
catalysis in the last century, when chemists used small organic molecules as asymmetric 
catalysts even though some of the very first asymmetric reactions were catalyzed with purely 
organic molecules. For example in 1908 a milestone achievement was related to Haler´s work 
that led to the preparation of mandelonitrile by the addition of HCN to benzaldehyde in the 
presence of an isolated enzyme emulsion.
10
 In 1912, Bredig
11
 also reported this reaction to be 
optically accelerated in the presence of the alkaloids, quinine 13 and quinidine 5, by the 
addition of HCN to benzaldehyde.  
Scheme 4 
 In the early work usually nitrogen-containing natural products such as alkaloids, 
(strychnine, brucine and cinchona alkaloids) amino acids and oligopeptides were tested. During 
the late 1920s Vavon and Peignier in France
12
 and Wegler in Germany
13
 independently worked 
on the acylative kinetic resolution of racemic secondary alcohols with brucine and strychnine. 
Langebeck used simple amino acids or small oligopeptides for catalysis.
14
 In 1909, Dakin also 
used amino acid catalysts for Knoevenagel-type condensations.
15
 This reaction was extended to 
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aldol and related transformations in the 1930s onwards with notable success with non-
asymmetric systems. Prelog promoted the concept of asymmetric synthesis during the mid 
1950s,
16
 and in the late 1950s Pracejus reported that methyl phenyl ketene could be converted 
to (−)-α-phenyl methylpropionate in 74% ee by using O-acetylquinine as a catalyst17 as shown 
in Scheme 5. 
Scheme 5 
 Bergson and Langstrom reported the first Michael addition of β-keto esters to acrolein 
using 2-(hydroxymethyl)-quinuclidine as a catalyst.
18
 This result inspired others to investigate 
cinchona catalyst system for other reactions. Although they did not determine the enantiomeric 
excess, they noted the optical activity of their products. Wynberg and co-workers showed this 
class of alkaloids to be a versatile catalyst, promoting a variety of 1,2- and 1,4-additions of a 
wide range of nucleophiles to carbonyl compounds.
19
 
Scheme 6 
 The L-proline-mediated asymmetric Robinson annulation reported during the early 
1970s was another key event in the history of organocatalytic reactions and received a 
considerable synthetic and mechanistic interest.
20
 It was demonstrated that other amino acids, 
such as (R)-phenylalanine, could replace in some cases advantageously L-proline.
21
 An earlier 
application of organocatalysts in total synthesis was in Woodward’s synthesis of erythromycin 
17 from the racemic keto aldehyde 15 (Scheme 6).
22
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 Further breakthroughs in enantioselective transformations were achieved in 1971 by the 
discovery of the Hajos–Parrish–Eder–Sauer–Wiechert reaction (Scheme 7). This reaction leads 
to the formation of the unsaturated Wieland–Miescher ketone 19, an important intermediate in 
steroid synthesis.
23
 Surprisingly, until 2000 the catalytic potential of proline in asymmetric 
aldol reactions was not further explored. Then pioneering studies in intermolecular aldol 
reactions were carried out by List et al.
24
 
Scheme 7 
 More general efficient organocatalytic reactions were developed in the late 1970s and 
early 1980s, when Julia et al. discovered that poly-amino acid 20 catalyzed the epoxidation of 
chalcones by alkaline hydrogen peroxide (Scheme 7).
25
 Inoue et al. reported in 1981 that cyclic 
peptide 23 and L-phenylalanine catalyzed the addition of HCN to benzaldehyde with up to 90% 
ee (Scheme 7).
26
 This finding initiated intensive research in the field of peptide-catalyzed 
additions of nucleophiles to aldehydes and imines. Asymmetric phase-transfer reactions were 
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explored in the mid-1980s, when researchers at Merck reported the alkylation of substituted 2-
phenyl-1-indanone systems in the presence of catalytic amounts of substituted N-
benzylcinchonium halides (50% NaOH/toluene) with remarkably high enantioselectivities with 
up to 94%.
27
 
 During the late 1990s reinvestigation of the Hajos–Parrish–Eder–Sauer–Wiechert 
reaction by List and Barbas also opened an avenue for a number of related transformations 
such as the enantioselective intermolecular cross-aldol reaction, Mannich-, Michael- and 
Diels–Alder-type transformations, and the application of these transformations in multistep 
(domino) reactions.
28
 
 1.4.  Advantages of Organocatalysis 
 Organocatalysis has several significant advantages over conventional metal catalysis. 
Till now there is not much information available about the toxicity of many organic catalysts; 
however, the particular importance of these catalysts is that they mostly tolerate water and air, 
and also provide a significant advantage in terms of operational simplicity as compared to 
metal catalyzed reactions.
29
 Moreover, there is no risk of metal leakage in immobilized systems 
and expensive recovery processes for waste treatment are not required. Therefore, nowadays, 
their industrial applications are increased and their environmental friendly ‘‘green’’ aspects 
and the sustainability of the catalysts have replaced some standard metal-based catalyzed 
reactions.
30
 Organocatalytic methods are especially attractive for the preparation of compounds 
that do not tolerate metal contamination such as pharmaceutical and agrochemical products.  
  1.5.  Classes of Organocatalysts 
 There is no general rule for the classification of organocatalysts. Below are some 
classifications outlined. 
 Biomolecules or Synthetic Organocatalysts: 
 Biomolecules as organocatalysts: For example proline, phenylalanine, the 
  cinchona alkaloids, and certain oligopeptides. 
 Synthetic organocatalysts: catalysts derived from biomolecules, carbenes, 
  triazolium salts and phosphorus compounds. 
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 Interaction Types: 
 Covalent Organocatalysis  
 Non-Covalent Organocatalysis: Hydrogen bonding catalysts, including  
  TADDOLS, derivatives of BINOL and thiourea based organocatalysts.  
 Mechanism of Catalysis:
31
 
 Lewis Base 
 Lewis Acid 
 Brønsted Base  
 Brønsted Acid  
 1.6.  Biomolecules and Their Synthetic Derivatives 
 1.6.1.  Proline 
Scheme 8 
 The most famous organocatalyst is proline. Although the natural L-form is commonly 
used for catalysis, its D-form is also easily available, being an advantage as compared to 
enzymatic catalysts.
32
 Proline is the only natural secondary amino acid. It contains a rigid ring 
structure and has a higher pKa than other amino acids. Therefore it is more nucleophilic in 
comparison. Proline is a bifunctional catalyst since it is able to act as a nucleophile, in 
particular with carbonyl compounds or Michael acceptors to form either an iminium ion or 
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enamine, and since its carboxylic function acts as a Brønsted acid. Enantioselectivities of 
proline-mediated reactions are often high. This can be rationalized by highly organized 
transition states of an extensive hydrogen-bonding network.
33
 In order to overcome its 
shortcomings and enhance its scope extensive research was done for the development of 
proline based bioactive compounds, ligands, and organocatalysts.
34
 Scheme 8 represents some 
recent examples.
35
 
 1.6.2.  Cinchona Alkaloids 
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Scheme 9 
 A catalyst is more efficient, if it is catalyzing a variety of reactions, it is stable and its 
both enantiomers are readily available for a reasonable price. These entire criteria are fulfilled 
for cinchona alkaloids,
36
 which makes them one of the most used catalysts to date.
37
 Cinchona 
alkaloids consist of two pseudoenantiomeric pairs, including cinchonine 24, cinchonidine 25, 
quinine 13 and quinidine 5. The term pseudoenantiometric is used, because the molecules are 
not enantiomers but their properties are of enantiomeric nature. The key structural features are 
responsible for their synthetic utility. The features are the tertiary quinuclidine nitrogen (Lewis 
basic), and the proximal polar hydroxyl function (Brønsted acid). They can act as bifunctional 
catalysts.  
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 1.6.2.1. Application of Cinchona Alkaloids  
Scheme 10 
 One of the earliest uses of cinchona alkaloids in asymmetric catalysis was demonstrated 
by Pracejus in the asymmetric alcoholysis of ketenes (Scheme 5). On the basis of these initial 
studies, Wynberg later discovered the [2+2] cycloaddition of ketenes to polychlorinated 
aldehydes to yield β-lactones in high enantioselectivity (98% ee) and yield (89%).19 Another 
key event of cinchona based catalyst in synthesis was its application as dimer ligand for the 
asymmetric dihydroxylation of simple olefins.
38
 These results inspired other researchers to 
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derivatize them. In fact, now there are a large number of various cinchona derivatives, which 
offer very high levels of selectivity over a wide range of reactions. 
 There have been many publications describing the use of cinchona-ketene systems for 
asymmetric synthesis.
39
 Romo reported a catalytic asymmetric synthesis of bicyclic lactones 
via the intramolecular, Lewis base-catalyzed, aldol lactonization (70−82% yield and 91−98% 
ee).
40
 Oda was the first who demonstrated that cinchona alkaloids could be used for a 
desymmetrization and got moderate enantioselectivities. Deng optimized this reaction for many 
different substrates and found (DHQD) 2AQN 30 as an optimal catalyst (74-99 % yields, 90-98 
% ee).
41
 As a recent example Deng reported a bifunctional cinchona analogue as a highly 
enantioselective catalysts for the 1,4-addition reaction of thiols to cyclic enones.
42
 Seidel 
reported the synthesis of vicinal diamines by a quinidine derived bifunctional catalyst 29 
(Scheme 10).
43
 
 1.7.  Carbenes as Organocatalysts 
 Carbenes are neutral and possess a divalent carbon atom with a sextet of electrons and 
have a rich utility as efficient organocatalysts
44
 and ligands for complexes of transition
 
metals.
45
 Doering and Fischer are pioneer investigators in carbene chemistry.
46
 For a long time 
carbenes were considered only as fleeting intermediates. The major breakthrough in carbene 
chemistry was made by Bertrand and Arduengo with the synthesis of distillable 
phosphinosilylcarbene 31
47
 and the isolation of crystalline imidazol-2-ylidene 32
48
 in 1988 and 
1991, respectively (Scheme 11). They are stabilized by two heteroatoms interacting with the 
carbene center. The stabilities of 31 and 32 have opened a new, rapidly developing area in 
carbene chemistry.
49
 Due to these results numerous research groups from all over the world are 
actively working in this field. Some general structures of carbenes are shown in Scheme 12. So 
far the most studied members of the carbene family are N-heterocyclic carbenes (NHCs).
50
 
They are used frequently in metal free catalyzed processes as alternatives to classical organic 
transformations with the advantages of being more economical and environmentally friendly. 
Scheme 11 
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Scheme 12 
 N-Heterocyclic carbenes catalyze reactions as Lewis-base organic catalysts. NHCs have 
the ability to activate a variety of carbonyl compounds via Umpolung to homoenolates or 
Breslow intermediates, which allow the addition of a variety of different electrophiles to 
carbonyl and Michael system. This gives unconventional methods for traditional bond forming 
reactions. In the beginning, the use of N-heterocyclic carbenes in organocatalysis was limited 
to benzoin-type reactions. To date there are many other reactions catalyzed by carbenes being 
developed rapidly as new areas of exploration. Examples are [2+2], [3+2], [3+3] cycloaddition 
reactions, ring opening of smaller rings, enantioselective synthesis of lactones, lactams, 
Umpolung reactions of aldehydes and Michael acceptors, aza-Morita-Baylis-Hillman reactions 
and the addition of silylated nucleophiles.
51
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 1.7.1.  Benzoin Condensation 
 The carbene catalyzed benzoin condensation as well as its synthetic, mechanistic and 
catalytic aspects have been widely examined.
52
 The first research on the asymmetric benzoin 
condensation was presented by Sheehan et al. in 1966 employing the chiral thiazolium salt 33 
as the catalyst precursor.
53
 However, he observed an enantiomeric excess of only 2%. It was 
shown early in 1943 by Ugai et al. that naturally occurring thiamine 34 catalyzes the self-
condensation of benzaldehyde to produce benzoin (Scheme 14).
54
 
ee
42
Scheme 14 
Scheme 15 
 Bach et al. used the axially chiral N-arylthiazolium 35 for benzoin and Stetter 
reactions.
55
 Even though the yields and ee values were low (up to 40–50%) axial chirality was 
introduced as a new approach for these catalysts. In 2006, the asymmetric intramolecular cross-
benzoin reaction for α-hydroxyketones 36 was reported by Enders and Suzuki independently 
with good to high yields and enantioselectivities.
56
 Some representative examples are shown in 
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Scheme 15. It is worth noting that triazolium salts proved superior to the thiazolium framework 
for the asymmetric induction in the benzoin condensation. This condensation can also be 
catalyzed via electrolysis of simple commercially available organic ionic liquids [bmim]Br 
(butylmethylimidazolium bromide) and [emim]Br (ethylmethylimidazolium bromide).
57
 
 1.7.2.  Stetter Reaction 
Scheme 16 
 The Stetter reaction is the 1,4-addition (conjugate addition) of an aldehyde to an α,β-
unsaturated compound. For the stereoselective Stetter reaction various chiral catalysts have 
been developed over the past four decades. Carbenes catalyzed this reaction by the formation 
of a Breslow intermediate with an aldehyde.
58
 The first asymmetric Stetter reaction was 
reported in 1996 by Enders and co-workers. Instead of using previously reported thiazolium 
salts they used triazolium salt 41.
59
 Rovis et al. obtained a better asymmetric induction by 
using triazolium catalysts, in which the chiral group was fused to a second ring (42-43).
60
 
Miller used thiazolium-containing peptide 44 and obtained a moderate selectivity. Tomioka 
catalyzed the Stetter reaction with a C2-symmetric chiral imidazolium salt achieving an 
enantioselectivity of 80%.
61
 Recently, Rovis
62
 also reported a highly enantioselective and 
diastereoselective intermolecular Stetter reaction of glyoxamide and alkylidene ketoamides 
with triazolinylidene carbene precursor 43. 
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 1.7.3.  Generation of Homoenolates 
Scheme 17 
 The generation of conjugated homoenolates is a novel aspect of carbene chemistry. 
They are generated in situ from α, β-unsaturated aldehydes (Scheme 13) leading to 
unprecedented results. In 2004 Glorius
63
 and Bode
64
 independently reported a successful 
application of a conjugated homoenolate to form γ-butyrolactones from the conjugated enals 
and aromatic aldehydes. Fu et al. reported in 2006 that α,β-unsaturated esters are suitable 
precursors for the generation of homoenolates.
65
 In 2008 Scheidt reported that chiral N-
heterocyclic carbenes catalyzed highly diastereoselective and enantioselective [3+3] additions 
of homoenolates to nitrones delivering γ-amino ester derivatives in up to 93% ee.66 
 1.7.4.  [2+2] Cycloaddition 
Scheme 18 
 Ye
67
 and Smith
68
 independently reported in 2008 that chiral N-heterocyclic carbenes 
(NHC) are efficient catalysts for the formal [2+2] cycloaddition of ketenes with imines. Chiral 
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NHCs react with disubstituted ketenes in a similar manner as nucleophilic tertiary amines and 
form zwitterionic ketene enolates. This ketene enolate intermediate reacts with an imine to give 
the corresponding chiral trisubstituted β-lactam. 
Scheme 19a 
 Similarly, Ye also reported in 2008
69
 and 2009
70
 chiral N-heterocyclic carbenes as 
efficient catalysts for the synthesis of trisubstituted and tetrasubstituted β-lactones (Wynberg 
reaction) by the reaction of ketenes with 2-oxoaldehydes (Scheme 19a) and trifluoromethyl 
ketones, respectively (Scheme 19b). 
1
2
3
3
ee
2
12 3
Scheme 19b 
 1.7.5.  Carbene Based Chiral Ionic Liquids 
Scheme 20 
1. Introduction 
 
 
16 
 A. D. Headley developed in 2007 the pyrrolidine based chiral task specific ionic liquid 
49a, which was catalyzing a Michael addition reaction of aldehydes and nitrostyrenes with 
moderate yields (up to 64%), good enantioselectivities (up to 82% ee) and high 
diastereoselectivities (syn/anti ratio up to 97 : 3). Moreover the chiral pyrrolidine catalyst was 
easily recycled without loss of activity (Scheme 20).
71
 
 1.8.  Interaction Types 
 Reactions catalyzed by organocatalysts are normally carried out either by much 
‘‘tighter’’ or a much ‘‘looser’’ transition structures as compared to chiral metal complex-
mediated reactions.
72
 
 1.8.1.  Covalent Catalysis 
 Many of the reactions catalyzed by organocatalysts proceed via a covalent bonded 
catalytic adduct as an activated complex. Typical examples include the formation of enamines, 
iminium intermediates and carbene-mediated reactions. For most of the above mentioned 
reactions chiral amine based catalyst, formed from amino acids, peptides, alkaloids and 
synthetic nitrogen containing molecules, were employed. 
 1.8.2.  Non-Covalent Organocatalysis 
 Organocatalysis through weak interaction is called non covalent organocatalysis. The 
active complex between a catalyst and a substrate is a neutral host guest complex, or acid base 
association. Typical examples are hydrogen bond catalysts by weak acid-base chiral complexes 
and by cation-anion association under homogeneous and phase-transfer conditions.
73
 
 1.9.  Classification Based on the Mechanism of Catalysis 
 According to List the majority of organocatalysts can be largely classified as Lewis 
bases, Lewis acids (LB or LA), Brønsted bases, and Brønsted acids (BB or BA).
33
 Lewis base 
catalysts (B:) start the catalytic cycle via a nucleophilic addition to the substrate (S), Lewis acid 
catalysts (A) activate nucleophilic substrates (S:). Brønsted base and acid catalytic cycles are 
initiated via a (partial) deprotonation or protonation, respectively. The resulting complex 
undergoes a reaction and releases then the product and the catalyst for a further turnover. In 
acid/base catalysis usually both (Lewis and Brønsted) modes of interaction occur within a 
bifunctional catalyst. These catalysts are also classified as Lewis acid/Lewis base (LALB), 
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Lewis acid/Brønsted acid (LABA), Lewis acid/Brønsted base (LABB) and Brønsted 
acid/Brønsted base (BABB) types. 
 1.9.1.  Lewis Acid Organocatalysts 
 Lewis acids are considered to be species with a vacant orbital. Metal salts like 
aluminium chloride, titanium chloride, zinc chloride and others usually stand as Lewis acid 
catalysts. However, there are many compounds with carbenium, silyl or phosphonium cations, 
hypervalent phosphorus and silicon atoms, iodine or boron atoms and compounds based on 
ionic liquids, which show Lewis acid catalytic activity. 
 1.9.1.1. Silyl Cation Based Catalysts  
 There are many examples in the literature of silicon based Lewis acids such as 
Me3SiOTf, Me3SiNTf2 or Me3SiClO4, which are catalyzing achiral reactions.
74
 In 1998, the 
groups of Jørgensen and Helmchen reported the first chiral silyl cationic salt 50a.
75
 The salt 
50a catalyzed a Diels-Alder reaction as well as an aza-Diels-Alder reaction. Ghosez reported 
enantiopure silicon based catalysts 51-55.
76
 These salts, prepared in situ, were tested for the 
Diels-Alder reaction of cyclopentadiene and methyl acrylate (Scheme 21). 
Scheme 21 
 1.9.1.2. Hypervalent Silicon Based Catalysts 
 Chiral Lewis bases react with silicon containing reagents to form Lewis acid centers, 
which can activate a substrate. This is because silicon has the capacity to expand its valence 
shell. There is an avenue that chiral Lewis bases interact with vacant orbitals of silicon and 
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increase the electron density of the most labile ligand, so that the ligand is ionized and a 
positively charged silicon complex is formed, which is a strong Lewis acid, responsible for 
many organic transformations (Scheme 22).
77
  
Scheme 22 
 1.9.1.3. Asymmetric Allylation 
Scheme 23 
 Homoallylic alcohols can be easily converted to a number of other useful functions. 
The asymmetric allylation of carbonyl compounds with an allylating agent leads to homoallylic 
alcohols having two consecutive stereocentres along with a carbon-carbon bond formation. The 
traditional method for this is the use of a Lewis acid that activates the electrophilic aldehyde 
towards nucleophilic attack of an ally metal reagent.
78
 However, there is a lack of 
diastereoselectivity because of a non rigid transition state during the reaction. In contrast, the 
chiral Lewis base catalyzed allylation provides a dual activation, which involves binding of a 
Lewis base with a nucleophile (trichlorolsilane), thus generating a reactive hypercoordinated 
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silicone species, which further coordinates with an aldehydes. As a result a close assembly of 
allyltrichlorosilane, aldehyde and the chiral Lewis base provides a high degree of 
diastereoselectivity and enantioselectivity. 
 Denmark and co-workers and the Barret group developed chiral Lewis bases e.g. chiral 
phosphoramides and 2-(2-pyridinyl)-2-oxazolines, respectively. Stoichiometric amounts of 
these chiral Lewis bases were required to promote a complete stereochemical correlation 
between the geometry (E/Z) of the allylsilane and the diastereomeric ratio (syn/anti) of the 
products. 
Scheme 24 
 In 1996, Iseki and Kobayashi developed a catalytic version for the asymmetric 
allylation.
79
 They used proline-based chiral HMPA derivative 56. Later Malkov and 
Kocovsky
80
 applied 57 and 58, Hayashi et al.
81
 59 and Hoveyda and Snapper
82
 60 as catalysts 
for the allylation. Mechanistic analysis suggests that the N-oxide activates the trichlorolsilane 
functionality and the other nitrogen atoms stabilize the complex by chelation. Thus leading to a 
closed chair like transition state shown in Scheme 25. As compared to P(O) or N(O) catalysts, 
there are very rare cases, where chiral sulfoxides are used for catalysis. Massa
83
 and Barness
84
 
synthesized chiral sulfoxide catalysts 61 and 62, respectively. Most of the work on asymmetric 
allylation has been done on aromatic and heteroaromatic aldehydes, because both, the reaction 
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rate and the enantioselectivity decrease with non-conjugated aldehydes. Iseki et al. also 
reported 63 to be a highly enantioselective catalyst for aliphatic and non-conjugated aldehydes 
(Scheme 24).
85
 
Scheme 25 
 It is accepted that the Lewis acidity of silicon, as well as its high tendency to expand its 
valence shell increases,
86
 when it is tetravalent and it is incorporated into strained 4 or 5- 
membered ring systems (strain- release Lewis acidity).
87
 This is due to a smaller energy gap 
between the sp
3
 and dsp
3
 orbitals of a strained system compared to an acyclic species. Leighton 
has combined this concept of strain silacycles with the asymmetric allylation chemistry and 
reported this in series of publications.
88
 He also extended the scope to the allylation of 
aldimines and ketimines.
89
 
Scheme 26 
 1.9.1.4. Asymmetric Aldol Reactions 
 The bond cleavage of silyl enol ethers (O-Si), its structure and its mode of action 
resemble very much that of allylsilanes (C-Si). That is why Lewis base catalyzed aldol 
reactions of silyl enol ethers have also been extensively studied. The first example of a Lewis 
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base catalyzed asymmetric aldol reaction of trichlorosilyl enol ether with a chiral 
phosphoramide
90
 was reported in 1996 by Denmark et al. (Scheme 27). 
Scheme 27 
 1.9.1.5. Asymmetric Reduction 
 The asymmetric reduction of ketones and imines was reported by Matsumura and co-
workers by using trichlorosilane as reductant and the N-formylate pyrrolidine derivative 50 as a 
catalyst.
91
 Later Makov and Kocovsky reported an N-methyl L-valine derivative 51
92
 and Suna 
et al. reported S-chiral bissulfinamides 52 as highly enantioselective organocatalysts for the 
reduction of ketimines.
93
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 1.9.1.6 Asymmetric Ring Opening Reaction 
 The halide ring-opening of epoxides with tetrachlorosilane leads to chlorinated alcohols 
and is a successful method for the desymmetrization of epoxides. Denmark
94
 in addition 
reported chiral phosphoramide 53 and Hashimoto reported N-oxide 54
95
 and 55
96
 as good 
catalysts for the asymmetric ring opening reaction of epoxides and the synthesis of 
chlorohydrins, which were obtained in good yields and selectivity (Scheme 29). 
Scheme 29 
 1.9.1.7. Friedel-Craft Alkylation
Scheme 30a 
 Extending the application of strained silacycle reagents, Leighton et al. have described 
a method for the enantioselective Friedel-Crafts alkylation with benzoylhydrazones catalyzed 
by an extraordinarily simple chiral silane Lewis acid 56. The features of this chiral silane are: It 
can be prepared in bulk in a single step from (S, S or R, R) pseudoephedrine and PhSiCl3 and 
after employing it in a reaction, pseudoephedrine can be recovered in near quantitative yield. 
The best example is shown in Scheme 30 with 92% yield and 90% ee.
97
 The catalyst works 
well with heteroarenes too. A simple and most plausible model for the enantioselectivity of the 
Friedel-Crafts reaction is shown below. It is clear from the model that the arene would 
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approach from the front (Si) face, while the back (Re) face is blocked by the phenyl group 
present on the silicon atom. 
 Scheme 30b 
 1.9.1.8. Cycloaddition Reactions 
 Inspired by their previous results, Leighton also reported an enantioselective [3+2] 
acylhydrazone-enol ether cycloaddition reaction by employing the same pseudoephedrine 
based chiral silane 56. The best results were obtained with tert-butyl vinyl ether.
98
 
Scheme 31 
 The chiral ligand (ephedrine-derived amino phenol 57) carrying three functional groups 
for attachment to the silane proved to be a good ligand for the silane catalyst 58 in the 
cycloaddition reaction of enals with cyclopentadiene. The catalyst was generated in situ by 
treatment of 57 with SiCl4 and DBU.
99
 Simple changes to a sulphonamide group and a 
substituent on phenols produced a dramatic effect on the enantioselectivity. They also proved 
that a 5-membered strained ring is an essential component of the chiral Lewis acidity and that 
silane 59 being a 6-membered strain free species showed no catalytic activity under identical 
reaction conditions. 
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Scheme 32 
 1.9.1.9. Chalcogenide-Morita-Baylis-Hillman Reactions 
 The chalcogenide catalyzed Morita-Baylis-Hillman reaction was developed by Kataoka 
and co-workers by employing a sulfide and TiCl4 for dual Lewis acid-base activation. Later, in 
1996 the ability of the combination of sulfide/TBDMSOTf to promote the reaction was 
reported.
100
 The asymmetric version of this Baylis-Hillman reaction has been achieved by 
using chiral sulfide 60 in place of SMe2. The best ee was 94% in combination with a high yield 
of 88%.
101
 
Scheme 33 
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 1.10.  Phosphonium salts as Lewis Acid and Phase Transfer  
   Catalysts 
Scheme 34 
 Phosphonium salts also have the ability of hypervalent bonding with Lewis basic 
substrates resulting in a Lewis acidic catalyst (Scheme 34).
102
 It is possible for the lower lying 
σ* orbital of the phosphonium salts to interact with an electron withdrawing group and 
nonbonding ion pair of the Lewis base, achieving a hypervalent state,
103
 which is stabilized 
with electron-withdrawing substituents. 
Scheme 35 
 There are many fundamental reactions in organic synthesis such as C-C, C-O and C-N 
bond formations, catalyzed by phosphonium salts. They are also well recognized as phase-
transfer catalysts. Chiral phosphonium salts are used as catalysts.
104
 Recently, Maruoka et al. 
synthesized highly enantioselective β-keto esters by employing binaphthyl modified quaternary 
phosphonium salts 61 and 62 and applied them as a phase transfer catalysts.
105
 
 1.11.  Carbocation Based Catalysts 
 In order to expand the scope of Lewis acid catalysts, several organic salts were used as 
catalysts but there are very few examples in which carbocations were used as the 
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organocatalysts, compared to related silyl salts. The trityl perchlorate 63 represents an 
application of a carbenium catalyst in Mukaiyama aldol-type reactions and Michael 
transformations.
106
 Chen introduced the dibenzosuberone-derived salt 64 as a catalyst in the 
reaction of TBS ketene acetal with aldehyde.
107
 The chiral trityl salt 65, also introduced by 
Chen,
108
 brought clearness to a certain extent in the understanding of the mechanism of this 
catalysis. The enantioenriched product indicated a silyl-mediated catalysis accompanied by a 
carbenium-promoting catalysis. The key requisite for the enantioselective aldol-type addition 
was the rigid conformation of the carbenium catalyst. 
Scheme 36 
 There are a lot of examples in which carbenium ions act as hydride abstractor or one-
electron oxidant.
109
 By exploiting this feature, carbenium ion 66 was reported to abstract exo-
hydrogen enantioselectively as shown in Scheme 37.
110
 
Scheme 37 
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  1.12.  Ammonium Salt Based Phase Transfer Catalyst 
 Phase transfer catalysts are also an important class of organic catalysts. The Merck 
group reported the first efficient chiral phase-transfer catalyst, N-benzyl-cinchoninium salt 67, 
for the asymmetric α-methylation of indanone 72 in 95% yield and 92% ee.111 O’Donnel et 
al.
112
 used 67 for the α-alkylation of protected glycine derivative 73 to furnish α-amino acids 
enantioselectively. Lygo and Corey reported N-anthracenyl-cinchonidinium salts 69 and 70 
independently for the α-alkylation of glycine derivatives with high asymmetric inductions (up 
to 99%).
113
 The C2-symmetric chiral spiro ammonium salt 71 was a highly efficient and 
enantioselective catalyst for α-alkylations, aldol and Michael reactions. It was synthesized by 
Maruoka and co-workers from commercially available (S)- or (R)-1,1´-bi-2-naphthol.
114
 
Scheme 38 
Scheme 39a 
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Scheme 39b 
 1.13.  Brønsted Acid and Hydrogen Bond Catalysis  
 Brønsted acid and hydrogen bond catalysis is also growing area of organocatalysis. 
During the reaction a C-X bond (X = O, NR, CR2) is activated. The proton represents the 
smallest element of a Lewis acid. There is no clear boundary line between Brønsted acid and 
hydrogen bond catalysis. Carbonyl compounds or imines can be activated by three ways (1) 
double hydrogen bonding, (2) single hydrogen bonding, (3) or chiral Brønsted acid catalysis.  
Scheme 40 
 Chiral metal Lewis acid catalysts are often prepared in situ from a chiral ligand in 
contrast to chiral Brønsted acid catalysts, which are directly used as small organic molecules. 
Brønsted acids have some advantages over Lewis acids. They are easy to handle and generally 
stable towards oxygen and water and so storable for a long period of time and they are more 
environmental friendly and applicable to large-scale synthesis. There are two main categories 
of chiral Brønsted acid catalysis: 
 Neutral Brønsted acids, hydrogen-bonding catalysts (thiourea and TADDOL) 
 Stronger Brønsted acid catalysts 
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 1.13.1. Neutral Brønsted Acids 
 Thiourea and TADDOL are general examples for neutral Brønsted acid catalysts, which 
are activating a substrate via hydrogen bonding. Thiourea catalysts are further divided as 
monofunctional thiourea and bifunctional thiourea catalysts. In 1994 Curran et al. reported a 
good stereoselectivity in allylation reactions of cyclic α-sulfinyl radicals by the use of a urea 
derivative.
115
 Later Jacobsen et al. described a parallel-library approach to thiourea derivatives. 
The catalyst 74 was giving a high enantioselectivity in the hydrocyanation of imines
116
 75 gave 
in an asymmetric Mannich-type reaction up to 98% ee
117
 and 76 in a hydrophosphonylation of 
imines up to 98% ee.
118
 
Scheme 41 
 1.13.2. Bifunctional Thiourea Catalysts 
Scheme 42 
1. Introduction 
 
 
30 
 Takemoto et al. developed the novel bifunctional thiourea 77, bearing a tertiary amine 
moiety, that catalyzed the Michael reaction (81-93% ee), the aza-Henry reaction (63–75% ee), 
and the asymmetric hydrazination of 1,3-dicarbonyl compounds (80–91% ee). The bifunctional 
thiourea catalyst has a dual mode of activation and the amino group of the thiourea acts as a 
hydrogen bond donor or Brønsted acid site and the other amino group of the cyclohexyl ring 
acts as a Brønsted base site. Since Takemoto bifunctional thiourea catalyst is quite effective, a 
number of bifunctional catalysts bearing a thiourea moiety have appeared in the literature as 
shown in Scheme 43.
119
  
3
3
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Scheme 43 
 Jacobsen et al. reported catalyst 78 for the oxocarbenium ion addition to acetal in up to 
97% ee
120
 and 79 for the catalytic Protio-Pictet-Spengler reaction in up to 99% ee.
121
 Zhou et 
al. introduced thiourea catalyst 80 for the enantioselective aza-Henry reaction in up to 99% 
ee
122
 and Seidel reported 28 for the asymmetric Michael addition of thiols to cyclic enones in 
96% ee.  
 1.13.3. TADDOL Derivatives 
 Rawal et al. reported the simple diol 81 (TADDOL) as a highly selective chiral catalyst 
for a hetero-Diels-Alder reaction.
123
 Ding et al. used the same catalyst for the hetero-Diels-
Alder reaction of an aldehyde with Brassards diene affording γ-lactone derivatives with high 
enantioselectivity (Scheme 44).
124
 Yamamoto et al. extended the scope of the catalyst and used 
81 for the regio- and enantioselective nitroso aldol reaction (65-91% ee) and also found that 
glycolic acid derivative 82 furnished O-nitroso aldol products in 70–93% ee (Scheme 44).
125
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Scheme 44 
 Yamamoto and Rawal also synthesized axially chiral 1,1’-biaryl-2,2’-dimethanol 83, 
(BAMOL) as a highly selective catalyst for hetero-Diels–Alder reactions for a range of 
aliphatic and aromatic aldehydes with aminosiloxydienes to give the cycloadducts in 84–99% 
ee.
126
 They also obtained an X-ray structure of an inclusion complex of 2,2-
bis(diphenylhydroxymethyl)-binaphthylene and benzaldehyde. The X-ray reveals that there is 
an intramolecular hydrogen bond between the two hydroxyls and a 1:1 association between 
BAMOL and benzaldehyde. Therefore, it is postulated that there is a single-point hydrogen 
bond interaction in TADDOL catalysis (Scheme 45).  
Scheme 45 
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 1.13.4. Binaphthol Derivatives 
Scheme 46 
 Binaphthol derivatives act as weakly acidic chiral Brønsted acids. A few representatives 
of BINOL catalysts are shown in Scheme 46. The Morita-Baylis-Hillman reaction was 
catalyzed for a range of aliphatic aldehydes by BINOL derivative 85 in the presence of a 
stoichiometric amount of PEt3 (67-96% ee).
127
 Sasai and co-workers used bifunctional BINOL 
derived 86 for the aza Morita-Baylis-Hillman reaction and obtained excellent 
enantioselectivities (87-94%).
128
 The enamine Mannich reaction was catalyzed with diol 87 in 
84% ee. Ishihara and co-workers used the chiral Brønsted-acid catalyst 88, bearing a bis(triflyl) 
methyl group, for the enantioselective Mannich-type reaction of a ketene silyl acetal with 
aldimines obtaining high yields and good enantiomeric excesses 62-77% ee.
129
  
 1.13.5. Ammonium Salts as Brønsted Acids 
2
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Scheme 47 
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 Ammonium based salt 89, derived from cyclohexane, a diamine and quinoline, was 
reported by Johnston et al. for an aza-Henry reaction with up to 90% ee.
130
 The pKa value of 89 
is 5.78 measured with Perrin titration, so it is not acidic enough to protonate the imine. 
Therefore, it acts as a hydrogen bond catalyst.
131
 Later they extended the scope of chiral proton 
catalysts by synthesizing unsymmetrical bis-(amidine) complex 91 for the highly anti-
diastereoselective and enantioselective synthesis of glycine equivalents by the addition of 
nitroacetate to azomethines. They recently also reported a derivative of 91 for the synthesis of 
amino acid equivalents.
132
 
 1.13.6. Phosphoric Acids 
Scheme 48 
 Chiral phosphoric acids are stronger Brønsted acids. A well known example is the 
chiral cyclic (R)-BINOL derived phosphoric acid diester 92 containing a Brønsted-acidic and 
Lewis-basic site. It is acting as a bifunctional catalyst. In the beginning it was conventionally 
used as a chiral resolving agent and as a ligand in metal catalysis. In 2004 Akiyama et al. 
reported 92a as a chiral Brønsted acid catalyst for a Mannich-type reaction of ketene silyl 
acetal with aldimines with high selectivity.
133
 The aryl group in the 3,3` position should be 
substituted for high enantioselectivity. They used 92b and 92c for the hydrophosphorylation of 
aldimines and the aza-Diels–Alder reaction, respectively.
134
 Recently, they also reported that 
phosphoric acid 92c is catalyzing the enantioselective reduction of imines to amines with 
excellent enantioselectivities.
135
 Terada used 92d, 92e and 92f, Rueping employed 21b, List 
utilized 21c (1 mol%) and MacMillan 21g as enantioselective catalysts.
136
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 Chiral aziridines are significant intermediates for optically pure amines, α-amino acids, 
amino alcohols, diamines, and a variety of other amino compounds. Recently, their syntheses 
were reported by Akiyama et al.
137
 and Zhong et al.
138
 independently, applying chiral 
phosphoric acids 92h and 92f. 
Scheme 49 
 Chiral phosphoric acids are not only derived from BINOL. A TADDOL-based 
phosphoric acid diester 93 was developed by Akiyama et al. for a Mannich-type reaction.
139
 
 1.13.7. Charged Brønsted Acid 
 The majority of chiral Brønsted acid catalysts are neutral compounds.
140
 Recently Ooi 
et al. introduced a new class of charged Brønsted acids (CBA) for the activation of non-ionic 
Lewis bases. They applied their catalysts in an aza-Michael reaction (Scheme 50).
141
 
Scheme 50 
 There are very few examples of purely organic bases catalyzing the Henry reaction as 
compared to metal based catalytic methods in the last few years.
142
 In most cases the best 
results are achieved by employing cinchona derived ambifunctional catalysts, quinidine and 
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quinine-derived thioureas.
143
 Recently, Ooi and co-workers reported a Henry reaction, 
catalyzed by a chiral P-spiro-tetraaminophosphonium salt 105 
144
 in up to 97% ee. 
Scheme 51 
 The catalyst works well for aliphatic and aromatic aldehydes even at a low catalyst 
loading of 1 mol% with longer reaction time. The authors proposed that a 
triaminoiminophosphorane is generated in situ from 105 with 
t
BuOK abstracting a proton from 
a nitroalkane. The nitronate anions are bidentate hydrogen-bonding acceptors. It formed an ion-
pair 107, which was added to aldehydes in a highly stereoselective manner. The postulated 
intermediate was also supported to some extent by NMR studies. 
Scheme 52 
 Organic ion pair catalysis is also a growing class of catalysis, which is predominantly 
based on chiral nonracemic onium salts. The cation is more important in controlling reactivity 
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and selectivity, while the anion is important for neutralization of the charge in the chiral 
quaternary onium salt catalysis. There are several types of reaction modifications, in which the 
cationic moiety has a great influence on selectivity. Particular in a phase-transfer-catalyzed 
mechanism.
145
 Ooi also reported the chiral tetraaminophosphonium carboxylate 108 with 
functional anions for the direct Mannich-type reaction of azlactones with a 2 mol% catalyst 
loading in up to 96% ee.
146
 
Scheme 53 
 In the catalytic cycle the active methine proton of azlactone is abstracted by a basic 
carboxylate anion to furnish the subsequent chiral phosphonium enolate anion, which develops 
the ion pair assembly with a distinct hydrogen bonding network 109. A successive 
stereoselective bond formation with the imine affords phosphonium sulfonamide 110, which 
abstracts a proton from the carboxylic acid to regenerate the chiral phosphonium carboxylate. 
Scheme 54 
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 1.14.  Lewis Base Catalysis 
 Ligands with electron pair donor atoms like N, O, P, C and S are Lewis bases. These 
electron donor bases are used as ligands in metal catalysis and also as Lewis base 
organocatalysts. Lewis base catalysts convert the substrates either into activated nucleophiles 
or electrophiles. Typical reactive intermediates for this catalysis are iminium ions, enamines, 
acyl ammonium ions, 1-,2-,3-ammonium enolates, carbenes and S-ylides etc. (Scheme 55). 
Scheme 55 
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 1.14.1. Iminium Catalysis 
 In this catalysis the activated species is an iminium ion formed between an amine 
catalyst and a carbonyl substrate in a reversible manner. Reactions involving this intermediate 
are Knoevenagel condensations, Diels–Alder reactions
147
 1,3-dipolar cycloadditions of nitrones 
148
 Friedel–Crafts alkylations,
149
 Michael additions of malonates
150
 and nitroalkanes.
151,152
  
 1.14.2. Enamine Catalysis 
 The enamine intermediate is generated by deprotonation of an iminium ion, which is 
able to react with various electrophiles or undergoes pericyclic reactions. The first example of 
an asymmetric enamine catalysis was the Hajos–Parrish–Eder–Sauer–Wiechert reaction. 
Mannich reactions 
153
 and Michael additions
154
 are well known examples to date and are 
catalysed by an enamine pathway. 
Scheme 56a 
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Scheme 56b 
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 1.14.3. 1-Ammonium Enolate  
 Hatakeyama et al.
155
 and Gaunt et al. 
156
 reported a cinchona alkaloid catalyzed 
reactions of inter- and intramolecular cyclopropanation of α-halo ketones with electron 
withdrawing alkenes and the enantioselective Baylis–Hillmann reaction, repectively. The 
catalytic cycle involves the formation of an ammonium ylide or a 2-ammonium enolate 
species. 
 Cinchona alkaloids are also used for the enantioselective synthesis of β-lactones and β-
lactams.
157 
Fu et al. reported a highly enantioselective addition of amines, aldehydes, nitroso 
compounds, N-triflyl imines and azo compounds to ketenes catalyzed by a planar-chiral 4-
(pyrrolidino)pyridine derivative.
158
 The reaction was catalyzed by the formation of an 1-
ammonium enolate intermediate by interaction of a ketene with a nucleophilic amine catalyst 
followed by an electrophile. 
Scheme 57a 
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Scheme 57b 
 1.15.  Asymmetric Organocatalysis by Chiral Brønsted Bases 
Scheme 58 
 A molecular entity capable of accepting a hydrogen (or proton) from a corresponding 
chemical species is called a Brønsted base (BB). Well known examples are various nitrogen-
containing functionalities e.g. tertiary amines, guanidines, amidines, and imidazoles.
159
 Their 
utilities are highly dependent upon the availability of the corresponding non-racemic 
precursors from the chiral pool. Therefore, alkaloids from the cinchona family and amino acids 
are a straightforward source of enantiopure BB catalyst candidates. Chemical modifications 
provided a reasonable constitutional and stereochemical diversity of BBs. Non-natural 
compounds are also a catalyst sources due to a limited availability of D-amino acids. Examples 
are synthetic 1,2-diamines and binaphthols. 
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 For a long time chiral metal free Brønsted bases were known in asymmetric synthesis, 
however, in the last few years BB-catalyzed asymmetric transformations have become a 
distinct category. Now there are large range of reactions catalyzed by chiral BB such as 
fundamental C–C and C–X (X = N, O, S, P) bond-forming reactions, i.e. Mannich, (hetero) 
Michael, (aza)-Henry reactions. 
 1.15.1. Reactions Involving Enolates and Enolate-Like   
   Nucleophiles 
 The preferable substrates for BB catalytic activation are enolizable carbonyl 
compounds with relatively small pKa values. Mostly ketones, aldehydes, esters and other 
carboxylic acid derivatives with electron withdrawing groups are suitable substrates for 
asymmetric BB catalysis. Without an electron withdrawing group, the acidity of the C–H group 
adjacent to a single carbonyl group is insufficient. Asymmetric BB catalysis has been divided 
into two major reaction categories: Mannich-type reactions and 1,4-conjugate additions 
(Michael-type additions). 
 1.15.2. Mannich Reactions 
 Most chiral BB catalysts employed in Mannich-type reactions are bifunctional and have 
a hydrogen-bond donor site within the catalyst structure e.g. thiourea derived cinchona 
alkaloids and optically active 1,2-diamines.
160
  
 1.15.3. Michael Reactions 
Scheme 59 
 A Michael acceptor is an important substrate for the transformation of carbon skeletons 
with increasing complexity and structural diversity.
161
 Chiral bicyclic guanidines are the 
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second well uesd class of BB catalysts. For example the catalyst 100 has been found to be 
excellent for the conjugated addition of dithranol 102 to various maleimides.
162
 More recently, 
guanidine 101 was applicable in the enantioselective Michael addition of dithiomalonates and 
β-ketoesters to different kinds of acceptors like cyclic enones, furanone, or acyclic 1,4-
dicarbonylbutenes affording yields and enantiomeric excess above 90%.
163
  
 1.15.4. Cyanide as a Nucleophile: The Strecker Reaction 
 The simplest and well known economical method for the de novo synthesis of an amino 
acid is the Strecker synthesis. Schiff bases incorporating a thiourea group proved to be useful 
catalysts for the cyanation of N-allyl imines with good yields and enantioselectivities.
164
 
Recently, chiral guanidines 103,
165
 87 and 104
166
 have been documented as excellent catalysts 
for the addition reaction of HCN to N-benzyl aryl imines. If there is an imidazole group in 103 
instead of the terminal guanidine, it failed to introduce any asymmetric induction for the same 
reaction due to lower basicity of the imidazole moiety compared to the guanidine group. This 
aspect has relevance for the capacity of accelerated proton transfer in the Strecker reaction. 
Scheme 60 
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 1.16.  Summary 
 Today asymmetric synthesis by chiral organocatalysts is a well established and rapidly 
growing field. It provides an alternative route to organometallic mediated asymmetric 
processes. There are many fields demanding a single enantiomer, especially in drug synthesis, 
in biological probes and optical devices. In the last century small organic molecules especially 
enzymes were utilized for asymmetric synthesis but at the end of the century much was 
focused on designing organometallic complexes and on their use in enantioselective synthesis. 
In the last few years organocatalysts are making their place in asymmetric synthesis due to 
many advantages such as easy handling, easy separatablity and environmental friendly 
behaviour. There is no well defining criterion for the classification of organocatalysts. Mostly 
they are classified on the basis of mechanism, modes of interaction like covalent, ionic, and 
hydrogen bonding. Early well-known organocatalysts are proline and cinchona alkaloids, but 
nowadays carbenes are also a rapidly growing area. The other types of organocatalysts are 
ureas, thioureas, amines, binaphthol derivatives, phosphoric acids, phosphoramides, and 
ammonium salts. The mechanistic study of organocatalysts proved to be beneficial to design 
new catalysts and modify pre-existing organocatalysts according to the need of substrates. 
These modifications involve structural tunability and steric bulk variation of pre-existing 
catalysts. 
 1.17.  Future Work 
 There is still much room for improvements, like lowering the catalyst loading, which is 
still often 20 mol%. Also the synthesis of general asymmetric catalysts with improved turnover 
numbers is desireable. Finally, new reactions and domino reactions with new and established 
organocatalysts are an important future task. 
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 2.1  Aims 
 Despite the rich historical past on the usage of small organic molecules in catalysis, only 
in the last decade, organocatalysis has earned a reputation of being a highly dynamic area in 
chemical research both in industry as well as in academia. An overview of today’s catalytic 
systems shows that there is a variety of simple organic molecules as highly efficient and 
remarkably enantioselective catalysts for a range of fundamentally important transformations. 
Therefore, organocatalysts have acquired a place as a third class of asymmetric catalysts.
167
 
 The task was to synthesize novel chiral NHCs and to investigate their application as 
organocatalysts. Two different new types for precursors for nucleophilic chiral carbenes were 
prepared and utilized in catalysis. There are so far limited types of chiral carbenes known in 
asymmetric catalysis as compared to chiral phosphines. It is therefore desirable to synthesize 
new successful chiral carbene precursors. Moreover, NHCs are of nucleophilic character. 
Furthermore, it was intended to apply chiral amides and non-nucleophilic hindered Brønsted 
bases for catalysis and chiral zwitterions as chiral shift reagents. The work can be divided into 
the following parts: 
 Synthesis of imidazolinium based zwitterions or carbene precursors 
 Synthesis of novel enantiopure NHCs derived from camphor  
 Applications of NHCs in catalysis 
 Zwitterions as chiral shift reagents 
 Zwitterions as Lewis acid/Lewis base organocatalysts 
 Application of chiral amides in catalysis 
 Use of hindered Brønsted bases as Lewis base catalysts 
 2.2.  Imidazolinium Zwitterions in the Literature
 
 To date there have been only a few reports of imidazolium salts incorporating an anionic 
substituent, such as a carboxylate,
168
 sulphonate,
168, 169, 170
 or amide
171
 group. Imidazolinium 
zwitterions containing sulphonate or sulphamidate groups in the side chain were prepared. The 
presence of sulphonate or sulphamidate was beneficial for reactions involving organosilicon 
mediated reactions because of the additional coordination ability of the sulphonate group to 
activate the silicon atom.
172
 Few examples are the TMS-Nu addition to aldehydes, ketones or 
imines and the allylation of aldehydes with allyltrichlorosilane regents. Furthermore, the 
sulphonate group with an appropriate counter cation could influence the diastereoselectivity in 
2. Results and Discussion 
 
 
46 
[2+2] reactions. In Lewis base catalyzed [2+2] reactions ionic intermediates were formed.
173
 
The previously reported sulphonate based imidazoles are shown below: 
 2.2.1.  As Ionic Liquids 
Scheme 60 
 In 2002 the group of Davis
174
 reported novel Brønsted acid ionic liquids 112a and 113 
(Scheme 60). 112a is representing an imidazolium salt with an alkylsulphonate substituent. 
Davis et al. used them as dual solvent catalysts in the Fischer esterification. Later in 2004, 
Ohno
175
 reported 1-(1-buty-l-3-imidazolio) propane-3-sulphonate 114 and HTFSI (bis 
(trifluoromethylsulfonyl) amide) as anhydrous proton transporter with an ionic conductivity of 
about 10
-2
 S cm
-1
 at 150 °C. Recently the Funabiki
176
 group reported acid ionic liquid 112b for 
the direct benzylation, allylation and propargylation of 1,3-diketones with various alcohols with 
up to 98% yield. 
 2.2.2.  Precursors for Chiral Ionic Liquids 
Scheme 61 
Cheng
177
 et al. used chiral cyclic sulphate and sulphamidate imidazole zwitterions for the 
synthesis of Brønsted acidic and Brønsted basic chiral ionic liquids (CILs) 115 and 116. They 
also used them as organocatalysts in aldol reactions. 
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 2.2.3.  As Ligands in Metal Complexes 
Scheme 62 
 In 2006, Shaughnessy
168
 reported alkylsulphonate imidazolium silver and palladium 
imidazol-2-ylidene complexes without coordination of the sulphonate group with a metal center. 
Later in 2007 Hoveyda and co-workers
169
 reported a chiral imidazolium sulphonate salt as a 
bidentate ligand for the synthesis of NHC-sulphonate silver complex 117a and very recently 
Nozaki
170
 reported NHC-sulphonate palladium complex 117b. 
 2.3.  Synthesis of New Imidazolinium Zwitterions 
 Novel enantiopure unsymmetrical imidazolinium zwitterions bearing alkylsulphonate or 
sulphamidate substituents were prepared by two main steps (Scheme 63). 
 First step: Synthesis of imidazoline rings 
 Second step: Quaternization of imidazoline rings having chiral centers in the 
backbone or side arms with cyclic sulphonate or sulphamidate groups. 
Scheme 63 
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 2.3.1.  Synthesis of Imidazoline Rings 
 For the synthesis of imidazolinium rings enantiomerically pure (1R,2R)-1,2-
diphenylethane-1,2-diamine (119), which is commercially available, was used. Later 119 was 
also prepared by a method reported by Corey
178
 in three steps as shown in Scheme 64. The 
synthesis of 119 involves the formation of 2,2-spirocyclohexane-4,5-diphenyl-2H-imidazole 
(118) and its conversion into (±)1,2-diphenyl-1,2-ethylenediamine. The later was resolved to the 
final product by treatment with enantiopure tartaric acid as represented in Scheme 64. 
Scheme 64 
Three types of imidazoline ring were synthesized as discussed below: 
Enantiomerically pure (1R,2R)-1,2-diphenylethane-1,2-diamine (119) was treated with 1 
eq mesitylaldehyde in order to get a mono-substituted diamine. The reaction gave 99% yield of 
the corresponding imine 120 in water. The NMR spectrum of the imine showed the cis and trans 
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isomers of the imine. The compound was clean enough to use it in the next step of the reduction. 
The reduction was performed by sodium borohydride in quantitative yield. 
Scheme 65 
 It is well established that diamines undergo facile ring closure to imidazolines by the 
reaction with an electrophile such as an orthoester.
179
 The method reported by Genisson
180
 was 
followed. The diamine 121 was treated with trimethylorthoformate in the presence of an 
equimolar amount of acetic acid. The product was purified with flash column chromatography 
(FCC) and the yield of the reaction varied between 70 to 80% (Scheme 66). There is a tendency 
of imidazoline rings towards opening, when interacting with silica gel. Similarly ent-122 was 
also synthesized by using the opposite enantiomer (1S,2S) of diamine 119. 
Scheme 66 
 Monoalkylated diamine 124 was synthesized in one step. The 1,2-diaminoethane was 
reacted with mesitylaldehyde in methanol for 24 h and the imine was reduced in situ by the 
addition of sodium borohydride.
181 
Monoalkylated diamine 124 was obtained in 91% yield as 
oil. 
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Scheme 67 
Scheme 68 
 For the cyclization of 124 neat reaction conditions were applied. The diamine 124 was 
treated with trimethylorthoformate at 80 °C for 2 h, but there was no desired imidazoline 125 
formed. After that, it was decided to perform the reaction at a higher temperature. For this 
purpose the dimethoxy-N,N-dimethylformamide was used instead of trimethylorthoformate The 
ethylenediamine 124 was heated with dimethoxy-N,N-dimethylformamide at 90-95 °C for 2 h. 
In order to remove MeOH and HNMe2, generated as side products during the reaction, the 
temperature was raised to 120 °C for 1 h. Thereafter a high vacuum was applied to remove the 
rest of MeOH and HNMe2. The remaining yellow viscous crude product was distilled and the 
product was obtained as a colorless thick liquid in 90% yield, which solidified on standing.
182
 
Scheme 69 
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 The imidazoline 127 is different from the above mentioned imidazolines as now an 
aromatic ring is directly attached to the nitrogen atom. This feature can be beneficial, when a 
carbene is used as a ligand in metal catalyzed reactions. The o-substituted aryl ring provides 
steric bulk for stereo controlled reactions and decreases the electronic character of the carbene. 
127 was synthesized in two steps as shown in Scheme 69. The monoalkylation of the diamine 
was performed by a modified procedure reported by Grubbs.
183
 The diamine 119 was heated 
with palladium acetate, sodium tert-butoxide, BINAP and bromotoluene in toluene to form the 
desired product 126 in 96% yield. The monoalkylated diamine 126 was cyclized to product 127 
by treatment with trimethylorthoformate.  
 2.3.2.  Quarternization of Imidazolines  
 Imidazolines were quaternized with 1,3-propanesultone 128 and with chiral cyclic 
sulphamidates 132 and 134. The 1,3-propanesultone is commercially available while 132 and 
134 were synthesized by the following procedure. 
 2.3.2.1. Synthesis of Chiral Cyclic Sulphamidates184 
Scheme 70 
 The chiral cyclic sulphamidates were synthesized from readily available cheap chiral 
pseudoephedrine 129 and prolinol 130. For the synthesis of 132 and 134 a reported procedure of 
Cheng et al. was used.
185
 The chiral amino alcohol pseudoephedrine 129 was treated with 
thionyl chloride (SOCl2) to obtain 131. In the next step 131 was oxidized with RuCl3/NaIO4 and 
converted into the desired product 132. However, only traces of the product 132 were obtained. 
Therefore a procedure of Avenoza 
186
 from 2007 was followed. 
Scheme 71 
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 Sulfuryl chloride and triethylamine were reacted with prolinol at low temperature to give 
sulphamidate 134. A number of runs were made as shown in Table 1. In the first run 30% yield 
was obtained. In order to improve the yield, a second run, which included an increased amount 
of reagent and longer reaction time, was performed. But only 7% yield was isolated. The 
reaction was very much dependent on the purity of the sulfuryl chloride. It should be moisture 
free and extra pure. The reaction also depended on time and temperature. The best yield 
obtained was 66% (entry 6, Table 1), when 1.5 eq sulfuryl chloride was used in the presence of 
4 eq triethylamine at −20-0 °C for 4 h. Pseudoephedrine based chiral cyclic sulphamidate 132 
was also synthesized by applying the same condition as shown in entry 6 of Table 1 with 66% 
yield. 
Table 1: Synthesis of Sulphamidate 134 
Entry SO2Cl2 Et3N Time T [°C] Yield [%] 
1 2 eq 4.6 eq 1 h −20-0 30 
2 2.5 eq 5 eq 16 h −20-rt 7 
3 2.5 eq 4.6 eq 16 h −20-5 6 
4 3 eq 4.6 eq 16 h −20-0 4 
5 2 eq 4.6 eq 4 h −20-10 40 
6 1.5 eq 4 eq 4 h −20-0 66 
Scheme 72 
 2.3.3. Quarternization of Imidazolines by Ring Opening Reactions 
 Imidazolinium zwitterions bearing sulphonate or sulphamidate groups were synthesized 
by ring-opening reactions of cyclic sulfates and sulphamidates. 
 Imidazolinium zwitterions 136a-136b, bearing sulphonate or sulphamidate groups, were 
synthesized from 122. Imidazolinium zwitterion 136a contains its chirality only in the 
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backbone, while 136b and 136c have a chiral center both in the backbone as well as in the side 
arm. Imidazoline 122 was stirred with a cyclic sulphonate or sulphamidate. Zwitterion 136a was 
isolated in 81% yield in acetone with 2 eq 1,3-propane sultone, while for the synthesis of 
imidazolinium zwitterions 136b and 136c, 1.5 eq of reactants were used. The quarternization 
reaction was performed in CH2Cl2 and in acetone at rt. An excellent yield of 99% was obtained, 
when 122 was quaternized with chiral cyclic sulphamidate 129 (Scheme 73) 
Scheme 73 
a
 prepared from ent-122 
 The imidazolinium zwitterion 137 was prepared by the reaction of ent-122 [(4S,5S-4,5-
diphenyl-1-(2,4,6-trimethylbenzyl)-1H-imidazoline)] with 129 in 99% yield. It was synthesized 
to explore match/mismatched influences. The depicted inner salt 137 is a diastereomere of 136b. 
Scheme 74 
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 Chiral imidazolinium zwitterions 138a and 138b were synthesized by the reaction of 
achiral imidazoline and chiral cyclic sulphamidates with excellent yields of 95% and 90%, 
respectively (Scheme 75). 
Scheme 75 
Table. 2: Synthesis of Zwitterion 139a 
Entry Solvent T [°C] Time Yield [%] 
1 CH2Cl2 rt 6 d 51 
2 toluene 80 4 d 56 
Scheme 76 
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 The aryl substituted zwitterion 139a was prepared by reacting 1-arylimidazoline 127 
with cyclic sulphamidate 129 in CH2Cl2 in 51% yield. In order to increase the yield the reaction 
was carried out in toluene at 80 °C. However, no improvement was observed. 
Scheme 77 
 The aryl substituted zwitterions 139b and 139c were prepared by reacting 1-
arylimidazoline 127 with 1,3-propane sultone 128 and with cyclic sulphamidate 130. 
Zwitterions 139b and 139c were purified via flash column chromatography with good to 
moderate yields (Scheme 77). 
 2.4.  Synthesis of Phenylisocyanide Imidazolinium Zwitterions  
Imidazoline 127 was treated with phenylisocyanate at rt in CH2Cl2 for the formation of 
zwitterion 140a, but the desired product was not isolated (Scheme 78). The phenylisocyanide 
itself dimerized or trimerized at high temperature. Therefore the reaction was repeated at a lower 
temperature, but no target product was obtained. 122 gave in the reaction any product neither. 
An additional attempt was also made for the synthesis of phenylisocyanide imidazolinium 
zwitterion, in which first the carbene was generated from carbene precursor 141, which was 
treated with phenylisocyanide. Product 142 was not obtained. 
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Scheme 78 
Scheme 79 
 2.5.  Synthesis of Imidazolinium Sulfonyl Salts 
Scheme 80 
 For the synthesis of imidazolinium salt 143 many attempts were made with different 
commercially available sulphonyl compounds. The first compound of choice was sulfonyl 
chloride 144a. The reaction was carried out in diethyl ether at −78 °C to rt, in acetonitrile at rt 
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and at 80 °C, in CH2Cl2 at 40 °C and also in toluene at 100 °C. In all cases product 143a was not 
obtained. After unsuccessful attempts for the synthesis of 143a, imidazoline 122 was treated 
with other sulphonyl reagents 144b-144d as shown in Scheme 81. These attempts remained also 
unsuccessful. 
Scheme 81 
 2.6.  Synthesis of an Imidazolinium Sulphinyl Salt 
Scheme 82 
 The synthesis of 143e was explored by the reaction of 122 with tert-butylsuphinyl 
chloride 144e. The reaction was performed in different solvents like diethyl ether, DMF and 
acetonitrile. The temperature parameter was also changed in order to obtain the product but the 
reactions did not result the desired product. 
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 2.7.  Synthesis of Novel Enantiopure NHCs Derived from 
   Camphor 
 NHCs (N-heterocyclic carbenes) have recently emerged as a new important family of 
ligands in various applications in organometallic chemistry. Furthermore, carbenes themselves 
can be used as organocatalysts. As the next consequent step, several enantiopure NHCs have 
been prepared so far
 
and applied as chiral ligands or as asymmetric organocatalysts. Camphor is 
a cheap desirable starting material from the chiral pool, yet only a few carbene precursors such 
as 145
187
, 146
188
 and recently camphor-imidazoline ligands 147
189
 have been prepared, which 
are shown in Scheme 83.  
Scheme 83 
 However, chiral carbenes of type 148 have not been reported so far (Scheme 83). The 
NCN unit would be embedded in a rigid bicyclic system being part of a six and seven-
membered ring. Hence, the carbene 148 possesses a higher basicity than carbenes based on 
imidazolium and imidazolinium moieties.
190 
 In addition, the free rotation of a substituent next 
to the C-10 methyl group of the camphor skeleton could be limited due to steric hindrance, 
which could provide an asymmetric differentiation in a catalytic reaction step. 
 2.7.1.  Synthesis of Camphor Diamine 149 
 The diamine 149 can be readily prepared via a Schmidt reaction
191
 from (+)-camphoric 
acid or (1R,3S)-1,2,2-trimethyl-1,3-cyclopentanedicarboxylic acid, a cheap chiral building block 
derived from camphor. A vigorously stirred mixture of (+)-camphoric acid and concentrated 
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H2SO4 in ethanol free chloroform was treated with sodium azide for 20 h. The diamine 149 was 
formed in 86% yield (Scheme 84). 
Scheme 84 
 Different types of carbene precursor were prepared from diamine 149. 
 Both Nitrogen atoms with the same substituent. 
 Nitrogen atoms having different substituted aryl groups 
 Synthesis of bidentate ligands where one nitrogen atom is substituted with pyridine 
 The sterically demanding nitrogen atom is carrying the bulkier substituent 
 2.7.2.  Synthesis of Camphor Salts having the Same Substituent
   on Both Nitrogen atoms 
Scheme 85 
 The camphor based carbene precursors were readily prepared in two steps 
 1. Alkylation of diamine: The alkylation reaction was performed either by treating 
  the diamine with an aromatic aldehyde followed by the reduction of the imine 
  or directly with an arylmethylene chloride. 
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 2. Cyclization: Diamine 149 was converted to the corresponding camphor salt by 
  cyclization with trimethylorthoformate 
 2.7.2.1. Step One: Alkylation of Diamine 
Scheme 86 
 Dialkylated diamine 151a was prepared by refluxing diamine 149 in toluene for 16 h 
with anthracene-9-carbaldehyde. After that, it was directly reduced to the diamine 151a with 
NaBH4. The crude product 151a was purified by FCC to give a yellow solid in 60% yield over 
two steps. A reaction can be also performed in a single step by the reaction of 149 with 9-
(chloromethyl)anthracene (150) in acetonitrile in the presence of triethylamine for 20 h with 
60% isolated yield. 
 Similarly, diamine 151b was also prepared by the reaction of diamine 149 and 2,4,6-
trimethyl benzyl chloride (152a) in refluxing acetonitrile. After that, the title compound 151b 
was purified via FCC as an oil in 67% yield.  
Scheme 87 
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 2.7.2.2. Step two: Cyclization with Triethylorthoformate  
 The diamines were transformed to the salts with triethylorthoformate in the presence of 
ammonium tetrafluoroborate.  
 Diamine 151a, triethylorthoformate and ammonium tetrafluoroborate were heated in dry 
toluene for 5 h at 100 °C in a closed vessel. Therefore, the product was filtered and purified by 
washing twice with diethyl ether, hexane and also with water to give a yellow solid 153a in 81% 
yield. 
Scheme 88 
 Similarly, salt 153b was also prepared with a yield of 63%. In order to improve the 
yield, an alternative solvent free procedure at high temperature was also performed. The 
camphor diamine 153b was added to 10.0 eq trimethylorthoformate followed by the addition of 
1.3 eq of ammonium tetrafluoroborate and 1 drop of formic acid as catalyst. The mixture was 
heated under a nitrogen atmosphere at 120 °C for 4 h. The crude reaction mixture was purified 
by washing with water, hexane and diethyl ether as white solid in 63% yield. 
Scheme 89 
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 In salts 153a and 153b a restricted rotation is present, which was impressively shown by 
the 
1
H-NMR signal of the C(2)-H. The salts 153a and 153b are shifted downfield to 4.79 and 
5.89, respectively. On the other hand the signal of the C(2)-H of the salt, in which instead of the 
anthracene unit simple phenyl groups are present, appears at 8.47. This salt was previously 
prepared in our group.
192
 The large downfield shift of the protons of 153a and 153b is due to the 
fact that they are in close proximity to the middle of the arene rings next to the C-10 methyl 
group of the camphor skeleton. 
 2.7.3.  Synthesis of Camphor Salts with Different Substituent on 
   Each Nitrogen Atom 
 The camphor based carbene precursors 156a-156c, 157a and 157b were prepared in two 
main steps  
1. Synthesis of tetrahydro-
1
H-1,3-diazepine 155a and 155b 
2. Quarternization of tetrahydro-
1
H-1,3-diazepine with aryl halides 
Scheme 90 
2.7.3.1. Synthesis of Tetrahydro-
1
H-1,3-diazepine 
 The synthesis of tetrahydro-
1
H-1,3-diazepine involved two steps. First the reaction of 
diamine 149 was performed with an aryl halide followed by a cyclization with 
trimethylorthoformate. The diamine was coupled with bromotoluene or bromopyridine in the 
presence of a palladium salt, BINAP and a base. 
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 The yield of the coupling reaction was dependent upon the source of palladium and the 
base used. In the present case the coupled product 154a was obtained in only 25% yield in the 
presence of palladium acetate and KO
t
Bu.  
Scheme 91 
 The synthesis of 154a was also performed with a modified procedure reported by 
Dorta.
193
 In this modified procedure a catalyst loading of 4 mol% of Pd2(dba)3 and 6 mol% of ± 
BINAP with NaO
t
Bu were used. The product was purified simply by acid base treatment and 
was then dissolved in pentane. Upon evaporation the desired product was obtained in 100% 
yield. 
Scheme 92 
 In this reaction only the desired monoalkylated product 154a was obtained and its other 
regioisomer 154b was not formed. This fact was confirmed with 
1
H, 
13
C-NMR and by 2D 
spectra (HMBC). The HMBC spectrum showed that the CH proton of 154a appears at 3.7 ppm, 
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coupled with the quaternary aromatic carbon at 146.6 ppm. Similarly 154d was also synthesized 
in 99% yield and 100% selectivity. The HMBC of 154d also showed that the CH proton coupled 
with a quaternary carbon of the pyridine ring. These selectivities were further confirmed by 
taking 2D spectra of the products formed in each step of the salt formation.  
Scheme 93 
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Figure 1: HMBC interaction in 154a 
Scheme 94 
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 2.7.3.2. Cyclization of Diamines 
 The monoalkylated diamines 154a and 154b were cyclized with triethoxyorthoformate 
in the presence of acetic acid with excellent yields of 99% as an oil. The products were pure 
enough to be employed directly in the next step. 
 2.7.4.  Quarternization of Tetrahydro-
1
H-1,3-diazepine with Aryl 
  Halides for the Synthesis of Carbene Precursors 
Scheme 95 
 Tetrahydro-
1
H-1,3-diazepine ring 156a was converted smoothly to the corresponding 
carbene precursors 156a-156c by heating it with aryl halides such as methyl iodide, 
mesitylmethylene chloride and diphenylmethyl chloride (Scheme 95). In a similar manner salts 
157a and 157b were also prepared by the reaction of 155d with the corresponding aryl halide in 
refluxing acetonitrile and the obtained yields were 98% and 95%, respectively. 
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Scheme 96 
Scheme 97 
 2.7.4.1.  Synthesis of Carbene Precursors by Counter Anion 
    Exchange 
 In order to observe the effect of the counter anion of the catalyst in a reaction, camphor 
salts 158a-158d were also synthesized by an anion exchange reaction with NaBF4 in a 
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CH2Cl2/H2O mixture at rt for 16 h. The C(2)-H of the camphor salts 156a-156c with halide 
anions appears at 8.49, 6.93 and 6.89 ppm, respectively. The C(2)-H of the salts 158a and 158b, 
having a less coordinating anion BF4, moved upfield to 6.7 and 6.4 ppm, respectively.  
2.7.5.  Bulkier Substituents on the Sterically Demanding Nitrogen 
  Atom 
 As mentioned above, there is a restricted rotation at the C-10 methyl group in the 
camphor skeleton due to the presence of a bulkier Ar
 
group. In order to exploit this advantage in 
catalysis, camphor salts like 159 were prepared. Its synthetic strategy involved the following 
steps: 
1. Selective protection of the less hindered nitrogen atom. 
2. Alkylation of the more hindered amino group. 
3. Removal of the protecting group. 
4. And finally, the preparation of the carbene precursors by the synthesis of tetrahydro-
1
H-1,3-diazepine followed by quarternization with an aryl halide or alkylation of the 
second nitrogen followed by cyclization. 
Scheme 98 
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 2.7.5.1. Selective Protection of the Less Hindered Nitrogen Atom 
Scheme 99 
 In the literature only one example for the selective protection of diamine 149 was 
reported by Sato.
194
 He did not outline the exact method and the isolated yield. The synthesis of 
161 was performed by the drop wise addition of a benzyl chloroformate (CbzCl) solution in 
CH2Cl2 over a period of 3 to 4 h into a stirred solution of diamine 149 and Et3N at −78 °C. The 
NMR of the crude product showed a low yield. Benzyl chloroformate is a common reagent used 
for the protection of amino groups but there is no procedure for the selective protection of 
diamines. Attempts to purify the product with FCC were not successful. 
 Since the yield for carbamate 161 was very low, an alternative modified process reported 
by Carter was also used in order to improve the yield.
195
 K2CO3 and CbzCl were added to a 
stirred solution of diamine 149 in a mixture of acetone/H2O at 0 °C. After that, the mixture was 
brought to rt. 7% yield of the desired product was obtained. 
Scheme 100 
 2.7.5.2. Alkylation of Carbamate 161 
 The crude product 161 was treated with arylmethylene chloride or an aromatic aldehyde 
for alkylation. 162b was isolated by FCC in 60% yield and 162c was only found in traces. For 
the deprotection of 162b, 6 N HCl was used under refluxing conditions.
196
 The target product 
163 was not obtained (Scheme 102). An alternative method was not used, because the overall 
yield of 162b was also very low (Scheme 102). 
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Scheme 101 
Scheme 102 
 Therefore, it was decided to investigate other protecting groups. The second choice was 
ethyl chloroformate since it can be later converted to a methyl group by the reduction with 
LiAlH4. 
 To a solution of diamine 149 and triethylamine in CH2Cl2 cooled to −78 °C was added 
drop wise a solution of ethyl chloroformate in CH2Cl2. The reaction mixture was allowed to 
warm to rt. After that, it was treated with anthracene aldehyde and without purification 
subjected to reduction with LiAlH4 for 3 h as mentioned in the literature.
197
 After purification, 
only 167 was found instead of the desired product. A prolonged reaction time resulted in an 
inseparable mixture of products (Scheme 103). 
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Scheme 103 
 The crude 164 was reacted with diphenyl methyl bromide to obtain 168. After 
purification by FCC, the reduction of 168 was performed with LiAlH4 for a prolonged time of 
48 h. The NMR spectrum of 169 showed two methyl signals at 2.1 and 2.19 ppm. This indicated 
that there may be other regional or conformational isomers. Therefore, a 
1
H-NMR of 169 was 
taken at higher temperatures but there were still two methyl signals. This indicates a lack of 
selectivity in the preparation of 164. Furthermore, the reduction of ethyl format 168 to 169 could 
also lead to polymerization, since the ethoxy group is a leaving group and there is also the 
possibility of the formation of a cyclic urea. Therefore, the route via selective addition of ethyl 
chloroformate to diamine 149 was not further pursued. 
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Scheme 104 
 2.7.6.  Camphor Salt Synthesis via Selective Acetylation 
 Next, a protection of the less hindered diamine was performed, in which no deportection 
would be required. Acetyl chloride was chosen as an alkylating reagent since it could be later 
converted to an ethyl group by reduction. This route neglects the possibility of polymerization or 
the formation of a cyclic urea, since no leaving group is present in the protected molecule. The 
synthesis of carbene precursor 172 began with a reaction of camphor diamine 149 with acetyl 
chloride followed by alkylation of the hindered amino group. After that, the acetyl group was 
reduced to the ethyl group. The desired substituted diamine 171 bearing a larger substituent on 
the hindered nitrogen was finally subjected to the salt formation step by treating it with 
triethoxyorthoformate in the presence of NH4BF4 (Scheme 105). 
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Scheme 105 
 2.7.6.1. Selective Acetylation of Diamine 149 
Scheme 106 
 The acetylated diamine 169 was obtained by the reaction of diamine 149 with acetyl 
chloride. In the first attempt a solution of diamine 149 and triethylamine was cooled to −78 °C 
and 1 eq of an acetyl chloride solution in CH2Cl2 was added. The observed yield was low and 
there was no regioselectivity as shown by the NMR spectrum. Instead of using CH2Cl2, 
diethylether was used as solvent. The reaction mixture was cooled to 0 °C and 0.85 eq of acetyl 
chloride solution in diethylether was added very slowly. The reaction mixture was allowed to 
rise to rt. The NMR spectra showed that a small amount of the undesired regioisomer was also 
formed. In order to get rid of the later, the reaction was performed at 0-10 °C with 0.75 eq of 
acetyl chloride. The product 169 was formed as a white solid. Diethylether was filtered off and 
the product was washed with diethylether and with a mixture of CH2Cl2/diethylether. The crude 
product was dissolved in water, basified and extracted with CH2Cl2. The excess of diamine 149 
was removed from product 169 under high vacuum. 
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Table 3: Acetylation of Diamine 149 
Entry Solvent Acetyl chloride T [°C] Yield [%] 
1 CH2Cl2 1 eq −78-rt 40 
2 Et2O 0.85 eq 0-rt 86 
3 Et2O 0.75 eq 0-10 86 
 2.7.6.2. Alkylation of the Hindered Amino Group 
 The alkylation of the hindered nitrogen atom was performed by the reaction of the acetyl 
substituted camphor diamine 169 at 100 °C for 5-16 h with mesityl methylene chloride 152a or 
diphenyl methyl bromide 152b with moderate yields for 170a and 170b. The NMR of the crude 
product showed that the starting diamine 169 was not completely consumed. Therefore, there is 
a chance that the yield of the product may be raised by performing the reaction for a longer time 
and using 2 or 3 eq of the regents 152a or 152b. Here, 1.1 eq of the regent had been used. 
Scheme 107 
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 2.7.6.3. Reduction of Acetylated Diamine 
4
4
Scheme 108 
 To a suspended solution of LiAlH4 in THF at 0 °C was added slowly a solution of 
diamine 170a. Thereafter, the temperature was raised to reflux for 36 h. The desired product 
171a was obtained as an oil. The reduction of 170b was performed for 48 h with 7 eq reagent. 
An excellent yield of 99% was obtained. In case of 170a 5 eq of LiAlH4 were used. 
 2.7.6.4. Synthesis of Carbene Precursors  
3, 4 4
4
44
Scheme 109 
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 The salts 172a and 172b were prepared by the direct reaction of diamines 171a and 172b 
with orthoesters in the presence of ammonium salts, which protonated one ethoxy group of the 
orthoesters and also acted as a source of the counter anion for the corresponding camphor salts. 
Excellent yields of the corresponding salts were obtained. 
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 2.8.  Application of the Catalysts 
 2.8.1.  Imidazolinium Zwitterions as Organocatalysts in the  
   Allylation of Aldehydes 
Scheme 110 
 The asymmetric allylation reaction is one of the most efficient asymmetric C–C bond 
forming reactions.
198
 This is because enantiomerically enriched homoallylic alcohols are 
important intermediates in organic synthesis, which can be converted to a wide variety of 
synthetically useful compounds.
199
 Therefore, there has been intense research activity in this 
area leading to the development of a large and diverse array of chiral catalysts, especially 
concerning chiral Lewis base catalyzed additions of allyl transfer reagents to carbonyl 
functionalities. 
 In 1993, Kobayashi was the first who reported Lewis-basic molecules such as N,N-
dimethylformamide as efficient catalysts for the allylation of aldehydes with 
allyltrichlorosilanes by the formation of hypervalent silicon intermediates.
200
 After this 
pioneering research Lewis-basic molecules have been developed as one of the most important 
activators of organosilanes in organic synthesis. Nowadays, there are a variety of well known 
Lewis bases being exploited in base-catalyzed asymmetric reactions.
201
 Examples include 
common dipolar aprotic solvents, such as DMF,
202
 DMSO,
203
 and HMPA,
204
 and other 
substances possessing a strongly Lewis basic oxygen, such as phosphoramides,
205
  
formamides,
206
 N-oxides,
207
 phosphine oxides,
208
 sulfoxides,
209
 and ureas.
210
 
 2.8.1.1. Allylation of Aldehyde with Enantiopure Imidazolinium 
   Zwitterions 
 Although various types of chiral Lewis bases have been developed, no report has been 
published of an asymmetric reaction using chiral carbene ligands as Lewis base catalysts. 
Therefore, this reaction was chosen as a test reaction with the enantiopure imidazolinium 
zwitterions. First, the potential of the zwitterions as bifunctional catalysts was explored. The 
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oxygen of the aldehyde could be activated with the Lewis acid moiety of the imidazolinium unit 
and the silicon atom of the allyltrichlorosilane with the Lewis basic sulphonate or sulphamidate 
moiety. The double activation ability may enhance the reaction efficiency. 
Scheme 111 
Table 4: Allylation of Benzaldehyde with 10 mol% Zwitterion 
Entry Additive Time Zwitterion Yield [%] ee [%] 
1 No additive 7 d 
 
136a 
95 9 
2 
i
Pr2NEt, 2eq 46 h 
 
139b 
75 10 
3 
i
Pr2NEt, 5eq 60 h 136a 65 16 
4 
i
Pr2NEt, 5eq 36 h 139b 66 19 
5 Bu4N
+
I,1.2eq 64 h 139b 20 8 
6 
Bu4N
+
I,1.2eq
 
i
Pr2NEt, 5eq 
24 h 139b 57 10 
7 
i
Pr2NEt, 5eq 6 d 
139a 
60 14 
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8 
i
Pr2NEt, 5eq 7 d 
139c 
22 5 
9 
i
Pr2NEt, 5eq 7 d 
136b 
11 0 
 The chiral zwitterion 136a was applied in the allylation of benzaldehyde 173 with 
allyltrichlorosilane 174 in CH2Cl2 at rt and the corresponding homoallylic alcohol 175 was 
formed in 95% yield and 9% ee as shown in entry 1 of Table 4. In order to improve the yield 
and the selectivity different additives were used. It has been reported in the literature that the 
addition of diisopropylethylamine
211
 or tetrabutylammonium salts
212
 or the combination of 
diisopropylethylamine and tetrabutylammonium iodide
213
 remarkably increased the catalytic 
activity without decreasing the selectivity. 
 2.8.1.2. Screening of Additives 
 First diisopropylethylamine was used as an additive because it is a commonly used 
additive in allylations. With this additive the sulphonate zwitterion 136a gave 66% yield and 
16% ee whereas 139b gave 66% yield and 19% ee. The additive Bu4NI alone and a mixture of 
i
Pr2EtN/Bu4NI were also used, but there was no improvement as shown in entries 5-7 of Table 4.  
 2.8.1.3. Comparison of Zwitterions  
 It is possible to divide the zwitterions into two classes: 
1. Zwitterions with sulphonate groups 
2. Zwitterions with sulphamidate groups 
 The sulphonate based zwitterions gave an ee of up to 19%. Sulphamidate based 
zwitterion 139a provided 60% yield and 14% ee. The other sulphamidate based zwitterions 139c 
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and 136b with chirality only in the side chain were also tested, but they did not give better 
results compared to sulphonate based zwitterions (entries 8 and 9, Table 4). 
 2.8.1.4. Scope of Substrate 
 p-Nitrobenzaldehyde and p-chlorobenzaldehyde were also applied in this reaction with 
zwitterion 136a in the presence of 
i
Pr2NEt and resulting in 11 and 10% ee respectively, as 
shown in Scheme 112. 
Scheme 112 
 2.8.1.5. Allylation of Aldehyde with Carbenes 
 Next, carbenes were generated in situ from the corresponding zwitterions. Three 
different types of zwitterions 139b, 138a and 138b were used. The zwitterion 139b was 
deprotonated with NaH in THF and gave 51% yield and 15% ee of the product 175. There was 
no enantioselectivity observed, when KHMDS in toluene was used for the deprotonation. 
However, KHMDS in THF gave 10% ee (entry 3, Table 5). Catalysts 138a and 138b, which 
were having only chiral centers in a side chain gave 5% enantiomeric excess (entries 4 and 5, 
Table 5). The carbene, generated from camphor salt 153a, was also tested, but it did not give the 
product 175 even after 84 h. The results are summarized in Table 5. 
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Table 5: Allylation of Benzaldehyde with 10 mol% Zwitterion and 9 mol% Base
a
 
Entry Solvent Base Zwitterion Time Yield [%] ee [%] 
1 THF NaH 
 
139b 
48 h 51 15 
2 Toluene KHMDS 139b 20 h 31 0 
3 THF KHMDS 139b 20 h 57 10 
4 THF NaH 
 
138a 
65 h 15 5 
5 THF NaH 
 
138b 
65 h 13 5 
6
a
 THF KHMDS 
 
153a 
84 h 0 0 
a −78 °C - rt, KHMDS 8 mol% 
 In order to improve the selectivity, carbenes were also used with additives like 
diisopropylethylamine. For this purpose zwitterion 139b was chosen as it gave the best results 
compared to others. Different solvents like THF, CH2Cl2, toluene or acetonitrile were screened. 
The best yield was 73% in toluene and the best ee was 30% in acetonitrile. Overall the results 
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are comparable with reactions being catalyzed with carbenes without an additive or zwitterions 
with an additive. However, shorter reaction times were observed. 
Scheme 113 
Table 6: Scope of Solvent in the Allylation of Benzaldehyde with 10 mol% Zwitterion 139b 
Entry Solvent Yield [%] ee [%] 
1 CH2Cl2 75 10 
2 THF 60 11 
3 Toluene 73 15 
4 CH3CN 14 30 
 Reactions were also performed at lower temperature with zwitterion 139b. The results 
are summarized in Table 7. CH2Cl2 was the best solvent of choice and gave 99% yield with 20% 
ee at −60 °C (entry 1, Table 7). From the results above it is possible to conclude that carbenes 
are good catalysts for the allylaion reactions with yields of up to 99%.  
Table 7: Allylation of Benzaldehyde with 10 mol% Zwitterion 139b at Low Temperature 
Entry T [°C] Solvent Time Yield [%] ee [%] 
1 −60 CH2Cl2 24 h 99 20 
2 −78 CH3CN 48 h 99 10 
3 −78 DMF 48 h 100 0 
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 2.8.2.  Allylation of Benzaldehyde with Trimethylallylsilane 
Scheme 114 
 The reaction of benzaldehyde 173 and trimethylallylsilane was carried out with catalyst 
139b in THF at rt. No yield of the target compound 175 was obtained. 
 2.8.3.  [2+2] Cycloaddition of Ketenes with Aldehydes or Imines 
 Ketenes are keystone reactive intermediates in organic chemistry. In 1905 Staudinger 
synthesized diphenyl ketene accidentally.
214
 Thereafter, it was proven to be a powerful reagent 
in the Staudinger synthesis of β-lactams as well as in the photochemical Wolff rearrangement. 
In the past several decades it has been used as an excellent precursor for several catalytic 
asymmetric reactions. The chiral centers were mainly created through addition at the C=C bond. 
In most of the catalytic cycles, zwitterionic enolates are formed by the reaction of the ketene 
with nucleophiles. Ketenes have been successfully utilized in asymmetric methodology which 
includes both electrophilic and nucleophilic additions, [2+2] and [4+2] cycloadditions, reductive 
couplings and nucleophilic SN2 substitutions.
215
 
 2.8.3.1. Structure and Reactivity of Ketenes 
 The unusual heteroallenic bond in ketenes is responsible for their unique reactivity. The 
LUMO (lowest unoccupied molecular orbital) is laid in the plane of the ketene, while the 
HOMO (highest occupied molecular orbital) is located perpendicular to the plane. This 
arrangement distributes a negative charge on both the oxygen and the β-carbon and a positive 
charge on the α-carbon. The stability or reactivity of the ketene depends upon its substituents. 
Resonance donor groups stabilize the ketene by donating electron density into the carbonyl 
group and steric bulk on the β-carbon, also stabilizes by shielding of the reactive sites. In 
contrast, electronegative groups destabilize the ketene. For example diphenylketene is quite 
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stable and can be stored neat at rt. On the other hand alkylated ketenes or non aromatic ketenes 
must be kept at low temperature or in a solution, which should be also stored at low 
temperatures to avoid degradation. Fluoroketenes are very reactive and even not stable in 
solution.
216
 
 2.8.3.2. [2+2] Cycloadditions: Wynberg Reaction  
 The development of effective methods for the asymmetric synthesis of β-lactones is an 
important challenge for a variety of reasons.
217
 Numerous natural and unnatural products 
containing biologically active β-lactones have been described, including Xenical 
(tetrahydrolipstatin), an anti-obesity drug developed by Roche.
218
 Furthermore, β-lactones serve 
as useful intermediates in an array of fields, including material science and synthetic organic 
chemistry.
219
 The strain of the four-membered lactone provides an opportunity for a range of 
functionalizations; for example, nucleophiles can react either at the carbonyl group through an 
addition-elimination sequence or at a C-O single bond through an SN2 process.
220 
Thus, a 
number of recent total syntheses, such as those of (−)-laulimalide,
221
 (−)-malyngolide,
222
 and 
trapoxin B,
223
 have exploited enantiopure β-lactones as intermediates. One attractive route to β-
lactones is the [2+2] cycloaddition of a ketene with an aldehyde known as the Wynberg 
reaction. 
 2.8.4.  Synthesis of Ketenes 
 2.8.4.1. Ketenes Synthesized from Acid Chlorides 
Scheme 115 
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 Ketenes are usually synthesized from an acid chloride or an α-bromo acid bromide. The 
disubstituted ketenes 178, 179 and 180 were obtained via the reaction of the corresponding acid 
chlorides with N,N-dimethylethylamine followed by purification via vacuum distillation as 
shown in Scheme 115.
224
 
 2.8.4.2. Ketenes Synthesized from α-Bromo Acid Bromides 
Scheme 116 
 The ketenes 182 and 183 were synthesized from 2-bromo-2-methylpropanoylbromide 
181a and 2-bromo-2-cyclopentylpropanoylbromide 181b, respectively. To a stirred slurry of Zn 
in a Schlenk tube at –78 °C was added a solution of 181a or 181b in THF. The reaction mixture 
was stirred for 10 min at –78 °C and then for 30 min at 0 °C or was sonicated for 30 min at rt. 
After that, the resulting solution of the ketene and the solvent was vacuum transferred into a 
second Schlenk tube. In order to determine the concentration, a specific amount of the yellow 
ketene solution was quenched with an excess of n-propylamine. The colour of the ketene 
solution disappeared immediately. After evaporation of the solvent and the excess amine, a 
white solid was identified by 
1
H-NMR to be 2-methyl-N-propylpropanamide or 2-cyclopentyl-
N-propylpropanamide.
225
 The ketene precursor 181b is commercially not available; therefore it 
was synthesized as described below: 
 2.8.5.  Synthesis of the Precursor for Ketene 183 
 2.8.5.1. α-Methylation of Acid  
 The reaction was performed by the formation of the enolate from commercially available 
cyclopentyl acetic acid 184 with the base LDA. The enolate was converted to the desired 
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product methylcyclopentyl acetic acid 185 after the reaction with methyl iodide.
226
 The crude 
product was purified by distillation with a yield of 77%. The NMR spectra of the product 
showed traces of DMAP and it was not possible to separate it from the product, because of 
similar boiling points of both the product 185 and DMAP. Therefore, 185 was subjected in the 
next step, by expecting that the small impurity of DAMP could be removed in the next step. 
Scheme 117 
 2.8.5.2. Bromination of Acid 
Scheme 118 
 The carboxylic acid 185, red phosphorus and bromine were heated very slowly from 55 
°C to 100 °C.
227
 The dibromo compound 186 was purified via distillation to give a yield of 35%. 
But when the reaction was repeated on a larger scale, the desired pure product 186 was not 
obtained. Instead a mixture of products were obtained, which could not be separated by several 
distillations. 
 2.8.5.3. Methylation of Ethylmalonate 
Scheme 119 
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 An alternative route was chosen for the synthesis of acid 185. Ethylmalonate was treated 
with the base sodium ethoxide in order to generate an enolate, which reacts with cyclopentyl 
bromide to produce diethyl cyclopentylmalonate 188. The crude product was isolated in 64% 
yield via distillation as a colorless oil.
228
 
 2.8.5.4. Conversion of the Diester to an Acid 
 Thereafter, the diester 188 was converted into the mono acid by following a method 
reported by Imbimbo et al.,
229
 in which the diester was treated with sodium hydroxide or 
potassium hydroxide in a mixture of water and ethanol for 8 h. A decarboxylation also took 
place. But in the present case after 8 h, 189 was observed instead of the desired product. After 
that, the reaction was repeated for 60 h and the diacid 190 was obtained in 95% yield as shown 
in Scheme 120. 
Scheme 120 
Scheme 121 
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 2.8.5.5. Conversion of the Diacid to Acid Halide 
 The decarboxylation of 190 at 180 °C for one hour gave a yield of 99% (Scheme 121). 
Next, 191 was converted into α-bromoacid bromide 122 or acid chloride by reaction with 
oxalylchloride.  
Scheme 122 
 2.8.5.5.6. Synthesis of Ketene 183 
Scheme 123 
Table 8: Synthesis of Ketene 183 
Entry Base Solvent Time T [°C] [mol/L]ketene 
1 N,N-dimethylethylamine Et2O 40 h rt 0 
2 N,N-dimethylethylamine toluene 16 h rt 0 
3 N,N-dimethylethylamine pentane 16 h rt 0 
4 
DABCO 
1,4-diazabicyclo[2.2.2]octane 
toluene 3h 80 0.3 M 
 It was not possible to synthesize cyclopentylmethyl ketene in solvents other than THF 
from literature procedures. Since it is known that the solvent has a great influence on [2+2] 
reactions, it was decided to prepare ketenes in other solutions. A new method was developed to 
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obtain 183. The use of α-bromo acid bromide in toluene with zinc was not successful. 
Therefore, acid chloride 192 was prepared. In order to convert 192 to ketene 183, different 
conditions were used as shown in Table 8. With the base dimethylethylamine, the reaction was 
performed in diethylether, toluene and pentane at rt. In order to perform the reaction at higher 
temperatures, DABCO was used in toluene. The corresponding ketene solution of 183 was 
obtained as a 0.3 M solution in toluene. 
 The n-butylethyl ketene 183b was also prepared by a similar method as shown in Table 8 
(entry 4). 
Scheme 124 
2.8.6.  Hindered Brønsted Bases as Lewis Base Catalysts for the 
 Wynberg Reaction 
  Alkali metal hexamethyldisilazanes are well known as non-nucleophilic hindered 
Brønsted bases and are extensively used in synthesis.
230
 HMDS has a pKa of 26 and N,N-
diisopropylamine of 36 in THF. HOtBu has a pKa of 29.4 in DMSO.
231
 The lower pKa of 
HMDS can be explained by α-silyl stabilization.232 However, also a few examples where 
these bases act as nucleophiles, are known. Despite its lower basicity and the more 
pronounced sterical screening of the nitrogen atom of MHMDS compared to LDA, more 
examples
233
 of the HMDS anion acting as nucleophiles are known than for LDA.
234 
Moreover, also KOtBu may act as a nucleophile.
235
 
 The Staudinger reaction
236
 as well as the [2+2] cycloaddition of aldehydes and 
ketenes, the Wynberg reaction,
237
 are established methods to obtain β-lactams and β-
lactones
238
 respectively, which are important compounds due to their biological activity and 
utility in synthesis.
239
 The reactions are often promoted by Lewis base catalysts. These 
catalysts are normally weak Brønsted bases. 
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Scheme 125 
 Previously our group reported that the hindered strong base NaHMDS/KHMDS was 
an efficient Lewis base catalyst for the Staudinger reaction of disubstituted ketenes and 
imines with a para-nosyl group.
240 
As continuity of this work, it was found that hindered 
Brønsted bases are also active catalysts for the cycloaddition of ketenes like 183 with 
aldehydes. Studies were conducted to exclude some possible mechanistic pathways.  
  First, reactions with NaHMDS or KHMDS as catalysts were carried out at −78 °C for 
1 h to obtain the product 193 with yields of 30% and 36%, respectively. Good 
diastereoselectivities were found. With LiHMDS no product was obtained (entry 3, Table 9). 
In addition, KOtBu was tested as a hindered non-nucleophilic base to give only traces of the 
product at −20 °C. When the reaction was repeated with KHMDS and NaHMDS and the 
reaction mixture was allowed to warm up to rt, quantitative yields were obtained. However, 
the diastereoselectivity decreased. With KOtBu, a yield of 54% was isolated at rt. In the 
absence of a catalyst no conversion occurred (entry 10, Table 9). 
Table 9: Base Catalyzed [2+2] Reaction with Ketene 183 and Benzaldehyde
a
 
Entry Base T [°C] Time Yield [%]
b
 Ratio cis : trans
c
 
1 NaHMDS −78 1 h 30 33:67 
2 KHMDS −78 1 h 36 22:78 
3 LiHMDS −78 1 h - - 
4 KO
t
Bu −78 to −20 5 h Traces - 
5 NaOTMS −78 5 h - - 
6 NaHMDS −78-rt 5 h 99 50:50 
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7 KHMDS −78-rt 5 h 99 50:50 
8 KOtBu −78-rt 5 h 54 37:63 
9 NaOTMS −10-rt 5 h 98 50:50 
10 - −78-rt 5 h - - 
a
 Ketene (2 equiv.) in a 0.3 M toluene solution. 
b
 Isolated yield. 
c
 Determined by 
1
H-NMR. 
Scheme 126 
  It is known that NaHMDS reacts with aldehydes to TMS-protected imines with the 
liberation of NaOTMS (Scheme 126). This reaction is much faster with LiHMDS and can be 
carried out at −40 °C, but it is much slower with KHMDS.
241 
A control reaction with 
NaOTMS as a catalyst was performed at −78 °C and no conversion was observed. This 
demonstrates that NaHMDS itself is the catalyst. If NaOTMS is applied as catalyst between 
−10 °C and rt, the product 193 is formed in 98% yield (entries 5 and 9, Table 9). Thus, 
NaOTMS is less active than NaHMDS. 
Table 10: Base catalyzed [2+2] Reaction with Ketene 183b and Benzaldehyde
a
 
Entry Base T [°C] Yield [%]
b
 Ratio cis:trans
c
 
1 NaHMDS −78 6 0.8:1 
2 NaOTMS −78 40 1:1 
3 NaHMDS −78-0 17 0.8:1 
4 KHMDS −78-0 26 0.8:1 
a
 Ketene (2 equiv.) in a 0.29 M toluene solution. 
b
 Isolated yield. 
c
 Determined by 
1
H-NMR 
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Scheme 127 
  Simillarly, ketene 183b was also tested in this reaction with benzaldehyde. The 
results are summarized in Table 10. The yields were low because ketene 183b is more 
reactive, therefore self dimeriztion can accour. 
Scheme 128 
Table 11: KHMDS Catalyzed Wynberg Reaction with Ketene 180
a
 
Entry Ar Yield [%]
b
 194 
1 Ph 59 194a 
2 4-Cl-C6H4 60 194b 
3 2-Me-C6H4 60 194c 
4 4-Me-C6H4 56 194d 
5
c
 4-CF3-C6H4 55 194e 
6
c
 4-F-C6H4 61 194f 
7 2,4-Cl2-C6H6 50 194g 
a Ketene (2 equiv.). b Isolated yield, c Reaction performed by Dr. Peddiahgari 
 In addition, ketene 180
242
 was tested with benzaldehyde at −78 °C or rt in the absence 
of a catalyst. No conversion into the product 194 was observed. However, with 10 mol% 
KHMDS the less hindered ketene 180 displayed with several aldehydes (Table 11) a far 
higher reactivity than ketene 183. Thus, the reactions were complete after 10 min to give the 
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desired products. Prolonged stirring did not result in a higher yield due to competing 
dimerization of the ketene. Electron-rich as well as electron deficient aldehydes gave similar 
yields. Furthermore, a reaction with ketene 180, benzaldehyde and 10 mol% NaOTMS at 
−78 °C gave the desired product in 32% yield after 10 min.  
Scheme 129 
  Furthermore, the very less hindered ketene 182
243
 was reacted with benzaldehyde or 
para-methylbenzaldehyde. The reactions were complete after 15 min. For easier handling, 
the products were directly transferred to diols 195 with LiAlH4 with an overall yield of 82 
and 89%, respectively (Scheme 129). 
Scheme 130 
  Furthermore, it was even possible to apply α,α,α-trifluoroacetophenone in the 
reaction with ketene 180 and to isolate the tetrasubstituted β-lactone 196 in 49% yield 
(Scheme 130). 
 2.8.6.1. Mechanism of the Wynberg Reaction 
 Based on the present results, the following mechanism can be proposed in Scheme 131. 
After the initial nucleophilic attack of the HMDS anion at the ketene, an amide enolate 197 
is formed, which obviously must allow a 1,3 silyl shift to anion 198. The process would be 
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encouraged by the oxophilicity of silicon. However, this rearrangement could be slow or 
lead to an equilibrating mixture of which 197 is consumed by aldehyde. 
Scheme 131 
 2.8.7.  Wynberg Reaction Catalyzed by Carbene 
Scheme 132 
 Carbenes, which were generated from camphor salts, were investigated for the first time 
in the Wynberg reaction as organocatalysts. The enantioselective Wynberg reaction
244
 is a useful 
way, in order to obtain β-lactones from aldehydes and ketenes since seven-membered carbenes 
do not catalyze the benzoin condensation. These optically active β-lactones are important 
synthons. 
 First, the reaction of ketene 180 and benzaldehyde was chosen in order to screen the 
different carbenes and to optimize conditions. This work was done by Dr. Peddiahgari in our 
group. The results are summarized in Table 12. The carbenes were generated from the different 
salts by treating them with a base at −60 °C for 2 h or warming the solution up to rt for 30 min 
to give a yellow solution. Thereafter, the reaction was cooled down to −20 °C and benzaldehyde 
was added, followed by the addition of 1.5 eq of ketene 180. The desired product was formed 
with salt 153a and KHMDS in toluene in 72% yield and 51% ee (entry 1, Table 12). 
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 The use of KO
t
Bu as a base and THF as a solvent resulted in a lower yield and ee 
(entries 2 and 3, Table 12). By lowering the temperature to −60 °C it was possible to increase 
the ee to 92%, while the yield remained the same (entries 4 and 5, Table 12). The reaction was 
repeated under the same conditions with the other salts. 153b gave nearly the same yield as 153a 
however a lower ee of 73% (entry 6, Table 12). 
Table 12: Wynberg Reaction with 10 mol% Salt and Base
a
 
Entry Salt Base Solvent T [°C] Yield [%] ee [%] 
1 
153a 
KHMDS toluene −20 72 51 
2 153a KOtBu toluene −20 55 10 
3 153a KHMDS THF −20 50 0 
4 153a KHMDS toluene −40 70 86 
5 153a KHMDS toluene −60 75 92 
6 
153b 
KHMDS toluene −60 69 73 
a
Reaction time 10 min, 8 mol% KHMDS 
 With the optimized conditions in hand different ketenes and aldehydes were applied in 
the reaction with salt 153a as a catalyst precursor as shown in Scheme 132. The results are 
summarized in Table 13. The reactions were carried out for convenience at −78 °C, although it 
did not have an influence on the results compared to −60 °C (entry 1, Table 13). 
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 Next, different aldehydes were used with ketene 180 and it was found that electron 
deficient and electron rich aldehydes gave up to 91% ee (entries 2-5, Table 13). Dimethyl ketene 
was used in the reaction with benzaldehyde to give the product in 75% yield with an ee of 54% 
(entries 6, Table 13) and 65% yield with an ee of 57% with p-chlorobenzaldehyde. Since the 
dimethyl ketene can be only prepared in a THF solution,
245 
the
 
enantioselectivity was less as 
compared to cycloheptyl ketene 180. Therefore a new method was developed to prepare ketenes 
in a toluene solution as described in scheme 123 (entry, 4. Table 8). Hence, a solution of 
cyclopentylmethyl ketene in toluene gave with benzaldehyde the product in 95% yield in a 
trans/cis ratio of 1:2. Both diastereomers had nearly the same ee of 80% (entry 7, Table 13). 
Scheme 133 
 In one example, the reaction was worked up with a 2% aq. solution of NH4BF4 and the 
regenerated salt 153a could be recovered during column chromatography in 81% yield by 
increasing the polarity of the mobile phase to 5% methanol/CH2Cl2 after purification of the 
target product. 
Table 13: Wynberg Reaction with Different Ketenes and Aldehydes with 10 mol% 153a and 8 
       mol% KHMDS in Toluene after 10 min at −78 °C 
Entry Ketene Aldehyde (Ar) Yield [%] ee [%] 
1  
180 
Ph 76 92 
2 180 4-F-C6H4 72 91 
3 180 4-Me-C6H4 82 91 
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4 180 2-Me-C6H4 73 80 
5 180 4-Cl-C6H4 80 86 
6 180 2,4-Cl-C6H6 70 53 
7
a
  
182 
Ph 75 54 
8 182 4-Me-C6H4 65 57 
9
b
  
183 
Ph 95 82, 79 
a
0.35 M solution in THF, product isolated as diol after reduction with LiAlH4. 
b
0.35 M solution in 
toluene, trans/cis ratio 1:2. 
Scheme 134 
 The possible mechanism is shown in Scheme 134. The carbene attacks the ketene. Since 
the ketene is shielded from one side, the aldehyde can only approach from the side opposite of 
the C-10 methyl-group of the camphor skeleton. After the new bond is formed the carbene is 
released under the formation of the (R)-β-lactone. 
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2.8.8.  Wynberg Reaction with Dimethyl Ketene 182 
Scheme 135 
 Camphor based salts having different substituted nitrogen atoms were used for the 
synthesis of β-lactones (Scheme 135, Table 14). The reaction of ketene 182 was done with 
benzaldehyde and the corresponding β−lactone was obtained in only up to 35% yield. There is 
need to repeat these reactions with fresh KHMDS. 
Table 14: Wynberg Reaction with 10 mol% Salt and Base
a
 
Entry Salt Yield [%] ee [%] 
1 
 
158a 
30 20 
2 
 
156c 
5 - 
3 
 
172a 
7 - 
4 
 
157a 
35 40 
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5 
 
157b 
6 - 
a
8 mol% KHMDS 
2.8.9.  Wynberg Reaction with 2-Oxaldehyde 
Scheme 136a 
Table 15: Wynberg Reaction with 2-Oxaldehyde, 10 mol% Salt and Base
a
 
Entry Ketene T [°C] Time Yield [%] ee [%] 
1  
179 
−78 16 h 50 0 
2 
 
202 
−78-rt 40 h 20 - 
3  
182 
−78-rt 16 h 62 0 
a8 mol% KHMDS 
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 The synthesis of β-lactones works well with alkylated ketenes. But there was no report 
with aromatic ketenes. Ye et al.
246
 reported recently, that carbenes generated from triazolium 
salts, were efficient organocatalysts for the formal [2+2] cycloaddition reaction of diaryl or 
arylalkyl ketenes with 2-oxaldehyde 201 with excellent enantioselectivity of up to 99%. 
Therefore, salt 153a was used as catalyst with aromatic ketenes and with aldehyde 201. The 
results are summarized in Table 15. The aldehyde 201 gave moderate yields with diphenyl 
ketene without any selectivity (entry 1, Table 15). With the more hindered ketene 202 only 20% 
yield was obtained. The dimethyl ketene was also investigated with aldehyde 201. 62% yield of 
the corresponding β-lactone was obtained. 
2.8.10. Tetrasubstituted β-Lactones 
 The camphor based salts were also used for the synthesis of β-lactones having two 
stereocenters. The reaction of ketene 180 was carried out with phenyltrifluoromehtyl ketone in 
the presence of 153a. The corresponding β-lactone was obtained in 45% yield. It was not 
possible to determine the enantioselectivity of 204 by HPLC, with AD-H or OD-H columns 
available in our group. Therefore, the β-lactone was reduced to the diol with LiAlH4. The ee was 
34% (entry 1, Table 16). Ketones 205b and 205c were applied in this reaction but no product 
was obtained. Furthermore, camphor based salts 153a and 153b were not catalyzing this 
reaction. 
Scheme 137 
Table 16: Synthesis of Tetrasubstituted β-Lactones 
Entry Salt Ketene Ketone T [°C] Time Yield [%] ee [%] 
1 
 
153a 
 
180 
 
205a 
−78-rt 16 h 45 34 
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2 
 
158b 
 
178 
205a rt 24 h 0 0 
2 
 
158c 
 
178 
205a rt 24 h 0 0 
4 153a  
182 
 
205b 
−78-rt 40 h 0 0 
5
a
 153a 180 
 
205c 
rt 40 h 0 0 
6
a
 
136b 
 
179 
 
205d 
rt 48 h 0 0 
aTHF 
 2.8.11. Wynberg Reaction Catalyzed with Chiral Anions 
 Since simple KHMDS was found to be a highly effective catalyst for the Wynberg 
reaction, it was decided to use chiral anions as catalysts for the β-lactone synthesis. The chiral 
phenyl ethyl amine 207 was used as the first analogue because it is commercially available for a 
reasonable price. The amine 207 was protected with a silyl group. As mentioned in the 
introduction, the silicon atom can interact with the Lewis basic part of the substrate and can lead 
to a tight/close transition state, which can help to obtain high enantioselectivity. Furthermore, 
the substituents of the silyl group provide the steric bulk for selectivity. The first group of choice 
was trimethylsilyl chloride. The primary amine 207 was treated with TMSCl in diethyl ether in 
the presence of n-butyllithium at −35 °C, but no product was obtained. Other attempts were 
2. Results and Discussion 
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made with triethylamine in acetonitrile or hexane at rt but these also remained unsuccessful. 
After that, diphenylisopropylsilylchloride 208 was used for the protection. The reaction was 
performed at rt in presence of triethylamine in acetonitrile for 16 h. The crude product 209a was 
purified by distillation with 85% yield as an oil. Two commercially available chiral diamines 
209b and 209c were also used as catalysts in the Wynberg reaction. 
Scheme 138 
 In order to confirm that any anion was generated, an experiment was performed in which 
209a was treated with 1 eq of KH in toluene at 40 °C. After that, one drop of deuterium oxide 
was added and an NMR spectra was taken, which showed that the proton of the amino group 
disappeared. 
Scheme 139 
Scheme 140 
 The synthesis of a β-lactone from cycloheptylketene 180 and benzaldehyde catalyzed by 
an amide anion generated in situ from the corresponding amine 209a was investigated. The yield 
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of the product was 52%. The amine 209b did not show any catalytic activity, while 209c gave 
the β-lactone in 55% yield. 
Table 17, Synthesis of β-Lactone from Cycloheptylketene 180 
Entry Amine Yield [%] ee [%] 
1  
209a 
52 0 
2 
 
209b 
7 0 
3  
209c 
55 0 
 2.8.12. Staudinger Reaction 
 β−Lactams or azetidini-2-ones or 4-membered cyclic amides were synthesized for the 
first time by Staudinger in 1907.
247
 After the discovery of penicillin by Fleming in 1928 and its 
structural proof by X-ray crystallography,
248
 the bioactivity of β-lactams was extensively 
studied. Today β-lactams have an important place in pharmaceutical science as well as in 
biochemistry.
249
 In addition, β-lactams are also versatile building blocks for the synthesis of 
natural products. Examples are β-amino acids, oligopeptides and azetidines.250 Also carbene 
precursors were exploited as organocatalysts for the Staudinger reaction between aromatic 
aldehydes and ketenes in different solvents. 
 2.8.13. Synthesis of Imines 
 For the synthesis of β-lactams the protected imines 212a-212c were synthesized by a 
procedure reported by Love.
251
 Aromatic aldehydes were treated with tosyl or nosyl protected 
amines in the presence of triethoxysilicone at 160 °C for 6 h. The corresponding amines were 
obtained in good yields as shown in Scheme 141. 
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Scheme 141 
 2.8.14. β-Lactam Synthesis Catalyzed by Carbenes 
Scheme 142 
 The phenylethyl ketene 178 was treated with imines 212a-212c as shown in Table 18. 
The diastereoselectivity was improved, when this reaction was performed at low temperature 
(entry 2, Table 18). The β-lactam was formed in 99% yield with a diastereoselective ratio of 
12:88 (entry 3, Table 18). The diastereoselectivity was further improved to 8:92 with tosylimine 
212c (entry 5, Table 18). No selectivity was observed, when the reaction was performed at rt. 
Unfortunately, the obtained products were racemic. 
Table 18: β-Lactam Synthesis Catalyzed by 10 mol% Zwitterion and Basea 
Entry Catalyst Imine Solvent Base T [°C] Yield [%] cis:trans ee [%] 
1 136a  
212a 
toluene KHMDS rt 92 22:78 0 
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2 136a 212a THF KHMDS −78-−40 99 12: 88 0 
3 136a 212a THF NaH −60 68 22:78 0 
4 136a 212a toluene nBuLi rt 50 - 0 
5 136a 
 
212c 
THF KHMDS −40-10 86 8:92 0 
6 136b 212c Et2O KHMDS rt 99 50:50 0 
7
a
 139c 
 
212b 
toluene LiHMDS −40 36 20:80 0 
8 136b 212a Et2O NaHMDS rt 40 - 0 
a8 mol% KHMDS 
  The β-lactam synthesis was also tried with diphenylketene in the presence of zwitterion 
136b. The tosyl protected imine gave 50% yield and 85% ee, while the nosyl protected imine 
212b gave only 20% enantioselectivity under similar conditions. The zwitterions 136a, 136c, 
139b, 139c and 138a were also tested for the β-lactam synthesis under similar reaction 
conditions but gave only traces of the product. 
Scheme 143 
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Table 19: β-Lactam Synthesis with 10 mol% Zwitterion and 9 mol% Basea 
Entry Imine Yield [%] ee [%] 
1  
212c 
50 85 
2
a
  
212b 
36 15 
a
8 mol% KHMDS 
Scheme 144 
 The β-lactam synthesis was carried out with diphenylketene and tosyl protected imine in 
the presence of 213 with 100% yield. The camphor salt 156a was also tested in this reaction but 
no yield of 214 was obtained (Scheme 144). 
 2.8.15. β-Lactam Synthesis Catalyzed by Amines 
 In another series of experiments, cycloheptyl ketenes 179 and 180 were reacted with N-
nosylated imine 212b, catalyzed by a chiral amide generated in situ from chiral amines 209a-
209c. A yield of 72% was achieved with amine 209a, when the reaction was performed at −78 
°C to rt while at −50 °C no yield was obtained (entries 1 and 2, Table 20). The catalyst 209a was 
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also tested with aromatic ketene 179 yielding 30% of the product. The catalyst 209c gave 20% 
yield with ketene 180 (entry 3, Table 20) and the catalyst 209b did not show any catalytic 
activity. 
Scheme 145 
Table 20: β-Lactam Synthesis Catalyzed by 10 mol% Amine 
Entry Base Ketene Amine T [°C] Yield [%] ee [%] 
1 NaH 
 
180 
 
209a 
−50 0 0 
2 KH 180 209a −78-rt 72 0 
3 NaH 180 
 
209b 
−78-rt 10 0 
4 KH 180 209b −20-rt 0 0 
5
a
 NaH 180 209b rt 0 0 
6 KH 180  
209c 
−78-rt 
50 
 
0 
7 
n
BuLi  
178 
209a  
30 
1:1.3 
0 
8 
n
BuLi 178 209b  0 0 
a
20 mol% amine 
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 2.8.16. Tetrasubstituted β-Lactams 
 The synthesis of β-lactams, having halide groups instead of a proton in the ring is 
desirable. This is because the halide substituted lactams may be good building blocks for other 
useful transformations. N-Tosylbenzimidoylchloride 207a and N-nosylbenzimidoylchloride 
207b were synthesized for this purpose.
252
 TsNH2 or NsNH2 were treated with benzoic acid 
chloride in the presence of K2CO3 for 12 h. The corresponding N-tosyl and nosylbenzamide 
were formed in 94% and 95% yields, respectively. After that, 216a and 216b were treated with 
PCl5 and the desired products 217a and 217b were obtained in up to 91% yield  
Scheme 146 
Scheme 147 
Table 21: Tetrasubstituted β-Lactam Synthesis Catalyzed by 10 mol% Zwitterion 
Entry Salt Imine Ketene Yield [%] 
1 
 
136b 
 
217a 
 
179 
0 
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2 136b  
217b 
 
178 
0 
3 136b 217a 178 0 
4  
213 
217a 179 0 
5 213 217b 179 0 
 The chloro-substituted imines were treated with diphenylketene 179 and also with the 
less hindered phenylethyl ketene 178 in the presence of zwitterion 136b. However, both ketenes 
gave no product. In addition, reactions were performed with commercially available imidazoline 
salt 213, but no products could be formed. 
Scheme 148 
Scheme 149 
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 Tetrasubstituted amine 319a and 319b were synthesized by the reaction of N-
tosylbenzimidoyl chloride 217a and 217b with p-methoxyphenyl boronic acid in the presence of 
a palladium salt. The products were purified by FCC with up to 65% yield. The imines 219a and 
219b were tested in the Staudinger reaction but no results were obtained. 
Table 22: Synthesis of Tetrasubstituted β-Lactams with 10 mol% Salt 
Entry Salt Imine Yield [%] 
1 
 
136b 
219b 0 
2 
 
213 
219a 0 
 2.8.17. [2+2] Reaction with Alkenes 
 The alkene 221 was used in the formal [2+2] cycloaddition reaction with ketene 179 and 
imine 212b. The reaction did not proceed.  
Scheme 150 
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 2.8.18. TMSCN Addition to Aldehydes 
Scheme 151 
 Cyanohydrins have importance in organic synthesis since they provide a handle for 
conversion into various other functional groups. Compared to various cyanating reagents such as 
KCN, NaCN, and HCN, trimethylsilyl cyanide (TMSCN) is easy to handle and an effective 
cyanide source for the nucleophilic addition to carbonyl compounds in the presence of Lewis 
acids or Lewis bases.
253
  
 Zwitterions 136a and 139b were employed in the TMSCN addition to benzaldehyde at 
different temperatures giving yields of up to 70% without any enantioselectivity. An attempt 
was made to increase the enantioselectivity by carrying out the reaction at −78 °C to −50 °C for 
48 h, however, only a decrease of the yield was observed. Nevertheless, it showed that SO3
−
 was 
Lewis basic enough to activate the TMSCN for the reaction. 
Table 23: TMSCN Addition with 10 mol% Zwitterions 
Entry Time T [°C] Zwitterion Yield [%] ee [%] 
1 24 h rt 
 
136a 
70 0 
2 48 h −78 - −50 136a 50 0 
3 9 d −50 - rt 
 
139b 
18 0 
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 In other experiments, the same zwitterion was deprotonated with a base like NaH, thus 
generating a carbene in situ and evaluating its catalytic activity in the TMSCN addition to 
benzaldehyde in solvents like THF and toluene. The highest ee was 11%.  
Scheme 152 
Table 24: TMSCN Addition with 10 mol% 136a and 9 mol% Base 
Entry Solvent Base Time T [°C] Yield [%] ee [%] 
1 CH2Cl2 NaH 48 h −78 0 0 
2 CH2Cl2 NaH 48 h 0 0 0 
3 toluene NaH 48 h −50 99 0 
4 THF NaH 48 h −50 99 11 
 2.8.19. TMSCF3 Addition to Aldehydes 
Scheme 153 
 Organofluorine compounds are becoming increasingly important in different fields, such 
as material science, agrochemistry, and the pharmaceutical industry. Nucleophilic 
trifluoromethylation is one of the most widely used methods to incorporate a trifluoromethyl 
moiety into organic molecules. 
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 The carbene from imidazolinium zwitterion 136a was exploited in the TMSCF3 addition 
towards benzaldehyde and 2-naphthaldehyde at rt obtaining the product in 90% and 99% yield, 
respectively. The product was racemic (Scheme 153). 
 The zwitterion 139b was also used in the TMSCF3 addition to aldehydes. The reaction 
was also performed after generating the carbene from the same zwitterion 139b with the help of 
NaH. In both cases, no catalytic activity was observed. Synthesis of 229 was also tried with 
camphor based salt 153a, but the reaction did not proceed. 
Table 25: TMSCF3 Addition with 10 mol% Salt and 9 mol% Base 
Entry Zwitterion Aldehyde T [°C] Base Yield [%] ee [%] 
1 
 
136a 
 
173 
rt NaH 90 0 
2 136a  
226 
rt NaH 99.9 0 
3 
 
139b 
173 rt NaH 0 0 
4 139b 173 rt No base 0 0 
5
a
 
153a 
226 −78-rt KHMDS 0 0 
a
Reaction performed in toluene  
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2.9.  Chiral Zwitterions as Versatile Chiral Shift Reagents 
 NMR spectroscopy is a very powerful technique in differentiating diastereomeric 
entities. Chiral shift reagents interact with racemic compounds and both enantiomers can be 
recognized by NMR spectroscopy. This helps to determine the relative ratio of the two 
enantiomers (enantiomeric excess) formed during a reaction and their absolute configuration. 
Different chiral shift reagents such as porphyrins,
254
 cyclodextrins,
255 
lanthanide complexes,
256
 
and crown ethers
257
 have been exploited.
258
 
 The newly synthesized zwitterions were evaluated as chiral resolving agents for the first 
time. The zwitterions were mixed with α-(trifluoromethyl)benzyl alcohol (230) in a 1:2 ratio and 
the splitting of the CF3 group in a 
19
F spectra was observed. The results are summarized in Table 
26. 
19
F spectra were recorded for the mixtures of alcohol and zwitterions 136b and 139c in 
different solvents. 136b showed the highest splitting of 30 Hz in toluene. No 
stereodiscrimination for the CF3 group was observed in CD3CN and CD3OD solvents from 
either zwitterion. In CDCl3, zwitterion 136b showed a splitting of 15 Hz, while 139c showed a 
splitting of 22 Hz. It was not possible to measure the splitting of 139c in toluene due to its 
insolubility. The results obtained from screening different solvents imply that more polar 
solvent weaken the hydrogen bonding between host and guest molecules. For further 
experiments, CDCl3 was chosen as a solvent of choice because of the better solubility of the 
zwitterions. 
Table 26: Chemical shifts δ of 2,2,2-trifluoro-1-phenylethanol (230) in ppm and Resolution 
  ∆δ values in Hz (378 MHz 
19
F-NMR) 
Entry Zwitterion Solvent δ(ppm)
 19
F ∆δ (Hz) 
1 - CDCl3 −78.88/−78.88 0 
2 
 
138b 
CDCl3 −78.55/−78.52 11.3 
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3 
 
138a 
CDCl3 −78.49/−78.46 11.3 
4 
 
137 
CDCl3 −78.475/−78.52 17 
5 
 
136b 
C7D8 −77.61/−77.53 30 
CDCl3 −78.50/−78.54 15 
CD2Cl2 −78.21/−78.225 5.7 
CD3CN −77.38/−77.38 0 
CD3OD −77.96/−77.96 0 
6 
 
136a 
 
C7D8 
 
−77.54/−77.52  
 
0 
CDCl3 
 
 
 
−78.49/−78.51 
 
 
 
7.6 
 
 
 
7 
 
139b 
CDCl3 −78.54/−78.53 3.8 
8 
 
136c 
 
 
C7D8 
 
 
−77.54/−77.525 
 
 
5.7 
CDCl3 
 
−78.57/−78.53 
 
15 
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9 
 
139c 
CDCl3 −78.715/−78.66 20.1 
CD2Cl2 −78.42/−78.39 11 
CD3CN −77.46/−77.46 0 
CD3OD −77.96/−77.96 0 
 
 The maximum splitting displayed by the zwitterions 138a-138b, having chiral centers at 
the side arms, was 11 Hz (entries 2 and 3, Table 26). Sulphonate based zwitterions 136a and 
139b were showed poor stereodiscrimination. (entries 6 and 7, Table 26). 139c was also mixed 
with Mosher’s acid and the chemical shift difference of the CF3 group was 26 Hz (Table 27). 
Table 27: Chemical Shifts δ of Mosher’s Carboxylic Acid in ppm and ∆δ Values in Hz (378 
       MHz 
19
F-NMR) 
Entry Zwitterion Mosher’s acid Solvent δ(ppm) 
19
F ∆δ (Hz) 
1 -  
231 
CDCl3 −71.62 - 
2 
 
139c 
231 CDCl3 −72.43/−72.36  26 
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2-9.1.   Some 
19
F Spectra Showing the Splitting of the CF3 Group 
  by Interaction with the Zwitterions 
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Figure 2:
19
F Spectra of 230 in CDCl3 
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Figure 3:
 19
F Spectra of Zwitterion 139c and 230 in CDCl3 
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F Spectra of Zwitterion 136c and 230 in CDCl3 
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Figure 6:
 19
F Spectra of Zwitterion 139c and 231 in CDCl3 
 Zwitterion 139c gave the best results with α-(trifluoromethyl)benzyl alcohol (230) and 
Mosher’s acid. Therefore, it was selected for further investigations. Keeping in view the 
importance of enantioenriched compounds such as alcohols, cyanohydrins, amino alcohols, nitro 
compounds, carboxylic acids etc., there is a need to examine their enantiomeric excess after 
asymmetric synthesis. The racemic compounds as mentioned in Table 28 were mixed with 139c 
and chemical shift differences in the 
1
H NMR were recorded. The results obtained are quite 
satisfactory and are summarized in Table 28. Since shift reagents have no measureable effect on 
coupling constant in 
1
H- and 
13
C-NMR therefore their values are not giving in Table 28. 
 The methine proton of α-trifluoromethyl benzyl alcohol showed a splitting of 52 Hz. 
BINOL interacted with 139c and the aromatic -CH showed a baseline separation of 8 Hz. The α-
proton of cyanohydrin had a split with a value of 40 Hz (entry 3, Table 28). Norephedrine was 
also tested and its methyl group was splited with a value of 4 Hz and the proton of the carbon 
bearing a hydroxyl group was split to 8 Hz. The methine proton of a nitroalcohol exhibited a 
chiral shift non-equivalence of 68 Hz. The methyl group of a nitroalcohol also showed a chiral 
discrimination with a magnitude of 8 Hz. 
 A series of racemic carboxylic acids was screened for observing baseline separation of 
characteristic protons, thus differentiating the two enantiomers. The proton, attached to the 
chiral center of α-cyclohexylphenyl acetic acid showed a splitting of 12 Hz, α-bromophenyl 
2. Results and Discussion 
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acetic acid of 48 Hz and α-hydroxy phenyl acetic acid of 60 Hz. The splitting was lowered to 20 
Hz when a hydroxyl group is at the β-carbon, but the baseline separation was clear enough to 
differentiate its both enantiomeres. The methyl group of Mosher acid also showed a strong 
interaction and the diastereomeric methoxy groups were spaced apart with a splitting value of 36 
Hz. Another member of the carboxylic acid series that contains a thiol group at the β-carbon can 
also be differentiated as the proton of the SH group splits to 24 Hz and the methyl to 36 Hz 
(entry 12, Table 28). 
 The mode of interaction of zwitterions with different guest molecules is hydrogen 
bonding. It is assumed that the negative part of the zwitterion forms a hydrogen bond with the 
acidic pole of the guest molecules. 
Table 28: Resolution of Racemic Compounds in the Presence of Chiral Zwitterion 139c
a
  
Entry Compound 
δ(ppm) without 
Zwitterion 
δ(ppm) with 
Zwitterion 
1
H Resolution ∆δ 
(Hz) 
1 
 
230 
5.02 5.02/4.89 52 (CH) 
2 
 
232 
8.00 8.03/8.01 8 (CHAr) 
3 
 
233 
5.39 5.72/5.62 40 (CH) 
4 
 
234 
4.46 
0.90 
4.48/4.46 
0.90/0.89 
8 (CH) 
4(CH3) 
5 
 
235 
4.72 
1.50 
4.69/4.53 
1.51/1.49 
64 (CH) 
8 (CH3) 
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6 
 
236 
1.20 1.20 interacted
b
 
7 
 
237 
3.23 3.23/3.20 12 (CH) 
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231 
3.56 3.42/3.33 36 (OCH3) 
9 
H
 
238 
5.35 5.21/5.09 48 (CH) 
10 
H
 
239 
5.19 5.0/4.85 60 (CH) 
11 
 
240 
4.06 3.98/3.93 20 (CH) 
12 
 
241 
2.28 
1.56 
2.06/2.00 
1.40/1.31 
24 (SH) 
36(CH3) 
13 
 
242 
4.17 4.17 0 
14 
 
243 
2.8 2.8 0 
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16 
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245 
5.25 5.25 0 
17  
246 
2.83 2.83 0 
18 
 
247 
5.88 5.88 0 
19  
249 
3.90 3.90 0 
20 
 
250 
3.29 3.29 0 
21 
 
251 
5.49 5.49 0 
a
CDCl3, 
b
there is a splitting but the base line of the splitting is not clear to give value 
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 2.9.2.  Some Figures of 
1
H-NMR Spectra Showing NMR Spectra 
   Before and After Interaction with Zwitterions 
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Figure 7:
 1
H Spectra of 230 and Zwitterion 139c/230 in CDCl3 
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Figure 8:
 1
H Spectra of 233 and Zwitterion 139c/233 in CDCl3 
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Figure 9:
 1
H Spectra of 231 and Zwitterion 139c/231 in CDCl3 
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Figure 10:
 1
H Spectra of 234 and Zwitterion 139c/234 in CDCl3 
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Figure 11:
 1
H Spectra of 237 and Zwitterion 139c/237 in CDCl3 
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Figure 12:
 1
H Spectra of 235 and Zwitterion 139c/235 in CDCl3 
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Figure 13:
 1
H Spectra of 241 and Zwitterion 139c/241 in CDCl3 
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2.9.3.  Camphor Salts as Chiral Shift Reagents 
 The newly synthesized camphor salts were investigated for their ability to interact with 
Mosher’s carboxylate. The chemical shifts differences of the the CF3 group of the two 
enantiomers of Mosher’s carboxylate was examinded. In order to assign the signals of the 
corresponding enantiomers, an enantioenriched (12% ee) Mosher’s carboxylate potassium salt 
was mixed with the enantiopure camphor salts with a 1:2 ratio. The mixture was dissolved in a 
deuterated solvent and 
19
F NMR spectra were recorded. The results are summarized in Table 29. 
 The CF3 group of the Mosher’s salt showed a singlet at a −71.19 Hz in the 
19
F-NMR. In 
general, by mixing the two salts together reshuffling of ion pairs could take place. The 
enantiopure camphor cation would interact with each of the two enantiomeric anions of the 
Mosher’s carboxylate resulting in the formation of diastereomeric ion pairs. Since diastereomers 
are different compounds, both physically and chemically, each diastereomer should show 
theoretically different chemical shift values. Salt 158c and 157a having a pyridine ring in the 
side arm showed in CDCl3 a splitting of 18.9 Hz and 26.5 Hz in the 
19
F NMR, respectively 
(entries 2-3, Table 29). Whereas salt 157a did not display any splitting in the 
19
F NMR in 
C3D6O. It can be postulated that the solvent influence the interaction of these chiral cations with 
the Mosher’s carboxylate salt. Salts 157a, 153b and 172a do not have a lone pair donating atom 
in the side chain and were not showing a splitting at all. The spectra of Mosher’s carboxylate 
and salts 157a are shown in Figure 14-15. 
Table 29: Chemical shifts δ of Mosher’s Carboxylate Potassium Salt in ppm and ∆δ Values in 
       Hz (378 MHz 
19
F-NMR) 
Entry Salt Solvent δ(ppm) (R)/(S)
 19
F Resolution ∆δ (Hz) 
1 - CDCl3 −70.19/−70.19 0 
2 
 
158c 
CDCl3 −70.74/−70.79 18.9 
2. Results and Discussion 
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3 
 
157a 
CDCl3 −70.77/−70.84 26.46 
4 
 
157a 
(CD3)2CO −70.56/−70.56 0 
5 
 
157a 
(CD3)2CO −69.80/−69.80 0 
6 
 
158a 
CDCl3 −70.82/−70.82 0 
7 
 
153b 
(CD3)2CO/CDCl3 −69.46/−69.46 0 
8 
 
172a 
(CD3)2CO −69.92/−69.926 0 
2. Results and Discussion 
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Figure 14: 
19
F Spectra of Mosher’s carboxylate potassium salt in CDCl3 
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Figure 15: 
19
F Spectra of Mosher’s carboxylate potassium salt/157a in CDCl3 
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2.10.   Summary and Outlook 
 The presented work began with the synthesis of novel enantiopure C1-symmetric 
imidazolinium zwitterions bearing alkylsulphonate or sulphamidate substituents. The 
zwitterions were prepared in two main steps. 
 The Synthesis of the zwitterions started with the monoalkylation of enthylene-1,2-
diamine with 1 eq of aldehyde or arylbromide followed by the conversion of the monoalkylated 
diamine to the imidazoline ring with trimethylorthoformate. 
Scheme 154 
 The final step was the quarternization of an imidazoline ring with a cyclic sulphonate or 
sulphamidate group. 
Scheme 155 
 The next group of newly synthesized carbene precursors was camphor based, since it is a 
cheap desirable starting material from the chiral pool. The following types of carbene precursors 
were prepared from camphor diamine 149. 
 Same substituents at both nitrogen atoms 
 Nitrogen atoms having different aryl substituents 
 Synthesis of bidentate ligands  
 The sterically demanding nitrogen atom carrying the bulkier substituent 
2. Results and Discussion 
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 Camphor salts having the same alkyl substituents on both nitrogen atoms were prepared 
in two steps. The first step involved the alkylation of a diamine with aromatic aldehydes 
followed by the reduction of the imine or direct alkylation with arylmethylene chloride. The 
final step was a cyclization with triethylorthoformate in the presence of NH4BF4. 
Scheme 156 
 The other series of camphor carbene precursors having different aryl substituents at the 
nitrogen atoms were prepared by the synthesis of tetrahydro-
1
H-1,3-diazepine and were then 
quarternized with an aryl halide. 
Scheme 157 
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 Camphor carbene precursors having sterically demanding nitrogen atoms have been also 
synthesized. The camphor diamine 149 was reacted with acetyl chloride followed by an 
alkylation of the other nitrogen atom. After that, reduction of the acetyl group to the ethyl group 
and finally to the substituted diamine was subjected to the salt formation step by treating it with 
triethylorthoformate in the presence of NH4BF4 (Scheme 158). 
Scheme 158 
 The salts were applied in different asymmetric catalytic reactions. The asymmetric 
allylation of aldehydes was investigated. The reaction was optimized by varying a number of 
conditions. The zwitterions or carbenes generated from the zwitterion precursors were used and 
an ee of up to 19% with nearly quantitative yields was obtained (Scheme 159). 
Scheme 159 
 The Wynberg reaction was catalyzed by highly nucleophilic camphor based carbenes. 
Good yields of up to 95% were achieved and significant ee of up to 92% were obtained. 
Scheme 160 
2. Results and Discussion 
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 Furthermore, potassium and sodium hexamethyldisilazane amides can act as highly 
active Lewis base catalysts in the [2+2] cycloaddition of ketenes with aldehydes. The speed 
and simplicity of the reported procedure makes it a valuable tool for preparing libraries of β-
lactones. It was also possible to obtain a tetrasubstituted β-lactone via the Wynberg reaction. 
In addition, it was shown that also KOtBu and NaOTMS are good Lewis base catalysts for 
these cycloadditions. These findings may encourage to explore tandem reactions with these 
bases or to develop chiral analogues. 
Scheme 160 
 A β-lactam synthesis was carried out with aromatic ketenes in the presence of carbenes 
derived from the zwitterions. Diphenylketene and tosyl protected imine 136b gave 50% yield 
and 85% ee, while nosyl protected imine 212b under similar conditions gave only 20% 
enantioselectivity. 
Scheme 161 
 The asymmetric TMSCN addition to aldehydes was performed by employing zwitterions 
as organocatalysts. The yield obtained in the reaction was up to 70% but no ee was observed, 
while with the carbene generated in situ from the corresponding zwitterion up to 99% yield and 
11% ee were obtained. 
Scheme 162 
2. Results and Discussion 
 
 
136 
 The carbene from imidazolinium zwitterion 136a was exploited in the TMSCF3 addition 
to benzaldehyde and 2-naphtaldehyde at rt obtaining yields of 90% and 99%, respectively, 
without enantioselectivity (Scheme 162). 
Scheme 163 
 The evaluation of zwitterions as chiral shift reagents was described in the last section of 
this chapter. The newly synthesized zwitterions were screened for their ability to resolve 
spectroscopically different racemic compounds like alcohols, cyanohydrins, carboxylic acids 
etc. The zwitterion 139c proved to be a versatile chiral discriminating agent for different types 
of racemic compounds. It interacted with α-(trifluoromethyl)benzyl alcohol and Mosher acid 
and splittings of 22 Hz and 26 Hz of the CF3 group were observed, respectively. The chemical 
shift differences of the protons for a number of racemic alcohols, cyanohydrins, and carboxylic 
acids were at an excellent level and their enantiomeric excesses can be measured simply by 
NMR experiment. Moreover problems associated with chiral lanthanide shift reagents like 
signal broadening due to their paramagnetic nature, are not present. 
 The prepared chiral carbene precursors are having still room for several other reactions 
especially [2+2] cycloaddition reaction for the synthesis of tetrasubstituted β-lactones and β-
lactams. They can also be used as ligands in metal catalyzed reactions. 
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 3.1.  General Experimental 
 Melting points 
Melting points were taken with an apparatus after Dr. Tottoli and are uncorrected. 
 IR 
Infrared spectra were recorded on a Bruker Vektor 22 FTIR spectrometer. With KBr 
pellets in case of solid compounds and as thin films between NaCl plates in cases of 
oils and liquids. 
 1H-NMR 
1
H-NMR spectra were acquired at ambient temperature on a Bruker AMX 400 (400 
MHz) and a Bruker AC 200F (200 MHz) in deuteriated solvents as stated. Chemical 
shifts are reported in ppm relative to tetramethylsilane as internal standard. 
 13C NMR 
13
C-NMR spectra were recorded at ambient temperature on a Bruker AMX 400 (100 
MHz) and a Bruker AC 200F (50 MHz) in the deuteriated solvents. Chemical shifts are 
reported in ppm relative to tetramethylsilane as internal standard. 
 19F-NMR 
19
F-NMR spectra were recorded at ambient temperature on a Bruker AMX 400 (378 
MHz). 
 LR-MS 
Mass spectra (EI) were recorded with a Hewlett Packard 5989B at 70 eV. Mass spectra 
(ESI) were recorded on Hewlett Packard MS LC/MSD Series 1100 MSD. 
 HR-MS 
High resolution mass spectra were measured on a Bruker Daltonik Tesla-Fourier 
Transform-Ion Cyclotron Resonance-Massspektrometer with Electrospray-Ionisation 
by Dr. Dräger at the Institute of Organic Chemistry, University of Hanover. 
3. Experimental 
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 Elemental Analysis 
Elemental analyses were carried out by the Microanalytical Laboratory of the Institut 
fur Pharmazeutische Chemie der Technische Universitat Braunschweig on “Elemental 
Analyzer” Model 1106 from the “Carlo Erba Instrumentazione” company.  
 Chromatography 
Flash column chromatography
[259] was performed on Sorbisil C-60. Reactions were 
monitored by TLC with Merck Silica gel 60 F254 plates. 
 HPLC Analysis 
HPLC analyses was carried out using a Daicel CHIRALPACK OD-H and a Daicel 
CHIRALPACK AD-H column with a Waters 510 Pump system, an ISCO Model UA-5 
UV/VIS Detector (254 nm) and a Waters 410 Differential Refractometer. 
 Solvent Purification THF and diethyl ether were distilled from sodium benzophenone 
ketyl. Toluene was distilled from sodium. CH2Cl2 and acetonitrile were distilled from 
calcium hydride. 
 Organic Compounds  
Organic compounds were either purchased from commercial sources like Merck, 
Aldrich, Fluka, Lancaster or Alfa Aesar or prepared as stated below. 
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 3.2.  Experimental Procedures for the Preparation of Carbene 
   Precursors 
 3.2.1.  Synthesis of 1,2-Diphenyl-1,2-ethylenediamine (119) 
(±) 2,2-Spirocyclohexane-4,5-diphenyl-2H-imidazole (118) 
 
 A three-necked round-bottom flask was charged with glacial acetic acid (500 mL), benzil 
(79 g, 0.375 mol, 1 eq), ammonium acetae (200 g) and cyclohexanone (40 mL, 0.38 mol, 1.026 
eq). The mixture was refluxed for 1.5 h and then, without cooling, poured into water (1.5 L). 
The reaction mixture was vigorously stirred. The mixture was left overnight to cool to ambient 
temperature. The crystals were collected by filtration, washed with water and dried to give 
imidazole 118 as yellowish-green crystals (105 g, 0.363 mol, 97% yield ). Spectral data were 
consistent with literature values.
260
 
(±)-1,2-Diphenyl-1,2-ethylenediamine (119)
 
 A 2 L three-necked round-bottom flask was charged with 2,2-spirocyclohexane-4,5-
diphenyl-2H-imidazole (72.0 g. 0.250 mol, 1 eq) and of THF (400 mL). The mixture was stirred 
until all solids dissolved, cooled to −78 °C and treated with a stream of gaseous ammonia until 
the volume of liquid increases by about 400 mL. Then lithium (6.94 g, 1.00 mol, 4 eq) was 
slowly introduced in a gentle stream of nitrogen. The slow rate of lithium addition ensured that 
the temperature did not rise above −65 °C. After that, the mixture was stirred for 30 min and 
ethanol (30 mL, 1.0 mol, 4 eq) was slowly added and additionally stirred for 20 min. 
Ammonium chloride (70 g) was added and the mixture was allowed to warm to 0 °C. Then 
water (400 mL) was carefully introduced. The phases were separated. The aqueous phase was 
washed with Et2O and the combined organic extracts were washed with brine, dried over 
anhydrous Na2SO4, filtered and concentrated to about 200 mL. The solution was transferred to a 
3. Experimental 
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1 L flask and cooled to 0 °C and treated with 2N HCl (300 mL). The biphasic mixture was 
vigorously stirred at ambient temperature for 1 h. Water (500 mL) was added and the phases 
were separated. The organic phase was washed with water and the combined aqueous phases 
were extracted with CH2Cl2. The aqueous solution was then treated with 2N NaOH (300 mL) 
and extracted with CH2Cl2. The combined organic extracts were washed with brine, dried over 
anhydrous Na2SO4 and filtered. Removal of the volatile material gave racemic diamine as a pale 
yellow solid (45 g, 0.21 mol, 89–94% yield). Spectral data were consistent with literature 
values.
261
 
Resolution of Racemate: (−)-(1S,2S) and (+)-(1R,2R)-1,2-Diphenyl-1,2-ethylenediamine
 
 The racemic diamine (21.25 g, 0.10 mol, 1 eq) was dissolved in ethanol (100 mL) by 
heating the mixture to 70 °C in a hot solution of L-(+)-tartaric acid (15.0 g, 0.100 mol) and 
ethanol (100 mL) was added. The tartarate salt precipitate out immediately. After the mixture 
was cooled to ambient temperature, the crystals were collected by filtration, washed with 
ethanol and dried. The solids were dissolved in boiling water (100 mL). Ethanol (1 L) was 
added and the homogeneous solution was allowed to cool slowly to rt. The crystals were 
collected by filtration, washed with ethanol and dried. The recrystallization procedure was then 
repeated twice using the same volume of solvents (100 mL of water and 100 mL of ethanol) to 
give the tartrate salt as colorless crystals (10.6 g, 50 mmol, 50% yield). Spectral data were 
consistent with literature values. 262 
 = −11 (H2O, c 1.3). 
 A round-bottom flask was charged with tartarate salt and water (150 mL). The mixture 
was vigorously stirred and cooled to 0–5 °C. Then 50% aqueous NaOH (12 mL) was added drop 
wise followed by CH2Cl2 (75 mL) and stirring was continued for 30 min. The phases were 
[ ]22Dα
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separated. The aqueous phase was washed with CH2Cl2 and the combined organic extracts were 
washed with brine, dried over anhydrous Na2SO4, filtered and dried. The obtained colorless 
solid was recrystallized from hexane as colorless crystals of (S,S)-(−)-diamine (yield 3.5 g). 
Spectral data were consistent with literature values.
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 = −106 (MeOH, c 1.1). 
 The filtrates from all crystallizations were combined and the solvent was evaporated. 
The residual solid was transferred to a round-bottom flask and water was added (150 mL). 
Thereafter 50% NaOH solution (12 mL) was slowly added followed by CH2Cl2 (100 mL) and 
the stirring was continued for 30 min. The phases were separated, the aqueous phase was 
washed with CH2Cl2 and the combined organic extracts were washed with brine, dried over 
anhydrous Na2SO4 and filtered. Removal of the volatile material gave 5 g of the enriched (R,R)-
diamine as pale yellow crystals. This material was treated with D-(−)-tartaric acid in exactly the 
same manner as described for the other enantiomer to give 5 g of colorless crystals. 
 = +4 (H2O, c 1.3). 
 Treatment with NaOH, as described above, followed by recrystallization from hexane 
gave 2 g of (R,R)-(+)-diamine as colorless crystals. 
 = +106 (MeOH, c 1.1). 
3.3.  Synthesis of Imidazolinium Zwitterions 
 3.4.  Monoalkylation of Diamine 119 
(1R,2R)-1,2-Diphenyl-N
1
-(2,4,6-trimethylbenzylidene)ethane-1,2-diamine (120)
 
 2,4,6-Trimethylbenzylaldyde (152a) (0.58 mL, 3.96 mmol, 1 eq) and (+)-(1R,2R)-1,2-
diphenyl-1,2-ethylenediamine (119) (841 mg, 3.969 mmol, 1 eq) were stirred in water (15 mL) 
overnight. The mixture was extracted three times with CH2Cl2 and the solvent was removed to 
[ ]22Dα
[ ]22Dα
[ ]22Dα
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afford the product as a cis/trans mixture of a yellow semisolid (1.35 g, 3.96 mmol, 99% yield). 
The product was used in the next step without purification. 
 1H-NMR (CDCl3, 200 MHz): δ = 8.64 (s, 1 H, Ar-CH-imine), 8.60 (s, 1 H, Ar-CH-
imine), 7.40 - 7.14 (m, 20 H, ArH), 6.89 (s, 2 H, ArH), 6.81 (s, 2 H, ArH), 4.75 (s, 1 
H, CH(N)-CH-Ar), 4.42 (d, J = 2.3 Hz, 2 H, CH(N)-CH-Ar), 2.40 (s, 6 H, Ar-2xCH3), 
2.32 (s, 9 H, Ar-3xCH3), 2.28 (s, 3 H, Ar-CH3), 2.08 (br s, 3 H, NH2). 
 13C-NMR (CDCl3, 50 MHz): δ = 162.3 (Ar-CH-imine), 161.2 (Ar-CH-imine), 142.6 
(ArC), 142.3 (ArC), 141.7 (ArC), 139.0 (ArC), 138.6 (ArC), 138.1 (ArC), 137.9 
(ArC), 130.5 (ArCH), 129.5 (ArCH), 129.3 (ArCH), 128.3 (ArCH), 128.3 (ArCH), 
128.0 (ArCH), 127.9 (ArCH), 127.8 (ArCH), 127.5 (ArCH), 127.1 (ArCH), 126.9 
(ArCH), 126.8 (ArCH), 126.6 (ArCH), 83.9 (CH(N)-CH-Ar), 83.6 (CH(N)-CH-Ar), 
62.3 (CH(N)-CH-Ar), 21.1 (CH3), 21.0 (CH3), 20.9 (CH3). 
(1R,2R)-1,2-Diphenyl-N
1
-(2,4,6-trimethylbenzyl)ethane-1,2-diamine (121)
 
 (1R,2R,)-1,2-Diphenyl-N
1
-(2,4,6-trimethylbenzylidene)ethane-1,2-diamine (120) (1.24 g, 
3.6 mmol, 1 eq) was dissolved in dry methanol (60 mL) under a stream of nitrogen and NaBH4 
(112 mg, 10.8 mmol, 3 eq) was added slowly. After stirring at rt overnight, water was carefully 
added and the methanol was removed under reduced pressure. Ethyl acetate was added and the 
organic layer was washed three times with a solution of 1N HCl. The aqueous layer was then 
basified with pellets of NaOH and extracted three times with CH2Cl2. The combined organic 
layers were dried (Na2SO4) and the solvent was removed to give a yellow oil (1.2 g, 3.49 mmol, 
97% yield). The product was used in the next step without purification. 
N
1
-(2,4,6-Trimethylbenzyl)ethane-1,2-diamine (124)
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 A round-bottom flask was charged with absolute methanol and ethylenediamine (10 mL, 
150 mmol, 2 eq), and then cooled in an ice bath. A solution of 2,4,6-trimethylbenzylaldyde 
(152a) (11.0 mL, 75 mmol, 1 eq) in absolute methanol (l20 mL) was added via a dropping 
funnel. The resulting solution was stirred for 24 h at rt and then the solution was cooled again in 
an ice bath and solid sodium borohydride (5.6 g, 150 mmol) was added in 5-7 portions over 20 
min. The reaction was allowed to warm to rt and stirred for an additional 24 h. After that, water 
was carefully added and the methanol was removed under reduced pressure. The aqueous layer 
was then basified with pellets of NaOH and extracted three times with CH2Cl2. The combined 
organic layers were dried (Na2SO4) and the solvent was removed to give a yellow oil. The 
excess of ethylenediamine was removed at low pressure and the desired product was obtained in 
91% as an oil. Spectral data were consistent with literature values.
180
  
 1H-NMR (CDCl3, 200 MHz): δ = 6.83 (s, 2H), 3.73 (s, 2H), 2.94 - 2.61 (m, 
 4H), 2.35 (s, 6H), 2.24 (s, 3H).  
 13C-NMR (CDCl3, 200 MHz): δ = 136.8, 136.3, 133.8, 128.9, 52.7, 47.5,  41.8, 
 20.8, 19.5. 
(1R,2R)-1,2-Diphenyl-N
1
-(o-tolyl)ethane-1,2-diamine (126) 
 
 Under an inert atmosphere, palladium acetate (0.526 mg, 0.235 mmol, 5 mol%), BINAP 
(293 mg, 0.47 mmol, 10 mol%), and sodium 
t
butoxide (1.36 g, 14.13 mmol) were added to 
toluene and stirred for 20 min. (R,R)-Diphenylethylenediamine (1.00 g, 4.71 mmol, 1 eq) and 2-
bromotoluene (805 mg, 4,71 mmol, 1 eq) were then added and the solution was heated to 100 °C 
for 16 h. The solution was cooled to ambient temperature, diluted with hexane (75 mL) and 
filtered through a plug of silica. The silica was washed with a CH2Cl2/MeOH mixture to elute 
the crude product. The filtrate was concentrated and dissolved in CH2Cl2. 12M HCl was added 
and the organic layer was separated. The water layer was washed with CH2Cl2 (2x) and the 
organic layer was discarded. After that, the water layer was cooled with an ice bath and 
carefully basified by drop wise addition of concentrated NaOH, till it became strongly basic (pH 
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14), followed by extraction with CH2Cl2. The desired product was obtained after removing the 
solvent as a white solid (1.37 g, 4.5 mmol, 96% yield). 
 mp: 94 °C 
 = +93.4 (c = 1, CH2Cl2). 
 IR (KBr): 3438, 3387, 3384, 3024, 2909, 2859, 2738, 1909, 1777, 1606, 1512, 1449, 
1351, 1319, 1209, 1124, 1048, 1025, 926, 902, 844, 789, 767, 744, 574, 531, 479, 443 
cm
−1
.  
 MS (EI): m/z 261 (M++H, 10%), 229 (15), 203 (25), 144 (25), 130 (100), 100 (50), 86 
(50), 74 (40), 57 (45). 
 HRMS (ESI): Calcd. for C14H33N2O2: 261.2542, found: 261.2546. 
 1H-NMR (CDCl3, 200 MHz): δ = 7.40 – 7.03 (m, 10H, ArH), 6.89 (dd, J = 7.3, 0.6 
Hz, 1H, ArH), 6.81 – 6.65 (m, 1H, ArH), 6.49 – 6.33 (m, 1H, ArH), 6.14 – 5.98 (m, 
1H, ArH), 4.41 (d, J = 4.3 Hz, 1H, CH(N)-CH-Ar), 4.25 (d, J = 4.3 Hz, 1H, CH(N)-
CH-Ar), 2.15 (s, 3H, Ar-CH3), 1.65 (br s, 2H, NH2). 
 13C-NMR (CDCl3, 50 MHz): δ = 145.3 (ArC), 142.8 (ArC), 141.6 (ArC), 129.8 
(ArCH), 128.64 (ArCH), 128.4 (ArCH), 127.5 (ArCH), 127.3 (ArCH), 126.9 (ArCH), 
126.8 (ArCH), 122.3 (ArC), 116.4 (ArCH), 110.9 (ArCH), 63.3 (CH(N)-CH-Ar), 61.3 
(CH(N)-CH-Ar), 17.7 (CH3). 
 3.5.  General Procedure for the Synthesis of Imidazoline.
264
 
 
 A mixture of monoalkylated diamine (1 eq), trimethyl orthoformate (1.06 eq) and acetic 
acid (1.06 eq) in CH3CN was refluxed for 1 h under an inert atmosphere. The resulting mixture 
was then allowed to cool to rt before being concentrated to dryness, taken up in 40% aqueous 
KOH and extracted with CH2Cl2. The combined organic layers were then dried with KOH 
pellets, filtrated, and concentrated to dryness. The expected dihydroimidazole was purified with 
FCC (MeOH/CH2Cl2, 5:95) as a solid. 
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(4R,5R)-4,5-Diphenyl-1-(2,4,6-trimethylbenzyl)-1H-imidazoline (122)
 
 Prepared from diamine 121 (1.00 g, 2.9 mmol, 1 eq), trimethyl orthoformate (0.3 mL, 
3.1 mmol, 1.06 eq) and acetic acid (0.176 mL, 3.1 mmol, 1.06 eq) in CH3CN by refluxing for 1 
h under an inert atmosphere. The dihydroimidazole 122 was purified with FCC (MeOH/CH2Cl2 
5:95) as a light yellow solid (712 mg, 2.03 mmol, 70% yield). 
 mp: 112 °C 
 = +17.8 (c = 1, CH2Cl2). 
 IR (KBr 3426, 3085, 3032, 2974, 2944, 2919, 2860 2800, 1950, 1880, 1880, 1748, 
1668, 1597, 1452, 1396, 1303, 1245, 1219, 1153, 1074, 1029, 1219, 993, 904,  858, 
797, 772, 751, 699, 626, 562, 499, 447 cm
−1
.  
 MS (EI): m/z 354 (M+, 50%), 238 (2), 221 (75), 133 (40), 117 (15), 91 (100), 77 (5), 
51 (2). 
 HRMS (ESI): Calcd. for C25H27N2: 355.2174, found: 355.2170. 
 1H-NMR (CDCl3, 200 MHz): δ = 7.29 – 7.18 (m, 10H, ArH and N-CH-N), 6.89 (d, J 
= 1.6 Hz, 1H, ArH), 6.77 (s, 2H, ArH), 4.92 (dd, J = 9.5, 1.6 Hz, 1H, N-CH2-Ar), 4.03 
(dt, J = 21.7, 11.2 Hz, 3H, N-CH2-Ar and 2xCH(N)-CH-Ar), 2.18 (s, 3H, Ar-CH3), 
2.10 (s, 6H, Ar-2xCH3). 
 13C-NMR (CDCl3, 50 MHz): δ = 155.1 (N-CH-N), 143.3 (ArC), 140.7 (ArC), 137.8 
(ArC), 137.5 (ArC), 129.3 (ArCH), 128.9 (ArCH), 128.5 (ArCH), 128.48 (ArC), 
128.0 (ArCH), 127.2 (ArCH), 126.6 (ArCH), 80.1 (CH(N)-CH-Ar), 74.4 (CH(N)-CH-
Ar), 44.6 (N-CH2-Ar), 20.9 (Ar-CH3), 19.7(Ar-2xCH3). 
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(4R,5R)-4,5-Diphenyl-1-o-tolyl-1H-imidazoline (127)
 
 Prepared from diamine 126 (362 mg, 1.2 mmol, 1 eq), trimethyl orthoformate (0.140 
mL, 1.27 mmol, 1.06 eq) and acetic acid (0.72 µL, 1.27 mmol, 1.06 eq) in CH3CN by refluxing 
for 1 h under an inert atmosphere. The dihydroimidazole 127 was obtained as as a light yellow 
solid with traces of impurities (300 mg, 0.96 mmol, 80% yield) after FCC (MeOH/CH2Cl2, 
5:95). The product was used in the next step without further purification. 
 MS (EI): m/z 312 (M+, 20%), 196 (100), 118 (25), 104 (6), 91 (40), 77 (25), 65 (25), 
51 (10). 
 HRMS (ESI): Calcd. for C22H21N2: 313.1705, found: 313.1694. 
 1H-NMR (CDCl3, 200 MHz): δ = 7.36 (d, J = 1.8 Hz, 1H, ArH), 7.34 - 7.11 (m, 10H, 
ArH and N-CH-N), 7.10 - 7.01 (m, 1H, ArH), 6.99 - 6.90 (m, 2H, ArH), 6.84 (dd, J = 
5.3, 4.0 Hz, 1H, ArH), 5.13 (dd, J = 9.1, 1.8 Hz, 1H, CH(N)-CH-Ar), 4.82 (d, J = 9.1 
Hz, 1H, CH(N)-CH-Ar), 2.24 (s, 3H, Ar-CH3). 
 13C-NMR (CDCl3, 50 MHz): δ = 161.6 (N-CH-N), 144.7 (ArC), 139.5 (ArC), 137.8 
(ArC), 130.1 (ArCH), 128.8 (ArCH), 128.3 (ArCH), 128.2 (ArCH), 127.6 (ArCH), 
127.5 (ArCH), 127.3 (ArCH), 126.9 (ArCH), 122.6 (ArC), 117.3 (ArCH), 110.9 
(ArC), 63.3 (CH(N)-CH-Ar), 57.9 (CH(N)-CH-Ar), 17.7 (Ar-CH3). 
1-(2,4,6-Trimethylbenzyl)-1H-imidazoline (125)
 
 N-(2,4,6-Trimethylbenzyl)ethylenediamine (124) (3.40 g, 17.64 mmol, 1 eq) and N,N-
dimethylformamide dimethylacetal (2.6 mL, 19.4 mmol, 1.1 eq) were heated at 90–95 °C for 2 
h. In order to remove MeOH and HNMe2, the residue was further heated to 120 °C for 1 h. The 
volatiles were removed under vacuum and the remaining yellow viscous liquid was distilled 
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under vacuum (108–109 °C/0.01 mmHg) to give a colorless liquid, which solidified on standing 
as a white solid (3.2 g 15.87 mmol, 90% yield). The spectroscopic properties concur with 
published data.
265
 
 1H-NMR (CDCl3, 200 MHz): δ = 6.84 (s, 2H), 6.68 (t, J = 1.6 Hz, 1H), 4.17 (s, 2H), 
3.76 (td, J = 9.9, 1.0 Hz, 2H), 3.14 (t, J = 9.9 Hz, 2H), 2.29 (s, 6H), 2.24 (s, 3H). 
 13C-NMR (CDCl3, 50 MHz): δ = 156.8, 137.6, 137.43, 129.7, 129.4, 77.9, 77.2, 76.6, 
55.2, 49.1, 45.7, 21.1, 19.9. 
 3.6.  General Procedure for the Synthesis of Chiral Cyclic  
   Sulphamidates.
 
 To a solution of an amino alcohol (1 eq) in CH2Cl2 at −20 °C was added triethylamine (4 
eq) followed by the drop wise addition of sulphuryl chloride (1.5 eq). The mixture was allowed 
to warm to 0 °C in 4 h. Then 1M HCl was added and the organic phase was separated. The 
aqueous phase was washed with CH2Cl2 two times. The combined organic phases were 
concentrated in vacuo, and the residue was purified by FCCon silica gel to afford the 
sulfamidate as a white solid. 
(S)-Tetrahydro-3H-pyrrolo[1,2-c][1,2,3]oxathiazolea1,1-dioxide (134)
 
 Prepared from of (S)-(+)-2-pyrrolidinemethanol (130) (103,6 mg, 1.036 mmol, 1 eq), 
triethylamine (0.575 mL, 4.13 mmol, 4 eq) and sulphuryl chloride (0.125 mL, 1.554 mmol, 1.5 
eq) at −20 - 0 °C in 4 h. The residue was purified by FCCon silica gel (ethyl acetate/petrol ether 
40:60) to afford the sulfamidate 134 as a white solid (102 mg, 0.62 mmol, 66% yield). Spectral 
data were consistent with literature values.
266
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 1H-NMR (CDCl3, 200 MHz): δ = 4.53 (dd, J = 8.6, 6.8 Hz, 1H), 4.25 (ddd, J = 13.0, 
6.8, 4.0 Hz, 1H), 4.02 (dd, J = 8.6, 6.0 Hz, 1H), 3.76 – 3.55 (m, 1H), 3.24 (dt, J = 11.2, 
6.9 Hz, 1H), 2.15 (ddd, J = 12.8, 9.3, 5.6 Hz, 1H), 2.03 - 1.67 (m, 3H). 
 13C-NMR (CDCl3, 50 MHz): δ = 71.8, 62.4, 51.1, 31.2, 25.1. 
(4R,5R)-3,4-Dimethyl-5-phenyl-1,2,3-oxathiazolidine 2,2-dioxide (132)
 
 Prepared from (1R,2R)-(−) pseudoephedrine alcohol 129 (100 mg, 0.61 mmol, 1 eq), 
triethylamine (0.340 mL, 2.44 mmol, 4 eq) and sulphuryl chloride (74µL, 0.91 mmol, 1.5 eq) at 
−20 °C-0 °C in 4 h. The residue was purified by FCCon silica gel (ethyl acetate/petrol ether 
40:60) to afford the sulfamidate 132 as a white solid (92 mg, 0.402 mmol, 66% yield). Spectral 
data were consistent with literature values.
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 1H-NMR (CDCl3, 200 MHz): δ = 7.32 (d, J = 33.6 Hz, 5H), 5.15 (d, J = 9.4 Hz, 1H), 
3.64 - 3.22 (m, 1H), 2.76 (s, 3H), 1.35 - 1.08 (m, 3H). 
 13C-NMR (CDCl3, 50 MHz): δ = 133.7, 130.2, 129.2, 127.4, 88.4, 63.7, 31.1, 14.7. 
 3.7.  General Procedure for Quaternization of Imidazoline 
 
 A solution of imidazoline (1 eq) in CH2Cl2 or acetone was treated with sulphonate or 
sulphamidate (1.5-2 eq) for 5-7 d at rt. After that, the solvent was removed under reduced 
pressure and the imidazolinium zwitterion was purified by FCC and obtained as white a solid.
268
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 3.7.1.  Synthesis of Imidazolinium Zwitterions from Imidazoline 
   122 
3-((4R,5R)-4,5-Diphenyl-1-(2,4,6-trimethylbenzyl)-4,5-dihydro-1H-imidazol-3-ium-3-
yl)propane-1-sulfonate (136a)
 
 Prepared from (4R,5R)-4,5-diphenyl-1-(2,4,6-trimethylbenzyl)-1H-imidazoline (122) 
(532mg, 1.5 mmol, 1 eq) and cyclic sulfonate esters 1,3-propane sultone 128 (367 mg, 3.0 
mmol, 2 eq) in acetone for 5 d. The residue was purified by FCC (MeOH/CH2Cl2 10:90) to 
afford the imidazolinium zwitterion 136a as a white solid (579 mg, 1.21 mmol, 81% yield).
 
 mp: >350 °C 
 = +105.6 (c = 1, CH2Cl2). 
 IR (KBr): 3442, 3034, 2923, 1638, 1496, 1457, 1207, 1039, 758, 701, 621, 523 cm−1. 
 MS (ESI): m/z = 499.2031 [M++Na]. 
 HRMS (ESI): Calcd. for C28H33N2O2S: 477.2212, found: 477.2201. 
 1H-NMR (CDCl3, 200 MHz): δ = 9.55 (s, 1H, N-CH-N), 7.45 - 6.99 (m, 12H, ArH), 
6.69 (s, 2H, ArH), 5.00 (dd, J = 25.3, 11.9 Hz, 2H, 2xCH(N)-CH-Ar), 4.41 (dd, J = 
19.8, 11.8 Hz, 2H, N-CH2-Ar), 3.45 - 3.20 (m, 1H, N(CH2)-CH2-SO3), 3.08 (dd, J = 
8.6, 6.1 Hz, 1H, N(CH2)-CH2-SO3), 2.92 (t, J = 6.8 Hz, 2H, N(CH2)-CH2-SO3), 2.14 
(s, 3H, Ar-CH3), 2.10 - 1.96 (m, 2H, N(CH2)-CH2-SO3), 1.90 (s, 6H, Ar-2xCH3). 
 13C-NMR (CDCl3, 50 MHz): δ = 159.9 (N-CH-N), 158.1 (ArC), 138.9 (ArC), 138.4 
(ArC), 135.22 (ArC), 134.9 (ArCH), 130.2 (ArCH), 130.1 (ArCH), 130.1 (ArCH), 
129.8 (ArCH), 127.8 (ArCH), 127.2 (ArCH), 124.8 (ArC), 73.5 (CH(N)-CH-Ar), 72.5 
(CH(N)-CH-Ar), 53.8 (N-CH2-Ar), 48.3 (N(CH2)-CH2-SO3), 45.6 (N(CH2)-CH2-
SO3), 22.6 (N(CH2)-CH2-SO3), 21.1 (Ar-CH3), 19.8 (Ar-CH3). 
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(S)-2-((4R,5R)-4,5-Diphenyl-1-(2,4,6-trimethylbenzyl)-4,5-dihydro-1H-imidazol-3-ium-3-
yl)methyl)pyrrolidine-1-sulfonate (136b)
 
 Prepared from imidazoline 122 (532 mg, 1.5 mmol, 1 eq) and sulphamidate 129 (367 
mg, 3.0 mmol, 2 eq) in CH2Cl2 for 7 d. The residue was purified by FCC (MeOH/CH2Cl2 10:90) 
to afford the imidazolinium zwitterion 136b as a white solid (579 mg, 1.21 mmol, 81% yield). 
 mp: 295 °C 
 = +129.7 (c = 1, CH2Cl2). 
 IR (KBr): 3449, 3035, 2960, 2870, 1735, 16370, 1497, 1457, 1372, 1198, 1112, 852, 
759, 703, 636, 581, 553 cm
−1
. 
 MS (ESI): m/z = 540.8 [M++Na]. 
 HRMS (ESI): Calcd. for C30H35N3O3S: 518.2477, found: 518.2474, Calcd. for 
C30H35N3O3NaS: 540.2297, found: 540.2290. 
 1H-NMR (CDCl3, 400 MHz): δ = 9.85 (s, 1 H, N-CH-N), 7.42 - 7.32 (m, 5 H, ArH), 
7.29 - 7.25 (m, 3 H, ArH), 7.17 - 7.11 (m, 2 H, ArH), 6.71 (s, 2 H, ArH), 5.44 (d, J = 
10.8 Hz, 1 H, CH(N)-CH-Ar), 5.26 (d, J = 14.9 Hz, 1 H, N-CH2-Ar), 4.58 (d, J = 14.7 
Hz, 1 H, N-CH2-Ar), 4.41 - 4.35 (m, 1 H, CH2-CH-NSO3), 4.33 (d, J = 10.8 Hz, 1 H, 
CH(N)-CH-Ar) 3.87 (dd, J = 4.0, 14.2 Hz, 1 H, CH2-NSO3), 3.61 (td, J = 7.5, 10.7 
Hz, 1 H, CH2-NSO3), 3.24 (ddd, J = 5.0, 6.4, 11.0 Hz, 1 H, CH2-NSO3), 2.77 (dd, J = 
9.1, 14.2 Hz, 1 H, CH2-NSO3), 2.20 (s, 3 H, Ar-CH3), 2.12 - 2.03 (m, 1 H, CH2-
NSO3), 2.02 - 1.92 (m, 1 H, CH2-NSO3), 1.89 (s, 6 H, Ar-2xCH3), 1.61 - 1.48 (m, 1 
H, CH2-NSO3), 1.42 - 1.32 (m, 1 H, CH2-NSO3). 
 13C-NMR (CDCl3, 100 MHz): δ = 161.4 (N-CH-N), 138.5 (ArC), 138.2 (2xArC), 
135.5 (ArC), 134.9 (ArC), 129.7 (ArCH), 129.6 (ArCH), 129.5 (ArCH), 129.5 
(ArCH), 128.6 (ArCH), 127.5 (ArCH), 125.1 (ArC), 76.6 (CH(N)-CH-Ar), 72.5 
[ ]22Dα
3. Experimental 
 
 
151 
(CH(N)-CH-Ar), 59.8 (CH2-CH-NSO3), 50.3 (CH2), 50.2 (CH2), 45.17 (CH2), 29.9 
(CH2), 24.8 (CH2), 20.9 (Ar-CH3), 19.7 (Ar-2xCH3). 
((1R,2R)-1-((4S,5S)-4,5-Diphenyl-1-(2,4,6-trimethylbenzyl)-4,5-dihydro-1H-imidazol-3-
ium-3-yl)-1-phenylpropan-2-yl)(methyl)sulfamate (136c)
 
 Prepared from imidazoline ent-122 (825 mg, 2.33 mmol, 1 eq) and sulphamidate 130 
(846 mg, 3.72 mmol, 1.6 eq) in CH2Cl2 for 7 d. The residue was purified by FCC 
(MeOH/CH2Cl2 10:90) to afford the imidazolinium zwitterion 136c as a white solid (745 mg, 
1.28 mmol, 55% yield). 
 mp: >450 °C 
 = − 117.8 (c = 1, CH2Cl2). 
 IR (KBr): 34540, 2922, 1628, 1456, 1203, 1036, 862, 756, 700, 669, 595 cm−1. 
 MS (ESI): m/z = 604 [M++Na]. 
 HRMS (ESI): Calcd. for C35H40N3O3S: 582.2790, found: 582.2790, Calcd. for 
C35H40N3O3NaS: 604.2610, found: 604.2605. 
 1H-NMR (CDCl3, 200 MHz): δ = δ 11.14 (s, 1H, N-CH-N), 7.48 – 7.33 (m, 9H, 
ArH), 7.29 – 7.20 (m, 2H, ArH), 7.02 – 6.86 (m, 4H, ArH), 6.75 (s, 2H, ArH), 5.15 
(d, J = 14.8 Hz, 1H, CH(N)-CH-Ar), 4.95 (tt, J = 6.9, 3.3 Hz, 1H, ArCH-CH-
CH3NSO3), 4.65 (d, J = 14.7 Hz, 1H, CH(N)-CH-Ar), 4.37 (dd, J = 19.6, 8.4 Hz, 2H, 
N-CH2-Ar), 3.81 (d, J = 2.3 Hz, 1H, CH(N)-CH-Ar), 2.21 (s, 3H, Ar-N-CH3), 2.11 (s, 
3H, Ar-CH3), 1.94 (s, 6H, Ar-CH3), 1.25 (d, J = 7.0 Hz, 3H, CH-CH3). 
 13C-NMR (CDCl3, 50 MHz): δ = 159.6 (ArCH), 138.9 (ArC), 138.1 (ArC), 135.4 
(ArC), 134.9 (ArC), 132.2 (ArC), 130.1 (ArCH), 130.0 (ArCH), 129.8 (ArCH), 129.7 
(ArCH), 129.3 (ArCH), 128.9 (ArCH), 128.5 (ArCH), 126.8 (ArCH), 126.7, 124.1 
(ArC), 73.6 (CH(N)-CH-Ar), 70.1 (CH(N)-CH-Ar), 65.4 (CH(N)-CH-Ar), 54.5 (CH3-
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CH), 45.8 (N-CH2-Ar), 32.0 (N-CH3), 20.8 (Ar-CH3), 19.6 (Ar-2xCH3), 14.5 (CH-
CH3). 
(S)-2-(((4S,5S)-4,5-Diphenyl-1-(2,4,6-trimethylbenzyl)-4,5-dihydro-1H-imidazol-3-ium-3-
yl)methyl)pyrrolidine-1-sulfonate (137) 
 
 Prepared from ent-122 (800 mg, 2.26 mmol, 1 eq) and sulphamidate 129 (553 mg, 3.38 
mmol, 1.5 eq) in CH2Cl2 for 7 d. The residue was purified by FCC (MeOH/CH2Cl2 10:90) to 
afford the imidazolinium zwitterion 137 as a white solid (1.15 g, 2.23 mmol, 99% yield).
 
 mp: 296 °C 
 = −13.5 (c = 1, CH2Cl2). 
 IR (KBr): 3452, 2963, 1634, 1496, 1457, 1379, 1197, 1109, 1037, 977, 852, 757, 
702, 634, 554 cm
−1
. 
 MS (ESI): m/z = 540.8 [M++Na]. 
 HRMS (ESI): Calcd. for C30H35N3O3NaS: 540.2306, found: 540.2297. 
 1H-NMR (CDCl3, 200 MHz): δ = 9.47 (s, 1 H, N-CH-N), 7.41 - 7.29 (m, 5 H, ArH), 
7.22 - 7.14 (m, 2 H, ArH), 7.09 (td, J = 3.2, 5.9 Hz, 3 H, ArH), 6.76 (s, 2 H, ArH), 
5.54 - 5.46 (m, 1 H, CH(N)-CH-Ar), 5.43 (d, J = 8.3 Hz, 1 H, CH(N)-CH-Ar), 4.37 - 
4.22 (m, 2 H, CH2-CH-NSO3 and CH2), 4.14 - 3.97 (m, 1 H, CH2), 3.80 - 3.37 (m, 3 
H, CH2), 3.03 - 2.83 (m, 1 H, CH2), 2.24 (s, 3 H, Ar-CH3), 2.14 - 2.01 (m, 1 H, CH2), 
2.01 - 1.93 (m, 1 H, CH2), 1.87 (s, 6 H, Ar-2xCH3), 1.80 - 1.67 (m, 1 H, CH2), 1.32 - 
1.20 (m, 1 H, CH2). 
 13C-NMR (CDCl3, 50 MHz): δ = 160.2 (N-CH-N), 138.5 (ArC), 138.2 (ArC), 134.4 
(ArC), 133.8 (ArC), 129.6 (ArCH), 129.5 (ArCH), 129.3 (ArCH), 129.2 (ArCH), 
127.5 (ArCH), 124.8 (ArC), 73.0 (CH(N)-CH-Ar), 72.8 (CH(N)-CH-Ar), 55.3 (CH2-
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CH-NSO3), 51.5 (CH2), 50.5 (CH2), 44.8 (CH2), 29.8 (CH2), 24.9 (CH2), 20.8 (Ar-
CH3), 19.8 (Ar-2xCH3). 
 3.7.2.  Synthesis of Imidazolinium Zwitterions from Imidazoline 
   125 
(S)-2-((1-(2,4,6-Trimethylbenzyl)-4,5-dihydro-1H-imidazol-3-ium-3-yl) ethyl)pyrrolidine-1-
sulfonate (138a) 
 
 Prepared from imidazoline 125 (413 mg, 2.04 mmol, 1 eq) and sulphamidate 129 (500 
mg, 3.06 mmol, 1.5 eq) in CH2Cl2 for 7 d. The residue was purified by FCC (MeOH/CH2Cl2 
15:85) to afford the imidazolinium zwitterion 138a as a white solid (709 mg, 1.39 mmol, 95% 
yield). 
 mp:>350 °C 
 = +40.3 (c = 1, CH2Cl2). 
 IR (KBr) 3455, 2964, 1651, 1449, 1278, 1190, 1124, 1039, 981, 853, 730, 689, 633, 
581, 471 cm
−1
. 
 MS (ESI): m/z = 388 [M++Na]. 
 HRMS (ESI): Calcd. for C18H28N3O3S: 366.1815, found: 366.1838, Calcd. for 
C18H27N3O3NaS: 388.1671, found: 388.1664. 
 1H-NMR (CDCl3, 200 MHz): δ = 8.31 (s, 1H, N-CH-N), 6.74 (s, 2H, ArH), 4.60 (q, J 
= 14.6 Hz, 2H, CH2), 4.04 (dd, J = 20.0, 9.6 Hz, 1H, CH2-CH-NSO3), 3.96 – 3.73 (m, 
2H, CH2), 3.72 – 3.50 (m, 2H, CH2), 3.48 – 3.29 (m, 2H, CH2), 3.27 – 3.07 (m, 2H, 
CH2), 2.21 (s, 6H, Ar-CH3), 2.13 (s, 3H, Ar-CH3), 2.07 – 1.83 (m, 1H, CH2), 1.83 – 
1.67 (m, 1H, CH2), 1.63 (dd, J = 13.3, 6.3 Hz, 1H, CH2), 1.49 – 1.25 (m, 1H, CH2). 
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 
13
C-NMR (CDCl3, 50 MHz): δ = 157.9 (N-CH-N), 138.6 (ArC), 137.9 (ArC), 129.6 
(ArCH), 125.7 (ArC), 56.9 (, CH2-CH-NSO3), 52.4 (CH2), 50.1 (CH2), 49.5 (CH2), 
48.0 (CH2), 45.8 (CH2), 29.3 (CH2), 24.6 (CH2), 20.8 (Ar-CH3), 19.7 (Ar-2xCH3). 
Methyl((1R,2R)-1-phenyl-1-(1-(2,4,6-trimethylbenzyl)-4,5-dihydro-1H-imidazol-3-ium-3-
yl)propan-2-yl) (138b)  
 
 Prepared from imidazoline 122 (297 mg, 1.46 mmol, 1 eq) and sulphamidate 129 (500 
mg, 2.2 mmol, 1.5 eq) in CH2Cl2 for 7 d. The residue was purified by FCC (MeOH/CH2Cl2 
10:90) to afford the imidazolinium zwitterion 138b as a white solid (596 mg, 1.38 mmol, 95% 
yield). 
 mp: 299 °C 
 = +35.5 (c = 1, CH2Cl2). 
 IR (KBr): 3457, 2969, 2236, 1641, 1456, 1379, 1197, 1097, 1036, 943, 923, 876, 
747, 591 cm
−1
. 
 MS (ESI): m/z = 451.7 [M++Na]. 
 HRMS (ESI): Calcd. for C23H32N3O3S: 430.2164, found: 430.2147, Calcd. for 
C23H31N3O3NaS: 452.1984, found: 452.1976. 
 1H-NMR (CDCl3, 200 MHz): δ = 10.16 (s, 1H, N-CH-N), 7.20 - 7.46 (m, 5H, ArH), 
6.87 (s, 2H, ArH), 4.70 - 4.98 (m, 3H, N-CH2-Ar, ArCH-CH-CH3NSO3), 4.55 (d, J = 
4.22 Hz, 1H, CH(N)-CH-Ar), 3.34 - 3.90 (m, 4H, N-2xCH2-N), 2.36 (s, 6H, Ar-
2xCH3), 2.25 (s, 3H, N-CH3), 2.18 (s, 3H, Ar-CH3), 1.38 (d, J = 6.91 Hz, 3H, CH-
CH3). 
 13C-NMR (CDCl3, 50 MHz): δ = 158.9 (NCHN), 138.8 (ArC), 137.9 (ArC), 133.8 
(ArC), 129.7 (ArCH), 128.7 (ArCH), 128.6 (ArCH), 125.8 (ArC), 66.9 (CH(N)-CH-
Ar), 53.7 (CH(N)-CH-Ar), 48.4 (CH(N)-CH-Ar), 46.3 (N-2xCH2-N), 31.8 (N-CH3), 
20.9 (Ar-CH3), 20.0 (Ar-2xCH3), 14.1 (CH-CH3). 
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 3.7.3.  Synthesis of Imidazolinium Zwitterions from Imidazoline 
   127 
(S)-2-(((4R,5R)-4,5-Diphenyl-1-(o-tolyl)-4,5-dihydro-1H-imidazol-3-ium-3-yl) methyl) 
pyrrolidine-1-sulfonate (139a)
 
 Prepared from imidazoline 127 (26.8 mg, 0.085 mmol, 1 eq) and sulphamidate 129 (21 
mg, 0.128 mmol, 1.5 eq) in CH2Cl2 for 6 d. The residue was purified by FCC 
(MeOH/ethylacetate/CH2Cl2 60:20:20) to afford the imidazolinium zwitterion 139a as a white 
solid (20.61 mg, 0.043 mmol, 55% yield). 
 1H-NMR (CDCl3, 400 MHz): δ = 9.20 (s, 1H, N-CH-N), 7.54 - 7.43 (m, 3H, ArH), 
7.40 - 7.32 (m, 4H, ArH), 7.33 - 7.26 (m, 4H, ArH), 7.16 - 7.01 (m, 3H, ArH), 5.49 
(d, J = 10.2 Hz, 1H, CH(N)-CH-Ar), 5.39 (d, J = 10.2 Hz, 1H, CH(N)-CH-Ar), 4.13 – 
4.00 (m, 2H, CH2-NSO3, and CH2-CH-NSO3), 3.54 (dt, J = 10.3, 7.5 Hz, 1H, CH2-
NSO3), 3.39 - 3.29 (m, 1H, CH2-NSO3), 3.08 (dd, J = 13.9, 5.0 Hz, 1H, CH2-NSO3), 
2.37 (s, 3H, Ar-CH3), 2.04 (dt, J = 7.9, 5.2 Hz, 1H, CH2-NSO3), 1.97 - 1.81 (m, 1H), 
1.68 - 1.56 (m, 1H, CH2-NSO3), 1.38 (td, J = 12.7, 5.3 Hz, 1H, CH2-NSO3). 
 13C-NMR (CDCl3, 100 MHz): δ = 160.2 (N-CH-N), 135.0 (ArC), 134.3 (ArC), 133.9 
(ArC), 133.6 (ArC), 131.9 (ArCH), 130.4 (ArCH), 130.2 (ArCH), 130.1 (ArCH), 
129.7 (C), 129.4 (ArCH), 128.4 (ArCH), 127.9 (ArCH), 127.5 (ArCH), 126.9 
(ArCH), 76.52 (CH(N)-CH-Ar), 76.22 (CH(N)-CH-Ar), 58.5 (NCH2-CH-CH2), 50.6 
(CH2-CH-NSO3), 49.8 (CH2), 30.8 (CH2), 24.4 (CH2), 18.6 (Ar-CH3). 
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3-((4R,5R)-4,5-Diphenyl-1-(o-tolyl)-4,5-dihydro-1H-imidazol-3-ium-3-yl)propane-1-
sulfonate (139b)
 
 Prepared from imidazoline 127 (500 mg, 1.6 mmol, 1 eq) and sulphamidate 128 (489 
mg, 4.0 mmol, 2.5 eq) in acetone for 5 d. The residue was purified by FCC (MeOH/CH2Cl2 
10:90) to afford the imidazolinium zwitterion 139b as a white solid (565 mg, 1.3 mmol, 81% 
yield). 
 mp: 297 °C 
 = +262.2 (c = 1, CH2Cl2). 
 IR (KBr): 34310, 3034, 2932, 1715, 1631, 1498, 1456, 1216, 1039, 759, 702, 524 
cm
−1
. 
 MS (ESI): m/z = 457 [M+ +Na]. 
 HRMS (ESI): Calcd. for C25H27N2O3S: 435.1728, found: 435.1742.,Calcd. for 
C25H27N2O3NaS: 457.1562, found: 457.1552 
 1H-NMR (CDCl3, 400 MHz): δ = 9.33 (s, 1H, N-CH-N), 7.50 (d, J = 7.3 Hz, 3H, 
ArH), 7.44 – 7.36 (m, 4H, ArH), 7.35 – 7.27 (m, 4H, ArH), 7.19 – 7.09 (m, 2H, ArH), 
7.09 – 7.02 (m, 1H, ArH), 5.47 (d, J = 9.3 Hz, 1 H, CH(N)-CH-Ar), 5.34 (d, J = 9.3 
Hz, 1 H, CH(N)-CH-Ar), 4.21 (td, J = 7.2, 14.2 Hz, 1 H, N(CH2)-CH2-SO3), 3.52 (td, 
J = 6.1, 14.0 Hz, 1 H, N(CH2)-CH2-SO3), 3.03 - 2.90 (m, 2 H, N(CH2)-CH2-SO3), 
2.37 (s, 3 H, Ar-CH3), 2.23 (tt, J = 7.3, 14.4 Hz, 1 H, N(CH2)-CH2-SO3), 2.06 - 1.97 
(m, 1 H, N(CH2)-CH2-SO3) 
 13C-NMR (CDCl3, 100 MHz)
 
δ = 159.5 (N-CH-N), 134.6 (ArC), 134.2 (ArC), 133.8, 
133.2 (ArC), 131.6 (ArC), 130.1 (ArCH), 130.0 (ArCH), 129.9 (ArCH), 129.5 
(ArCH), 129.4 (ArCH), 128.1 (ArCH), 127.5 (ArCH), 127.3 (ArCH), 127.2 (ArCH), 
76.1 (CH(N)-CH-Ar), 72.7 (CH(N)-CH-Ar), 48.2 (N(CH2)-CH2-SO3), 45.7 (N(CH2)-
CH2-SO3), 22.5 (N(CH2)-CH2-SO3), 18.4 (Ar-CH3). 
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((1R,2R)-1-((4R,5R)-4,5-Diphenyl-1-(o-tolyl)-4,5-dihydro-1H-imidazol-3-ium-3-yl)-1-
phenylpropan-2-yl)(methyl)sulfamate (139c)
 
 Prepared from imidazoline 127 (520 mg, 1.1 mmol, 1 eq) and sulphamidate 130 (376 
mg, 1.65 mmol, 1.5 eq) in CH2Cl2 for 6 d. The residue was purified by FCC 
(MeOH/ethylacetate/CH2Cl2 70:20:10) to afford the imidazolinium zwitterion 139c as a white 
solid (579 mg, 1.21 mmol, 81% yield).
 
 mp: >400 °C 
 = +183 (c = 0.5, CH2Cl2). 
 IR (KBr): 3443, 3062, 2983, 1616, 1497, 1456, 1233, 1107, 1035, 862, 759, 701, 
667, 632, 596. 
 MS (ESI): m/z = 562 [M+Na]. 
 HRMS (ESI): Calcd. for C32H34N3O3S: 540.2321, found: 540.2316, Calcd. for 
C32H33N3O3NaS: 562.22140, found: 562.22137. 
 1H-NMR (CDCl3, 400 MHz): δ = 9.45 (s, 1 H, N-CH-N), 8.02 (dd, J = 1.3, 7.7 Hz, 1 
H, ArH), 7.54 (dd, J = 1.9, 7.5 Hz, 2 H, ArH), 7.43 - 7.29 (m, 9 H, ArH), 7.26 - 7.16 
(m, 2 H, ArH), 7.15 - 7.04 (m, 5 H, ArH), 5.64 (d, J = 10.8 Hz, 1 H, CH(N)-CH-Ar), 
5.28 (d, J = 8.0 Hz, 1 H, CH(N)-CH-Ar), 4.88 (dq, J = 2.9, 7.2 Hz, 1 H, ArCH-CH-
CH3NSO3), 3.97 (d, J = 2.9 Hz, 1 H, CH(N)-CH-Ar), 2.47 (s, 3 H, N-CH3), 2.29 (s, 3 
H, Ar-CH3), 1.08 (d, J = 7.2 Hz, 3 H, CH-CH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 156.6 (N-CH-N), 134.4 (ArC), 134.3 (ArC), 133.5 
(ArC), 133.4 (ArC), 132.7 (ArC), 131.1 (ArCH), 130.1 (ArCH), 129.9 (ArCH), 129.7 
(ArCH), 129.6 (ArCH), 129.6 (ArCH), 129.3 (ArCH), 128.9 (ArCH), 128.9 (ArCH), 
128.8 (ArCH), 128.4 (ArCH), 128.1 (ArCH), 127.7 (ArCH), 77.5 (CH(N)-CH-Ar), 
74.8 (CH(N)-CH-Ar), 66.5 (CH(N)-CH-Ar), 53.4 (ArCH-CH-CH3NSO3), 32.7 (N-
CH3), 18.6 (Ar-CH3), 14.6 (CH-CH3). 
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 3.8.  Synthesis of Novel Enantiopure NHCs Derived From  
   Camphor 
 3.8.1.  Preparation of Camphor Diamine 
(1R,3S)-1,2,2-Trimethylcyclopentane-1,3-diamine (149)
 
 (+)-(1R,3S)-Camphoric acid (20.0 g, 0.10 mol, 1 eq) was added to a vigorously stirred 
mixture of concentrated H2SO4 (50 mL) and ethanol-free chloroform (300 mL) at 50 °C. After 
that, sodium azide (19.50 g, 0.30 mol, 3 eq) was added in small amounts over a period of 2 h. 
The mixture was stirred for further 18 h at 50 °C. The mixture was cooled, poured into H2O 
(500 mL) and extracted with CHCl3 (2×500 mL) in order to remove unreacted camphoric acid. 
The aqueous phase was strongly basified with 12N NaOH extracted into CHCl3 (2×500 mL) and 
the organic extracts were dried with anhydrous Na2SO4. The chloroform was removed in vacuo 
to give the diamine as clear oil. The oil was dissolved in diethyl ether (100 mL), the solution 
filtered, and the solvent removed in vacuo to give the product as a white solid (12.23 g, 86 
mmol, 86% yield). The spectroscopic properties concur with published data.
269
 
 1H-NMR (CDCl3, 400 MHz): δ = 2.84 (dd, J = 8.6, 7.0 Hz, 1H, N-CH-(C)CH2), 1.89 
(dddd, J = 13.9, 9.7, 8.6, 5.4 Hz, 1H, NCH(C)-CH2-CH2), 1.62 – 1.44 (m, 2H, NCH(C)-
CH2-CH2), 1.4 (s, 4H, NH2), 1.29 – 1.08 (m, 1H, NCH(C)-CH2-CH2), 0.88 (s, 3H, CH3), 
0.64 (d, J = 4.5 Hz, 6H, 2xCH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 60.9 (N-C-(CH3)CH2), 60.7 (N-CH-(C)CH2), 46.1 
(CH3-C-CH3), 38.2 (NCH(C)-CH2-CH2), 30.2 (NCH(C)-CH2-CH2), 25.8 (CH3), 22.2 
(CH3), 16.2 (CH3). 
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 3.8.2.  Both Nitrogens Atoms of Camphor Salts with Same  
   Substituents 
 3.8.2.1. Alkylation of Camphor Diamine 149 
General Procedure
 
 Alkylation reaction was performed either with aldehyde or arylmetylene chloride. 
 Method a: Alkylation reaction with aldehyde.192 
 Camphor diamine 149 (1 eq) and aldehyde (2.5 eq) were refluxed overnight in dry 
toluene in the presence of a catalytic amount of p-toluenesulfonic acid on a Dean Stark. After 
evaporation, the obtained yellow solid Schiff base was directly reduced in the next step. NaBH4 
(10 eq) was dissolved in anhydrous methanol and then added in small portions to a suspension 
of crude Schiff base in CHCl3/methanol (2:1 v/v) at 50 °C under nitrogen over 3 h and the 
resulting solution was allowed to react at rt overnight. The solvent was removed under reduced 
pressure and the residue was treated with excess water. It was extracted with CH2Cl2 and the 
solvent was evaporated under vacuum. The crude product was purified by FCC (ethyl 
acetate/CH2Cl2 10:90). 
 
 Method b: Alkylation reaction with arylmethylene chloride  
 An arylmethylene chloride (2 eq) in dry acetonitrile was added to a stirred solution of 
camphor diamine 149 (1 eq) and triethylamine (2 eq) at rt. The resulting mixture was heated at 
reflux for 20 h. Triethylamine hydrochloride was filtered off and the solvent was removed under 
vacuum. The crude product was purified by FCC (ethyl acetate/CH2Cl2 10:90).
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N,N-Bis(anthracen-9-ylmethyl)-1,2,2-trimethylcyclopentane-1,3-diamine (151a)
 
 Prepared from camphor diamine 149 (374 mg, 2.64 mmol, 1 eq) and 9-
(chloromethyl)anthracene (1,2 g, 5.29 mmol, 2 eq) 150 in dry acetonitrile (20 mL) at reflux for 
20 h. The product (151a) was separated by FCC on silica gel (ethyl acetate/CH2Cl2 10:90) as a 
yellow solid
 
(828 mg, 1.58 mmol, 60% yield).
 
 mp: 171 °C 
 = +4.6 (c = 0.5, CHCl3) 
 IR (KBr): 3307, 3285, 3057, 1807, 1682, 1497, 1337, 1227, 1179, 1157,731, 631. 
 MS (ESI, 0 V): m/z 523 (M+1, 100% yield) 
 MS (EI): m/z : 233 (M++H, 7%), 232 (50), 215 (5) 200 (25), 144 (10), 130 (10), 126 
(25), 118 (45), 107 (100), 91 (45), 77 (25),70 (80), 57 (50). 
 HRMS (ESI): Calcd. for C38H39N2
+
: 523.3113, found: 523.3113. 
 1H-NMR (CDCl3, 400 MHz): δ = 8.43-8.36 (m, 6 H, ArH), 8.04-7.93 (m, 4 H ArH), 
7.47-7.41 (m, 8 H, ArH), 4.79-4.61 (m, 4 H, 2 N-CH2-Ar), 3.21 (t, J = 8 Hz,1 H, N-
CH-(C)CH2), 2.38-2.21 (m, 2 H, NCH(C)-CH2-CH2), 2.07-1.71 (m, 2 H, NCH(C)-
CH2-CH2), 1.50 (s, 3 H, CH3), 1.45 (brs, 2 H, 2 NH), 1.05 (s, 3 H, CH3), 0.87 (s, 3 H, 
CH3). 
 13C-NMR (CDCl3, 100 MHz) δ = 132.7 (ArC), 132.5 (ArC), 131.7 (ArC), 131.5 
(ArC), 129.1 (ArC), 127.1 (ArC), 125.9 (ArC), 125.0 (ArC), 124.6 (ArC), 124.6 
(ArC), 68.2 (N-C-(CH3)CH2), 65.2 (N-CH-(C)CH2), 47.7 (N-CH2-Ar), 45.8 (N-CH2-
Ar), 39.7 (CH3-C-CH3), 34.8 (NCH(C)-CH2-CH2), 29.4 (NCH(C)-CH2-CH2), 23.9 
(CH3), 21.2 (CH3), 17.1 (CH3). 
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N,N-Bis(2′,4′,6′-trimethylbenzyl)-1,2,2-trimethylcyclopentane-1,3-diamine (151b) 
 
 151b was prerpared from 2,4,6-trimethylbenzylchloride (0.67 g, 4 mmol, 2 eq), camphor 
diamine 149 (0.284 g, 2 mmol, 1 eq) and triethyamine (0.55 mL, 4 mmol, 2 eq) in dry 
acetonitrile (20 mL) at reflux for 20 h. Excess 2,4,6-trimethylbenzylchloride was separated from 
the product by FCC on silica gel with CH2Cl2 as eluent and the product was eluted with 10% 
ethyl acetate- CH2Cl2. Evaporation of the solvent gave the title compound 151b as an oil (0.54 
g, 2 mmol, 67% yield) (Method b).
 
 = +4.2 (c = 0.5, CHCl3) 
 IR (KBr): 3290, 2960,1724, 1614, 1580, 1447, 1372, 850, 716 cm−1. 
 MS (ESI, 0 V): m/z 407 (M+1, 100%) 
 1H-NMR (CDCl3, 400 MHz): δ = 6.86 (d, J = 12 Hz, 4 H, ArH), 3.84-3.56 (m, 4 H, 2 
N-CH2-Ar), 2.91 (t, J = 8 Hz, 1 H, N-CH-(C)CH2), 2.37 (d, J = 12.0 Hz, 12 H, Ar-
4xCH3), 2.23 (s, 6 H, Ar-2xCH3), 2.19-1.47 (m, 4 H, NCH(C)-CH2-CH2), 1.25 (s, 3 
H, CH3), 0.96 (s, 3 H, CH3), 0.88 (s, 3 H, CH3) 
 13C-NMR (CDCl3, 100 MHz): δ = 137.1 (ArC), 136.3 (ArC), 136.1 (ArC), 134.7 
(ArC), 134.5 (ArC), 128.92 (ArC), 68.0 (N-C), 64.3 (N-CH-(C)CH2), 47.5 (N-CH2-
Ar), 40.9 (N-CH2-Ar), 34.1 (CCH3), 28.9 (CH2), 23.9 (Ar-CH3), 21.0 (CH2), 20.6 
(CH2), 19.5 (Ar-2xCH3), 19.5 (C-CH3-CH3)), 16.8 (CH3). 
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 3.8.2.2. Cyclization with Triethyl orthoformate  
2,4-Bis(anthracen-9-ylmethyl)-5,8,8-trimethyl-4-aza-2-azonia-bicyclo[3.2.1]oct-2-ene 
tetrafluoroborate (153a)
 
 N,N-Bis(anthracen-9-ylmethyl)-1,2,2-trimethylcyclopentane-1,3-diamine (151a) (0.52 g, 
1 mmol, 1 eq), triethylorthoformate (0.2 mL, 1.2 mmol, 1.2 eq) and ammonium 
tetrafluoroborate (104 mg, 1 mmol, 1 eq) were heated in dry toluene (10 mL) for 5 h at 120 °C 
in a closed vessel. The product was filtered and washed twice with diethyl ether and hexane to 
give a yellow solid (0.43 g, 1 mmol, 70% yield).
 
 = +38.0 (c = 0.5, CHCl3) 
 mp 197-198 °C 
 IR (KBr) 3156, 3056, 2985, 1815, 1672, 1297, 1194, 1160,729, 668, 634. 
 MS (ESI, 0 V): m/z 533 (M+, 100%) 
 HRMS: Anal. calcd for C39H37N2
+
: 533.2951, Found: 533.2525 
 1H-NMR (CDCl3, 400 MHz): δ = 7.74-7.44 (m, 6 H, ArH), 7.09-6.87 (m, 12 H, ArH), 
4.81-4.76 (m, 3 H, N-CH2-Ar), 4.79 (s, 1 H, N-CH-N, assigned by HSQC), 4.47 (d, J 
= 8 Hz, 1 H, N-CH2-Ar), 3.83 (broad s, 1 H, N-CH-(C)CH2), 2.61-2.11 (m, 4 H, 
NCH(C)-CH2-CH2), 1.53 (s, 3 H, CH3), 1.21 (s, 3 H, C(CH3)-CH3), 1.09 (s, 3 H, C-
CH3-CH3). 
 13C-NMR (CDCl3, 100 MHz): = 148.4 (N-CH-N), 130.2 (ArC), 129.9 (ArC), 129.8 
(ArC), 129.7 (ArC), 129.5 (ArC), 129.4 (ArC), 129.2 (ArC), 127.7 (ArC), 127.5 
(ArC), 125.0 (ArC), 124.9 (ArC), 120.3 (ArC), 118.5 (ArC), 118.4 (ArC), 71.8 (N-C-
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(CH3)CH2), 68.1 (N-CH-(C)CH2), 48.1 (N-CH2-Ar), 43.9 (N-CH2-Ar), 41.4 (CH3-C-
CH3), 39.9 (NCH(C)-CH2-CH2), 32.2 (NCH(C)-CH2-CH2), 21.3 (CH3), 16.8 (C-CH3), 
14.1 (CH3) 
2,4-Di(2′,4′,6′-trimethylbenzyl)-5,8,8-trimethyl-4-aza-2-azonia-bicyclo[3.2.1]oct-2-ene 
tetrafluoroborate. (153b)
 
 N,N-Di (2′,4′,6′- trimethylbenzyl)-1,2,2-trimethylcyclopentane-1,3-diamine (151b) (0.41 
g, 1 mmol, 1 eq), triethylorthoformate (0.2 mL, 1.2 mmol, 1.2 eq) and ammonium 
tetrafluoroborate (104 mg, 1 mmol, 1eq) were heated in dry toluene (5 mL) for 5 h at 100 °C in 
a closed vessel. The product was filtered and washed twice with diethyl ether and hexane to give 
a white solid (317 mg, 1 mmol, 63% yield).
 
 = +35(c = 0.5, CHCl3) 
 mp: 188-189 °C 
 IR (KBR): 3078, 2981, 1673, 1614, 1583, 1196, 955, 897, 722. 
 MS (ESI, 0 V): m/z 417 (M+, 100%) 
 HRMS: Anal. Calcd. for C29H41 N2
+
: 417.3264, Found: 417.2738 
 1H-NMR (CDCl3, 400 MHz): δ = 6.66 (d, J= 12 Hz, 4 H, ArH), 5.89 (s, 1 H, N-CH-
N, assigned by HSQC), 4.49-4.25 (m, 4 H, N-2xCH2-Ar), 3.72 (d, J = 4.0 Hz, 1 H, N-
CH-(C)CH2), 2.56-2.31 (m, 2 H, NCH(C)-CH2-CH2), 2.24 (d, J= 12 Hz, 6 H, Ar-
2xCH3), 2.16-2.08 (m, 2 H, NCH(C)-CH2-CH2), 2.00 (d, J= 4 Hz, 12 H, Ar-4xCH3), 
1.52 (s, 3 H, CH3), 1.23 (s, 3 H, C(CH3)-CH3), 1.11 (s, 3 H, C-CH3). 
 13C-NMR: (CDCl3, 100 MHz): δ = 146.9 (N-CH-N), 139.8 (ArCH), 139.5 (ArC), 
137.6 (2xArC), 129.7 (ArCH), 129.4 (ArCH), 123.7 (ArC), 71.6 (N-C-(CH3)CH2), 
67.8 (N-CH-(C)CH2), 50.9 (N-CH2-Ar), 46.3 (N-CH2-Ar), 41.1 (CH3-C-CH3), 39.4 
[ ]22Dα
3. Experimental 
 
 
164 
(NCH(C)-CH2-CH2), 31.8 (NCH(C)-CH2-CH2), 21.4 (CH3-Ar), 19.1 (NC-CH3-
(C)CH2), 19.0 (Ar-2xCH), 16.8 (C-CH3), 14.0 (CH3). 
 3.9.  Synthesis of Camphor Salts with Different Substituted 
   Nitrogen Atoms 
 3.9.1.  Selective Monoalkylation of Camphor Diamine 149 
General Procedure 
 
 A 250 mL Schlenk flask was charged with Pd2(dba)3 (4 mol%), (±)-BINAP (6 mol%), 
NaO
t
Bu (3 eq) and toluene and stirred for 20 min. 1-Bromo-toluene (1 eq) and camphor diamine 
149 (1 eq) were then added and the solution was heated to 100 °C for 48 h. After cooling to rt, 
the resulting mixture was filtered through a pad of silica and washed with a CH2Cl2/MeOH 
mixture. The filtrate was concentrated and dissolved in CH2Cl2. 12M HCl was added and the 
organic layer was seperated. The water layer was washed with CH2Cl2 (2x) and the organic 
layer was discarded. After that, the water layer was cooled with an ice bath and carefully 
basified by drop wise addition of concentrated NaOH till it became strongly basic (pH 14) 
followed by extraction with CH2Cl2 and concentration of the organic layer. The product was 
dissolved in pentane and filtered to remove solid impurities. The desired product was obtained 
after removing the solvent. 
(1R,3S)-1,2,2-Trimethyl-N
3
-(o-tolyl)cyclopentane-1,3-diamine (154a)
 
 For the synthesis of 154a Pd(dba)2 (257.5 mg, 0.505 mmol, 4 mol%), (±)-BINAP (525 
mg, 0.843 mmol, 6 mol%), NaO
t
Bu (4.1 g, 42.18 mmol, 3 eq) and toluene (250 mL) were stirred 
for 20 min. 1-Bromo-toluene (1.7mL, 2,4 g, 14,06 mmol, 1 eq) and camphor diamine 149 (1.27 
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g, 6 mmol, 1 eq) were added and the solution was heated to 100 °C for 48 h. After work up, the 
product was purified simply by acid-base treatment and dissolved in pentane and filtered to 
separate non dissolved impurities. Upon evaporation of the solvent the desired product 154a was 
obtained as off white solid (3.26 g, 14.06 mmol, 100% yield). 
 = +159.5 (c = 1, CH2Cl2). 
 IR (KBr): 3350, 3290, 2968, 2867, 1915, 1875, 1604, 1505, 1320, 1145, 1025, 911, 
858, 746, 448 cm
−1
. 
 MS (EI): m/z : 233 (M++H, 7%), 232 (50), 215 (5) 200 (25), 144 (10), 130 (10), 126 
(25), 118 (45), 107 (100), 91 (45), 77 (25),70 (80), 57 (50). 
 HRMS (ESI): Calcd. for C15H25N2 [M+H]: 233.2018, found 233.2017. 
 1H-NMR (CDCl3, 600 MHz): δ = 7.18 - 6.88 (m, 2H, ArH), 6.65 – 6.47 (m, 2H, 
ArH), 5.18 (d, J = 9.4 Hz, 1H, NH), 3.73 - 3.55 (m, 1H, N-CH-(C)CH2), 2.28 - 2.15 
(m, 1H, NCH(C)-CH2-CH2), 2.11 (s, 3H, Ar-CH3), 1.87 - 1.71 (m, 1H, NCH(C)-CH2-
CH2), 1.68 – 1.52 (m, 2H, NCH(C)-CH2-CH2), 1.13 (s, 3H, CH3), 0.99 (s, 3H, CH3), 
0.94 (s, 3H, CH3). 
 13C-NMR (CDCl3, 150 MHz): δ = 146.6 (ArC), 130.1 (ArCH), 127.0 (ArCH), 122.3 
(ArC), 115.6 (ArCH), 109.6 (ArCH), 62.6 (NH2C), 61.5 (N-CH-(C)CH2), 47.3 
(CH3)2C), 38.5 (NCH(C)-CH2-CH2), 29.4 (NCH(C)-CH2-CH2), 26.8 (CH3), 25.0 
(CH3), 18.0 (CH3), 17.3 (CH3). 
(1R,3S)-1,2,2-Trimethyl-N
3
-(pyridin-2-yl)cyclopentane-1,3-diamine (154c)
 
 For the synthesis of (154c), Pd(dba)2 (128.75 mg, 0.14 mmol, 4 mol%), (±)-BINAP 
(262.7 mg, 0.422 mmol, 6 mol%), NaO
t
Bu (2.03 g, 7.03 mmol, 3 eq), toluene (75 mL), bromo-
pyridine (0.686 mL, 21.09 mmol, 1 eq) and camphor diamine 149 (1 g, 7.03 mmol, 1 eq) were 
combined. The solution was heat to 100 °C for 48 h. After work up the product was purified 
simply by acid base treatment, dissolved in pentane and filtered to separate solid impurities. 
Upon evaporation the desired product was obtained as brown oil (2.13 g, 100% yield). 
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 = + 71.4 (c = 1.2, CH2Cl2). 
 IR (NaCl): 3345, 2964, 2870, 2360, 2342, 1603, 1502, 1369, 1287, 1150, 770, 
 735 cm
−1
. 
 MS (EI): m/z 220.1814 (M++H, 7%), 219 (10), 202 (5), 149 (7), 133 (10), 126 
 (100), 119 (40), 110 (40), 95 (50), 84 (10), 78 (40), 70 (50), 57 (50), 51 (10). 
 HRMS (ESI): Calcd. for C13H22N3: 220.1814, found: 220.1813. 
 1H-NMR (CDCl3, 600 MHz): δ = 8.02 (td, J = 0.94, 4.89 Hz, 1H, ArH), 7.32 
 (ddd, J = 1.88, 6.96, 8.47 Hz, 1H, ArH), 6.40 - 6.48 (m, 1H, ArH), 6.32 (d, J = 
 8.28 Hz, 1H), 6.03 (d, J = 9.79 Hz, 1H, ArH), 3.94 - 4.07 (m, 1H, N-CH-
 (C)CH2), 2.17 - 2.31 (m, 1H, NCH(C)-CH2-CH2), 1.71 - 1.82 (m, 1H, NCH(C)-
 CH2-CH2), 1.52 - 1.64 (m, 2H, NCH(C)-CH2-CH2), 1.12 (s, 3H, CH3), 0.92 (s, 
 6H 2xCH3). 
 13C-NMR (CDCl3, 150 MHz): δ = 159.0 (ArC), 148.2 (ArCH), 137.1 (ArCH), 
 111.7 (ArCH), 107.2 (ArCH), 61.5 (N-C-(CH3)CH2), 60.9 (N-CH-(C)CH2), 
 47.3 (CH3-C-CH3), 38.2 (NCH(C)-CH2-CH2), 29.4 (NCH(C)-CH2-CH2), 26.7 
 (CH3), 24.5 (CH3), 17.1 (CH3). 
 3.9.2.  Cyclization of Monoalkylated Diamine 
General Procedure
11
 
 
 Monoalkylated camphor diamine (1eq), triethylorthoformate (2.5 eq) and acetic acid (2.5 
eq) in CH3CN (10 mL) were refluxed for 2 h under an inert atmosphere. The resulting mixture 
was then allowed to cool to rt before being concentrated to dryness and was taken up in 40% 
aqueous KOH (10 mL) and extracted with CH2Cl2 (3 × 40 mL). The combined organic layers 
were then dried with KOH pellets, filtered, and concentrated to dryness to give the desired 
cyclized product as a brown oil. 
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(1R,5S)-1,8,8-Trimethyl-4-(o-tolyl)-2,4-diazabicyclo[3.2.1]oct-2-ene (155a)
 
 The dihydrodiazepinium 155a was prepared from monoalkylated camphor diamine 154a 
(464 mg, 2 mmol, 1eq), triethylorthoformate (0.832 mL, 5 mmol, 2.5 eq) and acetic acid (300 
mg, 0.286 mL, 5 mmol, 2.5 eq) in CH3CN (10 mL), which was refluxed for 2 h under an inert 
atmosphere. 155a was obtained as a brown oil (484.35 mg, 1.99 mmol, 99% yield).
 
 = −183.46 (c = 3.15, CH2Cl2). 
 IR (NaCl): 3023, 2962, 2870, 1619, 1597, 1493, 1390, 1370, 1341, 1254, 1164, 1118, 
760, 734, 558 cm
−1
. 
 MS (EI): m/z 242 (M+, 75%), 125 (60), 118 (65), 110 (75), 91 (100). 
 HRMS (ESI): Calcd. for C13H23N2 [M
+
+H]: 243.1861, found 243.1866. 
 1H-NMR (CDCl3, 600 MHz): δ = 7.15 (dt, J = 7.6, 4.3 Hz, 2H, ArH), 7.08 (td, J = 
7.4, 1.2 Hz, 1H, ArH), 6.97 (d, J = 7.6 Hz, 1H, ArH), 6.93 (d, J = 1.0 Hz, 1 H, N-CH-
N), 3.22 (d, J = 4.7 Hz, 1H, N-CH-(C)CH2), 2.29 (s, 3H, Ar-CH3), 2.26 - 2.16 (m, 1H, 
NCH(C)-CH2-CH2), 2.16 - 2.04 (m, 1H, NCH(C)-CH2-CH2), 2.01 - 1.89 (m, 1H, 
NCH(C)-CH2-CH2), 1.84 (td, J = 12.1, 4.2 Hz, 1H, NCH(C)-CH2-CH2), 1.17 (d, J = 
4.3 Hz, 6H, 2xCH3), 1.05 (s, 3H, CH3). 
 13C-NMR (CDCl3, 150 MHz): δ = 147.1 (N-CH-N), 142.7 (ArC), 133.3 (ArC), 131.7 
(ArCH), 126.9 (ArCH), 126.2 (ArCH), 126.0 (ArCH), 68.7 (N-CH-(C)CH2), 63.2 
(CH3CN), 40.8 (NCH(C)-CH2-CH2), 40.4 ((CH3)2-C), 32.0 (NCH(C)-CH2-CH2), 22.7 
(CH3), 20.2 (CH3), 18.7 (CH3), 18.1 (CH3). 
(1S,5S)-1,8,8-Trimethyl-4-(pyridin-2-yl)-2,4-diazabicyclo[3.2.1]oct-2-ene (155b)
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 The dihydrodiazepinium 155b was prepared from monoalkylated camphor diamine 154c 
(614 mg, 2.8 mmol, 1eq), triethylorthoformate (1,16 mL, 7 mmol, 2.5 eq) and acetic acid (0.42 
mL, 7 mmol, 2.5 eq) in CH3CN (10 mL), which was refluxed for 2 h under inert atmosphere. 
The product was obtained as a brown oil (630 mg, 2.74 mmol, 98% yield).
 
 = −15.1 (c = 1.87, CH2Cl2). 
 IR (NaCl): 3280, 2967, 2873, 2361, 2019, 1677, 1588, 1474, 1438, 1317, 1209, 1167, 
1107, 981, 861, 774, 736, 701, 618, 525 cm
−1
. 
 MS (EI): m/z 230. (M++H, 7%), 229 (75), 186 (10), 160 (15), 147 (12), 133 (10), 119 
(12), 95 (10), 84 (7) 78 (100), 67 (40), 51 (40). 
 HRMS (ESI): Calcd. for C14H20N3: 230.1657, found: 230.1654. 
 1H-NMR (CDCl3, 600 MHz): δ = 8.27 (ddd, J = 0.76, 1.95, 4.85 Hz, 1H, ArH), 7.98 
(d, J = 1.26 Hz, 1H, N-CH-N), 7.58 (ddd, J = 2.01, 7.30, 8.31 Hz, 1H, ArH), 6.82 - 
6.89 (m, 2H, ArH), 4.11 (d, J = 5.04 Hz, 1H, N-CH-(C)CH2), 2.11 - 2.26 (m, 2H, 
NCH(C)-CH2-CH2), 1.84 - 1.97 (m, 2H, NCH(C)-CH2-CH2), 1.22 (s, 3H, CH3), 1.12 
(s, 3H, CH3), 0.99 (s, 3H, CH3). 
 13C-NMR (150 MHz , CDCl3): δ = 153.6 (N-CH-N), 148.4 (ArCH), 142.2 (ArCH), 
138.2 (ArCH), 117.1 (ArCH), 112,3 (ArC), 108.2 (ArCH), 64.4 (N-C-(CH3)CH2), 
63.8 (N-CH-(C)CH2), 40.5 (CH3-C-CH3), 40.2 (NCH(C)-CH2-CH2), 31.8 (NCH(C)-
CH2-CH2), 22.6 (CH3), 19.9 (CH3), 17.4 (CH3). 
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 3.9.3.  Synthesis of Carbene Precursors by Quarternization of 
   Dihydro-1,3-diazepinium with Aryl Halides 
General Procedure 
 
 The dihydrodiazepinium compound (1 eq) and an aryl halide (3.5-1 eq) were refluxed in 
a solvent (2-10 mL) for 5 h. After cooling to rt, the solvent was removed under reduced pressure 
to obtain the solid compound, which was purified by washing or by FCC. 
(1R,5S)-1,2,8,8-Tetramethyl-4-(o-tolyl)-2,4-diazabicyclo[3.2.1]oct-2-en-2-ium iodide (156a) 
 
 The carbene precursor 156a was formed from dihydrodiazepinium 155a (458 mg, 1.9 
mmol, 1 eq) and iodomethane (810 mg, 0.355mL, 5,7 mmol, 3 eq) in CH3CN (10 mL). The 
reaction mixture was refluxed for 5 h. After cooling to rt, the solvent was removed under 
reduced pressure to obtain the solid compound, which was purified by washing with hexane and 
Et2O (723 mg, 1.88 mmol, 98% yield). 
 mp: 224 °C 
 = +− 35.8 (c = 1, CH2Cl2). 
 IR (KBr): 3425, 2978, 1653, 1496, 1469, 1288, 1173, 1098, 953, 770, 467, 456 cm−1. 
 MS (ESI): m/z 257.3 (M+, 100%). 
 HRMS (ESI): Calcd. for C17H25N2: 257.2018, found: 257.2017. 
 1H-NMR (CDCl3, 400 MHz): δ = 8.49 (s, 1H, N-CH-N), 7.64 (d, J = 5.1 Hz, 1H, , 
ArH), 7.34 – 7.23 (m, 3H, ArH), 3.54 (d, J = 5.0 Hz, 1H, N-CH-(C)CH2), 3.47 (s, 3H, 
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N-CH3), 2.99 (ddd, J = 14.2, 9.5, 4.5 Hz, 1H, NCH(C)-CH2-CH2), 2.61 (ddd, J = 14.3, 
9.6, 4.4 Hz, 1H, NCH(C)-CH2-CH2), 2.45 (s, 3H, Ar-CH3), 2.19 (ddt, J = 14.7, 12.1, 
4.8 Hz, 1H, NCH(C)-CH2-CH2), 2.07 - 1.95 (m, 1H, NCH(C)-CH2-CH2), 1.41 (s, 3H, 
CH3), 1.36 (s, 3H, CH3), 1.23 (s, 3H, CH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 153.9 (N2CH), 138.9 (ArC), 133.3 (ArC), 132.34 
(ArCH), 129.8 (ArCH), 128.1 (ArCH), 127.9 (ArCH), 71.0 (N-C-(CH3)CH2), 70.5 
(N-CH-(C)CH2), 41.9 (CH3-C-CH3), 39.2 (N-CH3), 38.2 (NCH(C)-CH2-CH2), 31.3 
(NCH(C)-CH2-CH2), 22.1 (CH3), 19.3 (CH3), 18.0 (CH3), 14.4 (CH3). 
(1R,5S)-1,8,8-Trimethyl-4-(o-tolyl)-2-(2,4,6-trimethylbenzyl)-2,4-diazabicyclo[3.2.1]oct-2-
en-2-ium chloride (156b)
 
 The carbene precursor 156b was prepared from dihydrodiazepinium 155a (520 mg, 2.15 
mmol, 1 eq) and 2,4,6-trimethylbenzylchloride (534 mg, 3.22 mmol, 1,5 eq) in DMF (2 mL). 
The reaction mixture was heated for 13 h at 80 °C. After cooling to rt, the solvent was removed 
under reduced pressure to obtain the solid compound, which was purified by FCC 
(MeOH/CH2Cl2 10:90) (865 mg, 2.1 mmol, 98% yield). 
 mp: 450 °C 
 = − 12.95 (c = 2, CH2Cl2). 
 IR (KBr): 3429, 3225, 2977, 2676, 2605, 2497, 1657, 1905, 1497, 1469, 1399, 1314, 
1194, 1037, 944, 862, 779, 725, 614, 458 cm
−1
.  
 MS (ESI): m/z 375.2 (M+, 100%). 
 HRMS (ESI): Calcd. for C26H35N2 [M
+
]: 375.2800, found 375.2799. 
 1H-NMR (CDCl3, 400 MHz): δ = 7.37 – 7.28 (m, 2H, ArH), 7.29 – 7.22 (m, 1H, 
ArH), 7.13 (dd, J = 5.9, 3.3 Hz, 1H, ArH), 6.92 (d, J = 2.6 Hz, 3H, (NC-H-N and Ar-
[ ]22Dα
3. Experimental 
 
 
171 
CH2), 5.06 (d, J = 14.2 Hz, 1H, N-CH2-Ar), 4.74 (d, J = 14.2 Hz, 1H, N-CH2-Ar), 
3.80 (broad s, 1H, N-CH-(C)CH2), 2.96 (d, J = 3.7 Hz, 1H, NCH(C)-CH2-CH2), 2.40 
(dd, J = 16.9, 4.6 Hz, 3 H, NCH(C)-CH2-CH2), 2.36 (s, 6H, Ar-2xCH3), 2.25 (s, 3H, 
Ar-CH3), 2.17 (s, 3H, ArCH3), 1.78 (s, 3H, CH3), 1.38 (s, 3H, CH3), 1.35 (s, 3H, 
CH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 150.1 (N-CH-N), 140.4 (ArC), 139.1 (ArC), 138.2 
(ArC), 132. 6 (ArCH), 132.2 (ArC), 130.4 (ArCH), 129.7 (ArCH), 128.4 (ArCH), 
126.3 (ArCH), 123.9 (ArC), 72.8 (N-C-(CH3)CH2), 71.5 (N-CH-(C)CH2), 48.2 (N-
CH2-Ar), 41.7 (CH3-C-CH3), 40.1 (NCH(C)-CH2-CH2), 32.1 (NCH(C)-CH2-CH2), 
21.8 (CH3), 21.1 (CH3), 19.9 (CH3), 18.2 (CH3), 17.8 (CH3), 14.5 (CH3). 
(1R,5S)-2-Benzhydryl-1,8,8-trimethyl-4-(o-tolyl)-2,4-diazabicyclo[3.2.1]oct-2-en-2-ium 
chloride (156c) 
 
 The carbene precursor 156c was formed from dihydrodiazepinium 155a (765 mg, 3.15 
mmol, 1 eq) and (chloromethylene)dibenzene (2.24 g, 2 mL, 11,05 mmol, 3.5 eq) in CH3CN (3 
mL). The reaction mixture was refluxed for 16 h. After cooling to rt the solvent was removed 
under reduced pressure to obtain the solid compound, which was purified by washing with 
pentane and Et2O (1.34 g, 3.01 mmol, 95% yield). 
 mp: 281 °C  
 = − 20.8 (c = 1, CH2Cl2). 
 IR (KBr): 3418, 3047, 2982, 1634, 1579, 1496, 1449, 1383, 1161, 1051, 781, 749, 
706, 913, 573 cm
−1
. 
 MS (ESI): m/z 409.2 (M+, 100%). 
 HRMS (ESI): Calcd. for C29H33N2 : 409.2644, found: 409.2635. 
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 1H-NMR (CDCl3, 600 MHz): δ = 7.47 - 7.32 (m, 8 H, ArH), 7.31 (s, 1 H), 7.30 - 7.25 
(m, 4 H, ArH), 7.22 - 7.18 (m, 1 H, ArH), 7.12 (dd, J = 1.5, 7.5 Hz, 1 H, ArH), 6.85 
(s, 1 H, Ar-CH-Ar), 3.78 (d, J = 4.9 Hz, 1 H, N-CH-(C)CH2), 3.04 - 2.98 (m, 1 H, 
NCH(C)-CH2-CH2), 2.43 - 2.37 (m, 1 H, NCH(C)-CH2-CH2), 2.34 - 2.21 (m, 2 H, 
NCH(C)-CH2-CH2), 1.93 (s, 3 H, Ar-CH3), 1.57 (s, 3 H, CH3), 1.35 (s, 3 H, CH3), 
1.24 (s, 3 H, CH3) 
 13C-NMR (CDCl3, 150 MHz): δ = 153.4 (N-CH-N), 139.2 (ArC), 137.0 (ArC), 136.4 
(ArC), 132.5 (ArCH), 132.1 (ArC), 130.0 (ArCH), 129.9 (ArCH), 129.6 (ArCH), 
129.5 (ArCH), 129.1 (ArCH), 128.4 (ArCH), 128.3 (ArCH), 126.2 (ArCH), 74.8 (N-
C-(CH3)CH2), 71.9 (N-CH-(C)CH2), 66.4 (Ar-CH-Ar), 42.1 (CH3-C-CH3), 40.8 
(NCH(C)-CH2-CH2), 32.3 (NCH(C)-CH2-CH2), 22.1 (CH3), 18.1 (Ar-CH3), 17.9 
(CH3), 15.2 (CH3). 
(1R,5S)-1,8,8-Trimethyl-4-(pyridin-2-yl)-2-(2,4,6-trimethylbenzyl)-2,4-diazabicyclo[3.2.1] 
oct-2-en-2-ium chloride (157a) 
 
 The carbene precursor 157a was prepared from dihydrodiazepinium 155b (303 mg, 1.32 
mmol, 1 eq) and 2,4,6-trimethylbenzylchloride (223 mg, 1.32 mmol, 1 eq) in CH3CN (4 mL). 
The reaction mixture was heated for 2 h at reflux. After cooling to rt, the solvent was removed 
under reduced pressure and the crude product was purified by washing with hexane, Et2O and 
THF (457 mg, 1.15 mmol, 87% yield). 
 mp: 222 °C 
 = +21.2 (c = 1, CH2Cl2). 
 IR (KBr): 3433, 2977, 1646, 1593, 1453, 1283, 1218, 1108, 1062, 1925, 949, 854, 
788, 724, 678, 625 cm
−1
.  
 MS (ESI): m/z 362.6 (M+, 100%). 
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 HRMS (ESI): Calcd. for C24H32N3: 362.2596, found: 362.2592. 
 1H-NMR (CDCl3, 400 MHz): δ = 9.03 (s, 1H, N-CH-N), 8.18 - 8.24 (m, 2H, ArH), 
7.90 - 7.97 (m, 1H, ArH), 7.17 - 7.23 (m, 1H, ArH), 6.95 (s, 2H, ArH), 5.16 (d, J = 
14.60 Hz, 1H, N-CH2-Ar), 4.89 - 4.97 (m, 2H, N-CH2-Ar and N-CH-(C)CH2), 2.50 - 
2.63 (m, 2H, NCH(C)-CH2-CH2), 2.37 (s, 6H, Ar-2xCH3), 2.30 (s, 3H, Ar-CH3), 2.22 
- 2.29 (m, 1H, NCH(C)-CH2-CH2), 2.08 - 2.18 (m, 1H, NCH(C)-CH2-CH2), 1.59 (s, 
3H, CH3), 1.36 (s, 3H, CH3), 1.16 (s, 3H, CH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 150.1 (ArC), 149.7 (N-CH-N), 148.4 (ArCH), 
140.6 (ArCH), 140.0 (ArCH), 138.1 (2xArC), 130.4 (ArCH), 124.7 (ArC), 122.7 
(ArCH), 113.7 (ArCH), 73.4 (N-C-(CH3)CH2), 65.6 (N-CH-(C)CH2), 49.4 (N-CH2-
Ar), 41.7 (CH3-C-CH3), 39.9 (NCH(C)-CH2-CH2), 32.1 (NCH(C)-CH2-CH2), 21.8 
(CH3), 21.1 (CH3), 20.0 (CH3), 17.0 (CH3), 14.3 (CH3). 
(1R,5S)-2-Benzhydryl-1,8,8-trimethyl-4-(pyridin-2-yl)-2,4-diazabicyclo[3.2.1]oct-2-en-2-
ium chloride (157b) 
3
 
 The carbene precursor 157b was formed from dihydrodiazepinium 155b (262 mg, 1.14 
mmol, 1 eq) and (chloromethylene)dibenzene (0.224 mL, 1.25 mmol, 1.1 eq) in CH3CN (3 mL). 
The reaction mixture was refluxed for 16 h. After cooling to rt, the solvent was removed under 
reduced pressure and the crude product was purified by washing with pentane and Et2O (433 
mg, 1.0 mmol, 95% yield). 
 mp: 243 °C (DSC) 
 = +5.4 (c = 1, CH2Cl2). 
 IR (KBr): 34187, 3036, 2988, 1633, 1592, 1568, 1456, 1365, 1279, 1171, 946, 797, 
753, 615, 552 cm
−1
.  
 MS (ESI): m/z 396.6 (M+, 100%). 
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 HRMS (ESI): Calcd. for C27H30N3: 396.2440, found: 396.2426. 
 1H-NMR (CDCl3, 400 MHz): δ = 8.71 (s, 1H, N-CH-N), 8.11 - 8.25 (m, 2H, ArH), 
7.92 - 8.04 (m, 1H, ArH), 7.36 - 7.60 (m, 8H, ArH), 7.16 - 7.34 (m, 3H, ArH), 6.45 (s, 
1H, , Ar-CH-Ar ), 5.10 (d, J = 4.28 Hz, 1H, N-CH-(C)CH2), 2.53 - 2.71 (m, 2H, 
NCH(C)-CH2-CH2), 2.22 - 2.39 (m, 1H, NCH(C)-CH2-CH2), 2.03 - 2.19 (m, 1H, 
NCH(C)-CH2-CH2), 1.58 (s, 3H, CH3), 1.34 - 1.44 (m, 3H, CH3), 1.15 - 1.26 (m, 3H, 
CH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 150.6 ((N-CH-N), 149.7 (ArC), 148.5 (ArCH), 
140.8 (ArCH), 136.4 (ArC), 136.1 (ArC), 129.9 (ArCH), 129.7 (ArCH), 128.7 
(ArCH), 128.4 (ArCH), 123.0 (ArCH), 113.6 (ArCH), 75.3 (N-C-(CH3)CH2), 67.2 
(N-CH-(C)CH2), 66.3 (Ar-CH-Ar), 42.1 (CH3-C-CH3), 40.5 (NCH(C)-CH2-CH2), 
32.1 (NCH(C)-CH2-CH2), 21.7 (CH3), 17.1 (CH3), 15.3 (CH3). 
 3.9.4.  Synthesis of Carbene Precursors by Counter Anion  
   Exchange 
General Procedure 
 
 Imidazolinium halide (1 eq) was dissolved in CH2Cl2 (5-10 mL) and stirred vigorously 
with a solution of NaBF4 (1-1.5 eq) in water (5-10 mL) for 16 h. The organic phase was 
separated, washed with water (3 x 3 mL) and dried over Na2SO4. The solvent was evaporated 
and the product was washed with Et2O, THF and dried overnight under high vacuum to give the 
corresponding imidazolinium tetrafluoroborate as a white solid. 
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(1R,5S)-1,8,8-Trimethyl-4-(o-tolyl)-2-(2,4,6-trimethylbenzyl)-2,4-diazabicyclo[3.2.1]oct-2-
en-2-ium tetrafluoroborate (158a)
 
 Synthesized from imidazolinium halide 156b (416 mg, 1.012 mmol, 1 eq) and NaBF4 
(111 mg, 1.012 mmol, 1 eq) in a CH2Cl2/water mixture (10:10 mL) for 16 h. The organic phase 
was separated, washed with water (3 x 3 mL) and dried over Na2SO4. The solvent was 
evaporated and the product was washed with Et2O, THF and dried overnight under high vacuum 
to give the corresponding imidazolinium tetrafluoroborate 158a as a white solid (375 mg, 0.81 
mmol, 80% yield). 
 mp: 236 °C 
 = − 13.4 (c = 1, CH2Cl2). 
 IR (KBr): 3424, 2980, 2951, 1658, 1497, 1463, 1359, 1315, 1051, 775, 520, 461 
cm
−1
.  
 MS (ESI): m/z 375.2 (M+, 100%). 
 HRMS (ESI): Calcd. for C26H35N2 [M
+
]: 375.2800, found 375.2795. 
 1H-NMR (CDCl3, 400 MHz): δ = 7.21 - 7.35 (m, 3H, ArH), 7.06 - 7.12 (m, 1H, 
ArH), 6.92 (s, 2H, ArH), 6.70 (s, 1H, N-CH-N), 4.84 (d, J = 14.10 Hz, 1H, N-CH2-
Ar), 4.60 (d, J = 14.10 Hz, 1H, N-CH2-Ar), 3.71 - 3.77 (m, 1H, N-CH-(C)CH2), 2.93 
(t, J = 9.69 Hz, 1H, NCH(C)-CH2-CH2), 2.34 - 2.49 (m, 1H, NCH(C)-CH2-CH2), 2.32 
(s, 6H, Ar2xCH3), 2.27 - 2.30 (m, 2H, NCH(C)-CH2-CH2), 2.25 (s, 3H, ArCH3), 2.14 
(s, 3H, ArCH3), 1.72 (s, 3H, CH3), 1.36 (s, 3H, CH3), 1.32 (s, 3H, CH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 149.9 (N-CH-N), 140.6 (ArC), 139.2 (ArC), 138.4 
(ArC), 132.5 (ArCH), 132.3 (ArC), 130.4 (ArCH), 129.8 (ArCH), 128.5 (ArCH), 
126.4 (ArCH), 123.5 (ArC), 72.9 (N-C-(CH3)CH2), 71.6 (N-CH-(C)CH2), 47.5 (N-
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CH2-Ar), 41.8 (CH3-C-CH3), 39.8 (NCH(C)-CH2-CH2), 31.9 (NCH(C)-CH2-CH2), 
21.7 (CH3), 21.1 (CH3), 19.6 (CH3), 18.0 (CH3), 17.7 (CH3), 14.1 (CH3). 
(1R,5S)-2-Benzhydryl-1,8,8-trimethyl-4-(o-tolyl)-2,4-diazabicyclo[3.2.1]oct-2-en-2-ium 
tetrafluoroborate (158b) 
 
 Prepared from imidazolinium halide 156c (469 mg, 1.05 mmol, 1 eq) and NaBF4 (174 
mg, 1.58 mmol, 1.5 eq) in a CH2Cl2/water mixture (10:10 mL) for 16 h. The organic phase was 
separated, washed with water (3 x 3 mL) and dried over Na2SO4. The solvent was evaporated 
and the product was washed with Et2O, THF and dried overnight under high vacuum to give the 
corresponding imidazolinium tetrafluoroborate 158b as a white solid (380 mg, 0.96 mmol 93% 
yield). 
 mp: 199 °C 
 = − 32 (c = 1, CH2Cl2). 
 IR (KBr): 3419, 2981, 1638, 1603, 1496, 1453, 1402, 1289, 1057, 774, 748, 703, 
614, 574, 521 cm
−1
. 
 MS (ESI): m/z 409.7 (M+, 100%). 
 HRMS (ESI): Calcd. for C29H33N2 : 409.2644, found: 409.2633. 
 1H-NMR (CDCl3, 400 MHz): δ = 7.52 - 7.34 (m, 8 H, ArH), 7.34 - 7.24 (m, 5 H, ArH 
and N-CH-N ), 7.23 - 7.19 (m, 1 H, ArH), 7.16 - 7.12 (m, 1 H, ArH), 6.47 (s, 1 H, Ar-
CH-Ar), 3.77 - 3.75 (m, 1 H, N-CH-(C)CH2), 2.98 - 2.89 (m, 1 H, NCH(C)-CH2-
CH2), 2.51 - 2.42 (m, 1 H, NCH(C)-CH2-CH2), 2.34 - 2.14 (m, 2 H, NCH(C)-CH2-
CH2), 1.96 (s, 3 H, Ar-CH3), 1.51 (s, 3 H, CH3), 1.36 (s, 3 H, CH3), 1.23 (s, 3 H, CH3) 
 13C-NMR (CDCl3, 100 MHz): δ = 153.4 (N-CH-N), 139.2 (ArC), 136.7 (ArC), 136.2 
(ArC), 132.4 (ArCH), 132.1 (ArC), 130.0 (ArCH), 129.9 (ArCH), 129.6 (ArCH), 
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129.5 (ArCH), 129.1 (ArCH), 128.4 (ArCH), 128.3 (ArCH), 126.2 (ArCH), 74.8 (N-
C-(CH3)CH2), 71.9 (N-CH-(C)CH2), 66.4 (Ar-CH-Ar), 42.1 (CH3-C-CH3), 40.8 
(NCH(C)-CH2-CH2), 32.3 (NCH(C)-CH2-CH2), 22.1 (CH3), 18.1 (CH3), 17.9 (CH3), 
15.2 (CH3). 
(1R,5S)-1,8,8-Trimethyl-4-(pyridin-2-yl)-2-(2,4,6-trimethylbenzyl)-2,4-diazabicyclo [3.2.1] 
oct-2-en-2-ium tetrafluoroborate (158c) 
 
 Prepared from imidazolinium halide 157a (419 mg, 1.05 mmol 1 eq) and NaBF4 (174 
mg, 1.58 mmol, 1.5 eq) in a CH2Cl2/water mixture 5:5 mL for 16 h. The organic phase was 
separated, washed with water (3 x 3 mL) and dried over Na2SO4. The solvent was evaporated 
and the product was washed with Et2O, THF and dried overnight under high vacuum to give the 
corresponding imidazolinium tetrafluoroborate 158c as a white solid (425 mg, 0.94 mmol 90% 
yield). 
 mp: 250 °C 
 = +47.4 (c = 0.5, CH2Cl2). 
 IR (KBr): 3421, 3070, 2970, 2739, 1654, 1593, 1453, 1284, 1063, 784, 521 cm−1.  
 MS (ESI): m/z 362.6 (M+, 100%). 
 HRMS (ESI): Calcd. for C24H32N3: 362.2596, found: 362.2597. 
 1H-NMR (CDCl3, 400 MHz): δ = 8.12 - 8.21 (m, 1H, ArH), 8.03 (s, 1H, N-CH-N), 
7.81 - 7.92 (m, 1H, ArH), 7.42 (d, J = 8.31 Hz, 1H, ArH), 7.15 - 7.24 (m, 1H, ArH), 
6.99 (s, 2H, ArH), 4.81 (d, J = 14.10 Hz, 1H, N-CH2-Ar,), 4.66 (d, J = 14.10 Hz, 1H, 
N-CH2-Ar,), 4.43 (d, J = 5.04 Hz, 1H, N-CH-(C)CH2), 2.64 - 2.79 (m, 1H, NCH(C)-
CH2-CH2), 2.47 - 2.63 (m, 1H, NCH(C)-CH2-CH2), 2.29 - 2.34 (m, 9H, Ar3xCH3), 
2.22 - 2.29 (m, 2H, NCH(C)-CH2-CH2), 1.69 (s, 3H, CH3), 1.34 (s, 3H, CH3), 1.13 (s, 
3H, CH3). 
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 13C-NMR (CDCl3, 100 MHz): δ = 150.0 (ArC), 148.7 (N-CH-N), 147.8 (ArCH), 
140.6 (ArCH), 140.5 (ArCH), 138.3 (ArCH), 130.4 (ArCH), 123.3 (ArC), 122.9 
(ArCH), 112.6 (ArCH), 73.6 (N-C-(CH3)CH2), 66.4 (N-CH-(C)CH2), 48.1 (CH3-C-
CH3), 41.7 (N-CH2-Ar), 39.9 (NCH(C)-CH2-CH2), 31.7 (NCH(C)-CH2-CH2), 21.6 
(CH3), 21.2 (CH3), 19.5 (CH3), 16.9 (CH3), 14.0 (CH3). 
 3.10.  Camphore Salts with the Steric Nitrogen Atom having a 
   Bulkier Substituent 
 3.10.1. Selective Protection of the Less Hindered Nitrogen Atom 
Benzyl ((1R,3S)-3-amino-2,2,3-trimethylcyclopentyl)carbamate (161) 
 
 The synthesis of 161 was performed by drop wise addition of a benzyl chloroformate 
(CbzCl) (60 mg, 0.35 mmol, 1eq) solution in CH2Cl2 over a period of 3 to 4 h into a stirred 
solution of the diamine 149 (50 mg, 0.35 mmol, 1 eq) and Et3N (78 mg, 0.77 mmol, 2.2 eq) at 
−78 °C. Then the reaction mixture was cooled to rt. The reaction was stirred for 24 h, filtered 
and concentrated under vacuum. 161 was obtained as an oil with traces of impurities (14 mg, 
0.052 mmol, 15% yield) after FCC (MeOH/CH2Cl2, 20:80). The further purification was not 
achievable; therefore the product was used in the next step without further purification. 
 MS (EI): m/z: 216 (M++H, 2%), 162 (5), 125 (32), 110 (30) 91 (100), 70 (75), 57 (50), 
51 (10). 
 1H-NMR (CDCl3, 600 MHz): δ = 7.30 – 7.19 (m, 5H, ArH), 6.52 (d, J = 9.9 Hz, 1H, 
N(COO)-CH2-Ar), 5.01 (d, J = 0.7 Hz, 2H, N(COO)-CH2-Ar), 3.83 – 3.73 (m, 1H, N-
CH-(C)CH2), 2.31 – 2.05 (m, 1H, NCH(C)-CH2-CH2), 1.73 – 1.37 (m, 3H, NCH(C)-
CH2-CH2), 1.02 (s, 3H, CH3), 0.82 (s, 6H, 2xCH3). 
 13C-NMR (CDCl3, 150 MHz): δ = 156.0 (NH-COO-CH2), 137.1 (ArC), 128.4 
(ArCH), 128.0 (ArCH), 127.8 (ArCH), 66.2 (N(COO)-CH2-Ar), 61.6 (N-C-
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(CH3)CH2), 61.1 (N-CH-(C)CH2), 47.1 (CH3-C-CH3), 38.0 (NCH(C)-CH2-CH2), 29.6 
(NCH(C)-CH2-CH2), 26.4 (CH3), 24.5 (CH3), 16.6 (CH3). 
Benzyl ((1R,3S)-3-amino-2,2,3-trimethylcyclopentyl)carbamate (161) 
2
2 2
2 3 2
 
 To a stirred solution of the diamine 149 (200 mg, 1.41 mmol, 1 eq) in acetone (1 mL) 
and H2O (1 mL) at rt was added sequentially K2CO3 (194 mg, 1.41 mmol, 13 eq) and CbzCl 
(240 mg, 1.41.mmol, 1 eq). After 30 min, the reaction was quenched with H2O (2 mL) and 
extracted with CH2Cl2. The combined organic layers were washed with sat. aq. NaCl solution, 
dried over Na2SO4 and concentrated in vacuo. 161 was obtained as an oil with traces of 
impurities (22 mg, 0.079 mmol, 7% yield) after FCC (MeOH/CH2Cl2, 20:80). The further 
purification was not achievable; therefore the product was used in the next step without further 
purification. 
Ethyl ((1R,3S)-3-amino-2,2,3-trimethylcyclopentyl)carbamate (164) 
 
 To a solution of diamine 149 (600 mg, 4.22 mmol, 1 eq) and triethylamine (956 mg, 1.3 
mL, 9.3 mmol, 2.2 eq) in CH2Cl2 (10 mL) at −78 °C was added drop wise a solution of benzyl 
chloroformate (503 mg, 4.22 mmol, 1 eq) in CH2Cl2 (10 mL). The reaction was stirred for 24 h. 
A 10M NaOH solution was added and extracted with CH2Cl2. The organic phase was 
concentrated and dried under high vacuum to yield 164 as a solid (72 mg, 0.33 mmol, 8% yield). 
 mp: 47 °C  
 = +36.3 (c = 1, CH2Cl2). [ ]
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 IR (KBr): , 3300, 2965, 2361, 2342, 1702, 1508, 1669, 1260, 1043, 914, 742, 490 
cm
−1
. 
 MS (EI): m/z : 215 (M++H, 5%), 197 (10), 198 (5), 182 (5) 168 (5), 125 (40),110 
(60), ), 93 (10), 82 (12) 70 (100), 55 (25). 
 HRMS (ESI): Calcd. for C11H23N2O2 [M+H]: 215.1760, found 215.1768. 
 1H-NMR (CDCl3, 400 MHz): δ = 6.41 (d, J = 9.6 Hz, 1 H, OCO-NH-CH2), 4.06 - 
3.99 (m, 2 H, N(COO)-CH2-CH3), 3.77 (ddd, J = 2.5, 8.3, 10.3 Hz, 1 H, N-CH-
(C)CH2), 2.21 - 2.05 (m, 1 H, NCH(C)-CH2-CH2), 1.74 - 1.60 (m, 1 H, NCH(C)-CH2-
CH2), 1.55 - 1.44 (m, 2 H, NCH(C)-CH2-CH2), 1.17 (t, J = 7.1 Hz, 3 H, CH2-CH3), 
1.04 (s, 3 H, CH3), 0.83 (d, J = 2.5 Hz, 6 H, 2xCH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 156.1 (NH-COO-CH2), 61.4 (N-CH-(C)CH2), 60.7 
(N-C-(CH3)CH2), 60.1 (CH2-CH3), 46.9 (CH3-C-CH3), 37.9 (NCH(C)-CH2-CH2), 
29.4 (NCH(C)-CH2-CH2), 26.3 (CH3), 24.3 (CH3), 16.5 (CH3), 14.6 (CH2-CH3). 
 3.10.2. Selective Acetylation of Diamine 149 
N-((1R,3S)-3-Amino-2,2,3-trimethylcyclopentyl)acetamide (169) 
 
 A solution of diamine 149 (5 g, 35.15 mmol, 1 eq) and triethylamine (5.53 mL, 52.7 
mmol, 1.5 eq) in Et2O (40 mL) was cooled to 0 °C. Acetyl chloride (2 g, 26.3 mmol, 0.75 eq) in 
Et2O (60 mL) was added slowly by a dropping funnel over a period of 4 h. The solution was 
warmed slowly to 10 °C in 24 h. The reaction mixture was filtered, the solid was washed with 
Et2O, dissolved in CH2Cl2 and a NaOH solution was added. The organic layer was separated and 
the water layer was extracted with CH2Cl2 (2x). The excess of starting diamine 149 was 
removed under high pressure for two days and the desired was product obtained as a white solid 
(4.2 g, 22.35 mmol, 86% yield). 
 mp: 66 °C  
 = +32.8 (c = 1, CH2Cl2). [ ]
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 IR (KBr): 3336, 2965, 1652, 1517, 1271, 1146, 979, 755, 603, 469 cm−1. 
 MS (EI): m/z : 185 (M++H,100%), 187 (20), 168 (18), 125 (30), 126 (10),110 (25), 84 
(5) 71 (25), 57 (25). 
 HRMS (ESI): Calcd. for C10H21N2O [M+H]: 185.1654, found 185.1650. 
 1H-NMR (CDCl3, 600 MHz): δ = 7.63 (br s, 1H, CO-NH-CH), 4.12 (ddd, J = 10.2, 
8.4, 2.2 Hz, 1H, N-CH-(C)CH2), 2.25 – 2.14 (m, 1H, NCH(C)-CH2-CH2), 1.94 (s, 3H, 
CO-CH3), 1.81 – 1.71 (m, 1H, NCH(C)-CH2-CH2), 1.58 – 1.48 (m, 2H, NCH(C)-
CH2-CH2), 1.12 (s, 3H, CH3), 0.89 (d, J = 6.0 Hz, 6H, 2xCH3). 
 13C-NMR (CDCl3, 150 MHz): δ = 168.6 (NH-CO-CH3), 61.9 (N-C-(CH3)CH2), 58.9 
(N-CH-(C)CH2), 46.8 (CH3-C-CH3), 38.1 (NCH(C)-CH2-CH2), 29.5 (NCH(C)-CH2-
CH2), 26.5 (CH3), 24.7 (CH3), 23.7 (CH3), 16.6 (CH3). 
 3.10.3. Alkylation of Monosubtituted Camphor Diamine 
General Procedure 
 
 An arylmetylene chloride solution (1-1.5 eq) in dry acetonitrile was added to a stirred 
solution of camphor diamine (1 eq) and triethylamine (1-1.2 eq) at rt. The resulting mixture was 
heated to reflux for 20 h. Triethylaminehydrochloride was filtered off and the solvent was 
removed under vacuum. The crude product was purified by FCC (MeOH/CH2Cl2 5:95). 
Benzyl-((1R,3S)-3-(benzhydrylamino)-2,2,3-trimethylcyclopentyl)carbamate (162b) 
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 Prepared from (bromomethylene)dibenzene (56.3 mg, 0.227 mmol, 1.05 eq), dry 
acetonitrile (3 mL), camphor diamine 161 (60 mg, 0.217 mmol) and triethylamine (23 mg, 0.227 
mmol, 1.05 eq). The resulting mixture was heated to reflux for 20 h. The product was purified 
by FCC on silica gel with 10% ethyl acetate-petrol ether as an oil (58 mg, 0.13 mmol, 60% 
yield). 
 =  −17.1 (c = 1.1, CH2Cl2). 
 IR (NaCl): 3438, 3055, 2973, 2874, 1715, 1497, 1265, 1216, 896, 739, 705 cm−1. 
 MS (ESI): m/z : 443.7 (M++H,100%). 
 HRMS (ESI): Calcd. for C29H35N2O2 [M+H]: 443.2699, found 443.2684. 
 1H-NMR (CDCl3, 200 MHz): δ = 7.37 - 7.24 (m, 7 H, ArH), 7.24 - 7.16 (m, 5 H, 
ArH), 7.16 - 7.06 (m, 3 H, ArH), 6.21 (d, J = 9.9 Hz, 1 H, OCO-NH-CH), 5.05 (dd, J 
= 6.0, 18.0 Hz, 2 H, NH-COO-CH2-Ar), 4.90 (s, 1 H, Ar-CH-Ar), 3.84 - 3.63 (m, 1 
H, N-CH-(C)CH2), 2.14 - 1.85 (m, 1 H, NCH(C)-CH2-CH2), 1.83 - 1.58 (m, 2 H, 
NCH(C)-CH2-CH2), 1.44 - 1.29 (m, 1 H, NCH(C)-CH2-CH2), 1.05 (s, 3 H, CH3), 
0.85 (s, 6 H, 2xCH3). 
 13C-NMR (CDCl3, 50 MHz): δ = 156.0 (NH-COO-CH2), 146.1 (ArC), 146.0 (ArC), 
145.9 (ArC), 137.13 (ArC), 128.8 (ArCH), 128.5 (ArCH), 127.9 (ArCH), 127.6 
(ArCH), 127.3 (ArCH), 126.9 (ArCH), 126.8 (ArCH), 126.7 (ArCH), 126.5 (ArCH), 
66.8 (NH-COO-CH2-Ar), 66.3 (N-C-(CH3)CH2), 62.0 (Ar-CH-Ar), 60.2 (N-CH-
(C)CH2), 48.5 (CH3-C-CH3), 33.1 (NCH(C)-CH2-CH2), 29.5 (NCH(C)-CH2-CH2), 
24.5 (CH3), 20.9 (CH3), 16.7 (CH3). 
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Ethyl-((1R,3S)-3-(benzhydrylamino)-2,2,3-trimethylcyclopentyl)carbamate (168) 
 
 Prepared from (bromomethylene)dibenzene (1.44 g, 5.81 mmol, 1.5 eq), dry acetonitrile 
(20 mL), camphor diamine 164 (830 mg, 3.87 mmol) and triethylamine (1.1 mL, 7.75 mmol, 2 
eq). The resulting mixture was heated to reflux for 20 h. The product was purified by FCC on 
silica gel with 15% ethyl acetate-petrol ether as a solid (294 mg, 0.77 mmol, 20% yield). 
 mp: 115 °C 
 = − 26.3 (c = 1, CH2Cl2). 
 IR (KBr): 3363, 3057, 2972, 1696, 1598, 1533, 1380, 1262, 1095, 749 cm−1. 
 MS (EI): m/z 381 (M++H, 25), 280 (12),326 (40), 167 (100), 128 (2), 84 (2), 56 (2). 
 HRMS (ESI): Calcd. for C24H33N2O2 [M+H]: 381.2542, found 381.2534. 
 1H-NMR (CDCl3, 600 MHz): δ = 7.38 - 7.52 (m, 2H, ArH), 7.26 - 7.38 (m, 6H, ArH), 
7.18 - 7.26 (m, 2H, ArH), 6.11 (d, J = 10.16 Hz, 1H, CO-NH-CH), 5.01 (s, 1H, Ar-
CH-Ar), 4.07 - 4.24 (m, 2H, NH-COO-CH2-CH3), 3.82 (dt, J = 4.14, 9.41 Hz, 1H, N-
CH-(C)CH2), 1.97 - 2.10 (m, 1H, NCH(C)-CH2-CH2), 1.77 (ddd, J = 3.76, 10.26, 
13.83 Hz, 1H, NCH(C)-CH2-CH2), 1.43 (ddd, J = 6.78, 10.92, 13.93 Hz, 2H, 
NCH(C)-CH2-CH2), 1.31 (t, J = 7.2 Hz, 3 H, COOCH2-CH3), 1.15 (s, 3H, CH3), 0.95 
(s, 3H, CH3), 0.94 (s, 3H, CH3). 
 13C-NMR (CDCl3, 150 MHz): δ = 156.4 (NH-COO-CH2), 146.3 (ArC), 146.1 (ArC), 
128.8 (ArCH), 128.4 (ArCH), 127.5 (ArCH), 127.4 (ArCH), 127.0 (ArCH), 126.8 
(ArCH), 126.7 (ArCH), 126.6 (ArCH), 66.7 (N-C-(CH3)CH2), 62.0 (Ar-CH-Ar), 60.4 
(NH-COO-CH2-CH3), 60.0 (N-CH-(C)CH2), 48.5 (CH3-C-CH3), 33.2 (NCH(C)-CH2-
CH2), 29.4 (NCH(C)-CH2-CH2), 24.4 (CH3), 20.9 (CH3), 16.7 (CH3), 14.8 (CH2-
CH3). 
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 3.10.4. Alkylation of Acetamide 
N-((1R,3S)-2,2,3-Trimethyl-3-((2,4,6-trimethylbenzyl)amino)cyclopentyl)acetamide (170a) 
 
 Prepared from 2,4,6-trimethylbenzylchloride (906.1 mg, 5.37 mmol, 1.1 eq), dry 
acetonitrile (10 mL), camphor diamine 169 (900 mg, 4,88 mmol) and triethylamine (593 mg, 
0.816 mL, 5.86 mmol, 1,2 eq) by refluxing for 5 h. The product was eluted with 5% MeOH- 
CH2Cl2. Evaporation of the solvent gave the title compound 170a as an oil (926 mg, 2.93 mmol, 
60% yield). 
 mp: 68 °C 
 = − 14.12 (c = 1.36 CH2Cl2). 
 IR (KBr): 3529, 3399, 3309, 2967, 2876, 1654, 1557, 1372, 1300, 1204, 1130, 850, 
744, 603, 567, 510 cm
−1
 
 MS (EI): m/z 316 (M++H, 18%), 257 (18), 202 (100), 188 (10), 174 (45), 133 (100), 
131 (27). 
 HRMS (ESI): Calcd. for C20H33N2O [M+H]: 317.2593, found 317.2586. 
 1H-NMR (CDCl3, 600 MHz): δ = 7.50 (d, J=9.32 Hz, 1 H, CO-NH-CH) 6.88 (s, 2 H, 
ArH) 4.05 - 4.17 (m, 1 H, N-CH-(C)CH2) 3.72 (d, J=10.58 Hz, 1 H, N-CH2-Ar) 3.62 
(d, J=10.83 Hz, 1 H, N-CH2-Ar) 2.36 (s, 6 H, 2xCH3) 2.31 (dt, J=8.06, 2.90 Hz, 1 H, 
NCH(C)-CH2-CH2) 2.28 (s, 3 H, ArCH3) 2.11 - 2.21 (m, 1 H, NCH(C)-CH2-CH2) 1.81 
(s, 3 H, COCH3) 1.42 - 1.66 (m, 2 H, NCH(C)-CH2-CH2) 1.22 (s, 3 H, CH3) 0.96 (s, 3 
H, CH3) 0.81 (s, 3 H, CH3).  
 13C-NMR (CDCl3, 150 MHz): δ = 168.4 (NH-CO-CH3), 136.8 (ArCH), 136.7 (ArC), 
133.6 (2xArC), 133. 6 (ArC), 129.2 (ArCH), 66.0 (N-C-(CH3)CH2), 58.5 (N-CH-
(C)CH2), 48.1 (CH3-C-CH3), 40.2 (N-CH2-Ar), 31.4 (NCH(C)-CH2-CH2), 30.4 
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(NCH(C)-CH2-CH2), 25.4 (CH3), 23.6 (CH3), 20.9 (CH3), 19.3 (CH3), 18.5 (CH3), 
16.4 (CH3). 
N-((1R (C),3S)-3-(Benzhydrylamino)-2,2,3-trimethylcyclopentyl)acetamide (170b) 
 
 Prepared from (bromomethylene)dibenzene (1.45 g, 5.88 mmol, 1.2 eq), dry acetonitrile 
(15 mL), camphor diamine 169 (900 mg, 4.88 mmol) and triethlyamine (0.952 mL, 6.84 mmol, 
1.4 eq). The resulting mixture was heated to reflux for 16 h. The product was eluted with 10% 
MeOH-CH2Cl2. Evaporation of the solvent gave the title compound 170b a as white solid (769 
mg, 2.19 mmol, 45% yield). 
 mp: 139 °C 
 = − 31.5 (c = 1, CH2Cl2) 
 IR (KBr): 3513, 3351, 3303, 2970, 2873, 1955, 1651, 1560, 1449, 1369, 1303, 1130, 
1028, 998, 923, 749, 701, 588, 494 cm
−1
.  
 MS (EI): m/z 261 (351M++H, 2%), 391(10), 237 (25), 336 (100), 223 (10), 168 (12), 
167(90) 
 HRMS (ESI): Calcd. for C23H31N2O [M+H]: 351.2436, found 351.2430. 
 1H-NMR (CDCl3, 600 MHz): δ = 7.33 - 7.37 (m, 2H, ArH), 7.23 - 7.31 (m, 6 H, 
ArH), 7.13 - 7.20 (m, 3H, ArH and CO-NH-CH), 4.96 (s, 1H, Ar-CH-Ar), 4.06 (ddd, 
J = 3.39, 8.66, 9.79 Hz, 1H, N-CH-(C)CH2), 2.01 - 2.09 (m, 1H, NCH(C)-CH2-CH2), 
1.91 (s, 3H, CO-CH3), 1.84 (ddd, J = 3.58, 10.26, 14.02 Hz, 1H, NCH(C)-CH2-CH2), 
1.45 (ddd, J = 7.15, 11.11, 14.12 Hz, 1H, NCH(C)-CH2-CH2), 1.07 - 1.14 (m, 1H, 
NCH(C)-CH2-CH2), 1.06 (s, 3H, CH3), 0.91 (s, 3H, CH3), 0.89 (s, 3H, CH3) 
 13C-NMR (CDCl3, 150 MHz): δ = 168.5 (NH-CO-CH3), 146.2 (ArC), 146.0 (ArC), 
128.8 (ArCH), 128.5 (ArCH), 127.2 (ArCH), 126.9 (ArCH), 126.8 (ArCH), 126.8 
(ArCH), 67.2 (N-C-(CH3)CH2), 61.7 (Ar-CH-Ar), 58.2 (N-CH-(C)CH2), 48.6 (CH3-
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C-CH3), 33.2 (NCH(C)-CH2-CH2), 29.5 (NCH(C)-CH2-CH2), 24.9 (CH3), 23.7 (CH3), 
20.9 (C), 16.7 (CH3). 
 3.10.5. Reduction of Acetylated Diamine 
General procedure 
 
 Acetylated diamine was added portionwise to a vigorously stirred suspension of 5-7 eq. 
LAH in THF at rt. After that, the reaction mixture was refluxed for 36-48 h. The reaction was 
quenched with 10% NaOH(aq.) and filtered through celite. The product was extracted with 
CH2Cl2. The combined organic phases were dried (Na2SO4) and concentrated. 
(1R,3S)-N
3
-Ethyl-1,2,2-trimethyl-N
1
-(2,4,6-trimethylbenzyl)cyclopentane-1,3-diamine 
(171a)
 
 Reduction of 170a (640 mg, 2.03 mmol, 1 eq) was performed with LAH (348 mg, 10.12 
mmol, 5 eq) in THF under reflux for 36 h by following the general procedure. The crude product 
was containing traces of the starting material. The product was used in the next step without 
purification.
 
 1H-NMR (CDCl3, 400 MHz): δ = 6.85 (s, 2 H, ArH), 3.72 (d, J = 10.6 Hz, 1 H, N-
CH2-Ar), 3.60 (d, J = 10.6 Hz, 1 H, N-CH2-Ar), 2.82 (dd, J = 6.7, 8.4 Hz, 1 H, N-
CH-(C)CH2), 2.74 - 2.66 (m, 1 H, NCH(C)-CH2-CH2), 2.60 - 2.50 (m, 1 H, NCH(C)-
CH2-CH2), 2.37 (s, 6 H, 2xCH3), 2.27 (s, 3 H, ArCH3), 2.11 - 2.00 (m, 1 H, NCH(C)-
CH2-CH2), 1.97 - 1.87 (m, 1 H, NCH(C)-CH2-CH2), 1.65 (ddd, J = 6.0, 10.0, 13.2 
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Hz, 1 H), 1.43 (tdd, J = 6.3, 11.1, 13.2 Hz, 1 H), 1.19 (s, 3 H, CH3), 1.08 (t, J = 7.1 
Hz, 3 H, CH2CH3), 0.94 (s, 3 H, CH3), 0.87 (s, 3 H, CH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 137.1 (ArC), 136.2 (ArC), 134.7 (ArC), 128.9 
(ArCH), 66.9 (N-CH-(C)CH2), 64.4 (N-C-(CH3)CH2), 47.2 (CH3-C-CH3), 42.8 (N-
CH2-Ar), 40.8 (N-CH2-CH3), 33.7 (NCH(C)-CH2-CH2), 28.8 (NCH(C)-CH2-CH2), 
24.1 (CH3), 20.9 (CH3), 20.3 (CH3), 19.4 (CH3), 16.8 (CH3), 15.7 (CH3). 
(1R,3S)-N
1
-Benzhydryl-N
3
-ethyl-1,2,2-trimethylcyclopentane-1,3-diamine (171b) 
 
 Reduction of 170b (540 mg, 1.54 mmol, 1 eq) was performed with LAH (410 mg, 10.79 
mmol, 7 eq) in THF under reflux for 48 h by following the general procedure. The product was 
obtained , as an oil (513 mg, 1.52 mmol, 99% yield).
 
 = − 41.9 (c = 1.26, CH2Cl2). 
 IR (NaCl): 3054, 2967, 2871, 1492, 1451, 1265, 1098, 1027, 740, 705 cm−1. 
 MS (EI): m/z 337 (M++H, 30%), 222 (30), 122 (10), 167 (100), 154 (15), 100 (15). 
 HRMS (ESI): Calcd. for C23H33N2 [M+H]: 337.2644, found 337.2642. 
 1H-NMR (CDCl3, 400 MHz): δ = 7.38 - 7.34 (m, 2 H, ArH), 7.29 - 7.24 (m, 2 H, 
ArH), 7.21 - 7.14 (m, 4 H, ArH), 7.11 - 7.05 (m, 2 H, ArH), 4.89 (s, 1 H, Ar-CH-Ar), 
2.68 (dd, J = 6.2, 8.4 Hz, 1 H, N-CH-(C)CH2), 2.52 (qd, J = 7.2, 11.2 Hz, 1 H, NH-
CH2-CH3), 2.41 (qd, J = 7.1, 11.1 Hz, 1 H, NH-CH2-CH3), 1.81 (dddd, J = 5.3, 8.4, 
10.2, 13.6 Hz, 1 H, NCH(C)-CH2-CH2), 1.72 - 1.61 (m, 1 H, NCH(C)-CH2-CH2), 1.42 
(ddd, J = 5.7, 10.1, 13.2 Hz, 1 H, NCH(C)-CH2-CH2), 1.20 - 1.05 (m, 1 H, NCH(C)-
CH2-CH2), 0.96 (t, J = 7.2 Hz, 3 H, CH2-CH3), 0.89 (s, 3 H, CH3), 0.87 (s, 3 H, CH3), 
0.85 (s, 3 H, CH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 147.3 (ArC), 147.0 (ArC), 128.2 (ArCH), 128.2 
(ArCH), 127.5 (ArCH), 127.2 (ArCH), 126.3 (ArCH), 126.3 (ArCH), 66.5 (Ar-CH-
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Ar), 65.7 (N-C-(CH3)CH2), 61.6 (N-CH-(C)CH2), 47.4 (CH3-C-CH3), 42.7 (NCH(C)-
CH2-CH2), 34.6 (NCH(C)-CH2-CH2), 28.3 (CH3), 23.6 (CH3), 21.9 (CH3), 17.0 
(CH3), 15.7 (CH3), 1.0 (CH3). 
 3.10.6. Synthesis of Carbene Precursors 
 
 The dialkylated camphor diamine was dissolved in triethylorthoformate (10.0 eq) 
followed by the addition of ammonium tetrafluoroborate (1.3 eq) and catalytic formic acid (1 
drop). The mixture was heated under a nitrogen atmosphere at 100 °C for 4 h. The crude 
reaction mixture was purified by FCC (MeOH/CH2Cl2 5:95) as a white solid. 
(1R,5S)-2-Ethyl-5,8,8-trimethyl-4-(2,4,6-trimethylbenzyl)-2,4-diazabicyclo[3.2.1]oct-2-en-2-
ium tetrafluoroborate (172b) 
 
 Following the general procedure, ammonium tetrafluoroborate (185 mg, 1.76 mmol, 1.3 
eq), triethyl orthoformate (2 g, 2.25mL, 13.55 mmol, 10 eq), 1 drop formic acid and 171a (410 
mg, 1.35 mmol, 1 eq) were employed to afford the pure salt 172a (513.4 mg, 1.28 mmol, 95% 
yield). 
 mp: 142 °C  
 =+100.1 (c = 1, CH2Cl2). 
 IR (KBr): 3408, 2982, 1667, 1468, 1399, 1308, 1205, 1061, 875, 727, 604, 520 cm−1. 
 MS (ESI): m/z 313.6 (M+, 100%). 
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 HRMS (ESI): Calcd. for C21H33N2 : 313.2644, found: 313.2637. 
 1H-NMR (CDCl3, 600 MHz): δ = 6.97 (s, 2H, ArH), 6.70 (s, 1H, N-CH-N), 4.56 (d, J 
= 13.55 Hz, 1H, N-CH2-Ar,), 4.45 (d, J = 13.55 Hz, 1H, N-CH2-Ar,), 3.36 - 3.44 (m, 
3H, N-CH-(C)CH2 and CH2-CH3), 2.57 - 2.64 (m, 1H, NCH(C)-CH2-CH2), 2.31 (s, 
3H, ArCH3), 2.28 (s, 6H, Ar2xCH3), 2.21 - 2.27 (m, 2H, NCH(C)-CH2-CH2), 2.05 - 
2.12 (m, 1H, NCH(C)-CH2-CH2), 1.54 (s, 3H, CH3), 1.23 (s, 3H, CH3), 1.15 (t, J = 
7.15 Hz, 3H, CH2CH3), 1.09 (s, 3H, CH3). 
 13C-NMR (CDCl3, 150 MHz): δ = 149.0 (N-CH-N), 140.2 (ArC), 138.2 (ArC), 130.3 
(ArCH), 123.9 (ArC), 71.4 (N-C-(CH3)CH2), 66.5 (N-CH-(C)CH2), 49.5 (CH2-CH3), 
46.8 (N-CH2-Ar), 40.8 (CH3-C-CH3), 39.4 (NCH(C)-CH2-CH2), 31.9 (NCH(C)-CH2-
CH2), 21.5 (CH3), 21.1 (CH3), 19.4 (CH3), 17.0 (CH3), 14.2 (CH3), 13.8 (CH2-CH3). 
(1R,5S)-4-Benzhydryl-2-ethyl-5,8,8-trimethyl-2,4-diazabicyclo[3.2.1]oct-2-en-2-ium 
tetrafluoroborate (172b) 
 
 Following the general procedure, ammonium tetrafluoroborate (227 mg, 1.76 mmol, 1.3 
eq), triethylorthoformate (2.46 g, 2.77 mL, 16.64 mmol, 10 eq), 1 drop formic acid and 171b 
(560 mg, 1.66 mmol, 1eq) were employed to afford the pure salt 172b (179 mg, 0.415 mmol, 
25% yield). 
 mp: 227 °C  
 =+26 (c =0.5, CH2Cl2). 
 IR (KBr): 3068, 3032, 2890, 1653, 1496, 1469, 1450, 1401, 1339, 1282, 1200, 1056, 
826, 748, 703, 629, 563, 520 cm
−1
. 
 MS (ESI): m/z 347.21 (M+, 100%). 
 HRMS (ESI): Calcd. for C24H31N2 : 347.2481, found: 347.2487. 
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 1H-NMR (CDCl3, 400 MHz): δ = 7.52 - 7.45 (m, 2 H, ArH), 7.43 - 7.36 (m, 5 H, 
ArH), 7.36 - 7.31 (m, 3 H, ArH), 7.22 - 7.19 (m, 1 H, ArH), 7.19 (s, 1 H N-CH-N), 
6.02 (s, 1 H, Ar-CH-Ar), 3.56 - 3.39 (m, 1 H, NCH2-CH3), 3.38 (d, J = 4.8 Hz, 1 H, 
N-CH-(C)CH2), 2.52 - 2.42 (m, 1 H, NCH(C)-CH2-CH2), 2.30 (quin, J = 4.8 Hz, 1 H, 
NCH(C)-CH2-CH2), 2.14 (tdd, J = 4.9, 12.1, 14.5 Hz, 1 H, NCH(C)-CH2-CH2), 1.89 
(ddd, J = 4.8, 12.1, 14.6 Hz, 1 H, NCH(C)-CH2-CH2), 1.43 (s, 3 H, CH3), 1.16 (s, 3 H, 
CH3), 1.13 (t, J = 7.1 Hz, 3 H, CH2-CH3), 1.10 (s, 3 H, CH3) 
 13C-NMR (CDCl3, 100 MHz): δ = 152.0 (N-CH-N), 136.6 (ArC), 136.5 (ArC), 129.7 
(ArCH), 129.6 (ArCH), 129.0 (ArCH), 129.0 (ArCH), 128.9 (ArCH), 128.3 (ArCH), 
72.6 (N-C-(CH3)CH2), 66.5 (N-CH-(C)CH2), 66.3 (Ar-CH-Ar), 49.6 (NCH2-CH3), 
40.9 (CH3-C-CH3), 39.8 (NCH(C)-CH2-CH2), 31.7 (NCH(C)-CH2-CH2), 21.6 (CH3), 
17.1 (CH3), 15.2 (CH3), 13.6 (CH2-CH3). 
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 3.11.  Application of the Catalysts 
 3.11.1. Allylation of Benzaldehyde 
 3.11.1.1 Allylation Reaction with 10 mol% Zwitterion 
1-Phenylbut-3-en-1-ol (175) 
 
 Under a nitogen atmosphere a dry Schlenk was charged with imidazolinium zwitterion 
136a (23.35 mg, 10 mol%), CH2Cl2 (1.5 mL) and benzaldehyde (0.05 mL, 0.49 mmol, 1 eq). 
After that, allyltrichlorosilane (0.105 mL, 0.735 mmol, 1.5 eq) was added drop wise. The 
reaction was allowed to stir for 6.5 d at rt. Then the reaction was carefully quenched with 10% 
NaOH (1 mL) and extracted with EtOAc. The organic layer was washed with 5% HCl (15 mL), 
saturated NaHCO3 (15 mL) and brine (15 mL) and was dried over Na2SO4 and concentrated. 
The crude material was purified by FCC (EtOAc/petrol ether 15:85) to give the corresponding 
homoallyl alcohol 175 as an oil with 95% yield and 9% ee. The spectral data were consistent in 
the literature.
270
  
 1H-NMR (CDCl3, 400 MHz): δ = 7.38-7.27 (m, 5H ), 5.82 (ddt, J = 17.2, 10.0, 7.2 
Hz, 1H), 5.17 (dd, J = 17.2, 1.2 Hz, 1H), 5.15 (dd, J = 10.4, 1.2 Hz, 1H), 4.74 (dt, J = 
6.4, 2.4 Hz, 1H), 2.58-2.6 (m, 2H), 2.06 (d, J = 2.8 Hz, 1H).  
 13C-NMR (CDCl3, 100 MHz): δ = 143.9, 134.5, 128.5, 127.6, 125.9, 118.5, 73.5, 
44.1. 
 3.11.1.2. Allylation in the Presence of an Additives 
1-Phenylbut-3-en-1-ol (175) 
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 To a stirred solution of an imidazolinium zwitterion (10 mol%) and benzaldehyde (0.05 
mL, 0.49 mmol, 1 eq) in CH2Cl2 (1.5 mL) were added diisopropylethylamine (0.41 mL, 2.35 
mmol, 5.0 eq) or tetrabutylammonium iodide (207 mg, 0.56 mmol, 1.2 eq). Alternatively, both 
were added in some experiments (see Table 6). After that, allyltrichlorosilane (0.105 mL, 0.735 
mmol, 1.5 eq) was added drop wise. The reaction was allowed to stir at rt for a fixed time as 
mentioned in Table 6. The reaction was carefully quenched with 10% NaOH (1 mL) and 
extracted with EtOAc. The organic layer was washed with 5% HCl (15 mL), NaHCO3 (15 mL) 
and brine (15 mL), dried over Na2SO4 and concentrated. The crude material was purified by 
FCC(EtOAc/petrol ether 15:85) to give the corresponding homoallyl alcohol 175 as an oil with 
yields of up to 75% and 19% ee. 
(R)-1-(3-Nitrophenyl)-3-buten-1-ol (176) 
 
 The general procedure was followed with p-nitrobenzaldehyde (50 mg, 0.33 mmol, 1 
eq). After workup, the product was purified by FCC (75:25 hexane/diethyl ether) to yield a 
yellow oil (49 mg, 0.251 mmol, 76% yield, 11% ee). HPLC analysis [AD-H; 
i
PrOH/hexane, 
0.8:99.2; 0.8 mLmin
–1
; t1(S) = 33.4 min, t2(R) = 47.05 min]. Spectral data were consistent with 
literature values.
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 1H-NMR (CDCl3, 400 MHz): δ 8.18 (d, J = 8.8 Hz, 2H), 7.52 (d, J = 8.8 Hz, 2H), 
5.83-5.72 (m, 1H), 5.21-5.14 (m, 2H), 4.85 (dd, J = 8.0, 4.8 Hz, 1H), 2.59-2.52 (m, 
1H), 2.49-2.40 (m, 1H), 2.32 (br s, 1H). 
 13C-NMR (CDCl3, 100 MHz): δ 151.3, 147.4, 133.4, 126.7, 123.8, 119.9, 72.3, 44.1. 
(R)-1-(4-Chlorophenyl)-3-buten-1-ol (177) 
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 The general procedure was followed with p-chlorobenzaldehyde (50 mg, 0.356 mmol, 1 
eq). After workup, the product was purified by FCC(75:25 hexane:diethyl ether) to yield a 
yellow oil (50 mg, 0.27 mmol, 76% yield, 11% ee). HPLC analysis [AD-H; 
i
PrOH/hexane, 1:99, 
1.0 mLmin
–1
; t1(S) = 28.3 min, t2(R) = 29.9 min]. Spectral data were consistent with literature 
values.
272
 
 1H-NMR (CDCl3, 400 MHz): δ = 7.34-7.28 (4H, m), 5.79 (1H, dddd, J = 17.6, 9.6, 
8.0, 6.4 Hz),5.17 (1H, d, J = 17.6 Hz), 5.16 (1H, d, J = 10.6 Hz), 4.73 (1H, ddd, J = 
8.0, 4.8, 3.2 Hz), 2.55-2.41, (2H, m), 2.03 (1H, d, J = 2.8 Hz). 
 13C-NMR (CDCl3, 100 MHz): δ 142.3, 134.0, 133.2, 128.6, 127.3, 119.0, 72.8, 44.2. 
 3.11.1.3. Allylation of Benzaldehyde Catalyzed by Carbenes  
1-Phenylbut-3-en-1-ol (175) 
3
 
 A stirred solution of imidazolinium zwitterion (10 mol%) was treated with 9 mol% base 
for 0.5-1.5h at rt or −60 - −40 °C as shown in Tables 7-9. Benzaldehyde (0.05 mL, 0.49 mmol, 1 
eq) and the additive diisopropylethylamine (0.41 mL, 2.35 mmol, 5.0 eq) were added. After 
stirring the workup was performed as mentioned in the above procedure. 
 3.11.2. Synthesis of Ketene Precursor 183 
 3.11.2.1. Methylation of Ethylmalonate 
Diethyl-2-cyclopentyl-2-methylmalonate (188) 
 
3. Experimental 
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 Diethyl-2-methylmalonate 187 (10.2 g,10 mL, 58.5 mmol, 1eq) was added to a 20% 
solution of sodium ethoxide in ethanol (3.98 g, 58.5 mmol, 1 eq), heated to 100 °C so that half 
of the ethanol was distilled off. The bromocyclopentane (8.72 g, 58.5 mmol, 1 eq) was added to 
the pasty residue and heating was continued to 105 °C for 60 h. Most of the remaining ethanol 
was also allowed to be distilled of. The cooled mixture was treated with water, extracted with 
ether, dried and the product was purified by distillation as colorless oil (9.1 g, 37.44 mmol, 64% 
yield). Analytical data were consistent with the literature.
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 1H-NMR (CDCl3, 200 MHz): δ = 4.16 (q, J = 7.1 Hz, 4 H), 2.67 - 2.40 (m, 1 H), 1.85 
- 1.64 (m, 2 H), 1.64 - 1.47 (m, 4 H), 1.47 - 1.37 (m, 1 H), 1.36 (s, 3 H), 1.34 - 1.28 
(m, J = 3.3 Hz, 1 H), 1.24 (t, J = 7.2 Hz, 6 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 172.3, 60.9, 56.1, 44.0, 27.8, 25.6, 17.3, 14.0. 
 3.11.2.2. Diester to Acid 
2-Cyclopentyl-2-methylmalonic acid (190) 
 
 To a solution of 188 (8.92 g, 37 mmol, 1 eq) in ethanol was added (52 mL) KOH (2.9 g, 
51.8 mmol, 1.4 eq) in water (52 mL). The mixture was heated to 100 °C for 60 h, and then 
concentrated under vacuum. The residue was dissolved in water (120 mL) and washed 2x with 
diethyl ether. Then the aqueous layer was acidified (pH 2) with HCl and extracted 3x with ethyl 
acetate. The organic extracts were washed with brine, dried over Na2SO4 and concentrated to 
afford desired the product 190 as an oil (6.54 g, 35.15 mmol, 95% yield). Analytical data were 
consistent with the literature.
273a 
 1H-NMR (CD3OD, 200 MHz): δ = 2.55 - 2.32 (m, 1 H), 1.76 - 1.55 (m, 2 H), 1.55 - 
1.41 (m, 4 H), 1.41 - 1.25 (m, 2 H), 1.23 (s, 3 H). 
 13C-NMR (CD3OD, 50 MHz): δ = 175.9, 57.0, 45.4, 28.9, 26.6. 
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2-Cyclopentylpropanoic acid (191) 
 
 The decarboxylation was performed by heating 2-cyclopentyl-2-methylmalonic acid 190 
(6.54 g, 35.15 mmol) under nitrogen at 180 °C for 1 h (4.95 g, 34.8mmol, 99% yield). 
Analytical data were consistent with the literature 
273a-274 
 1H-NMR (CDCl3, 200 MHz): δ = 2.27 (qd, J = 6.9, 9.0 Hz, 1 H), 2.11 - 1.91 (m, 1 H), 
1.90 - 1.68 (m, 2 H), 1.68 - 1.43 (m, 4 H), 1.35 - 1.22 (m, 1 H), 1.19 (d, J = 6.9 Hz, 3 
H), 1.17 - 1.09 (m, 1 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 182.5, 43.9, 42.1, 29.9, 29.1, 24.2, 15.0. 
2-Cyclopentylpropanoyl chloride (192) 
 
 Oxalyl chloride (6.86 mL, 79.4 mmol, 2 eq) was added over 15 min to a refluxing 
solution of acid 191 (5.65 g, 39.7 mmol, 1 eq) in CH2Cl2. The reaction was further refluxed for 
2.5 h. Then it was cooled to rt and concentrated. The product 192 was purified by distillation (32 
°C, 0.6 torr) as an oil (6.31 g, 39.3 mmol, 99% yield).
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 1H-NMR (CDCl3, 200 MHz): δ = 2.68 (qd, J = 6.9, 9.1 Hz, 1 H), 2.25 - 1.98 (m, 
1 H), 1.98 - 1.72 (m, 2 H), 1.72 - 1.46 (m, 4 H), 1.30 (d, J = 6.9 Hz, 3 H), 1.28 - 
1.02 (m, 2 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 177.4, 56.8, 43.0, 30.8, 29.8, 25.2, 16.0. 
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2-Bromo-2-cyclopentylpropanoyl bromide (186) 
 
 2-Cyclopentylpropanoic acid (7.5 g, 52.74 mmol, 1 eq) and red phosphorus (686 mg, 
22.15 mmol, 0.42 eq) were placed in a flask fitted with a reflux condenser and were treated with 
dry bromine (19 g, 6.12 mL, 119 mmol, 2.26 eq), which was added dropwise. After adding all 
bromine, the reaction mixture was warmed on an oil bath by raising the temperature by 5 °C 
gradually every ½ h until 100 °C were reached. The mixture was left at 100 °C for 1.5 h. After 
that, the product was cooled to rt. The crude product was purified by distillation at 72 °C with 
0.29 torr as an oil (7.45 g, 26.25 mmol, 50% yield). Analytical data were consistent with the 
literature.
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 1H-NMR (CDCl3, 200 MHz): δ = 2.68 (quin, J = 8.3 Hz, 1 H), 1.94 (s, 3 H), 1.92 - 1.75 
(m, 2 H), 1.75 - 1.59 (m, 4 H), 1.59 - 1.37 (m, 2 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 170.0, 76.6, 48.7, 29.4, 28.7, 26.6, 26.2, 25.7. 
  3.11.2.3. Synthesis of Ketenes 
Dimethylketene (2-methylprop-1-en-1-one) (182) 
 
 A stirred slurry of Zn (4.76 g, 73 mmol, 3 eq) in THF (30 mL) at –78 °C was treated 
with a solution of 2-bromo-2-methylpropanoylbromide 181 (5,58 g, 3 mL, 24.3 mmol, 1 eq) in 
THF (15 mL). The reaction mixture was stirred for 10 min at –78 °C and then for 20 min at 0 
°C. Afterward, the resulting solution of the ketene was vacuum transferred into a second 
Schlenk tube. To quantify the amount of ketene synthesized by this procedure, 300µL of the 
yellow ketene solution was quenched with excess n-propylamine. Evaporation of the solvent and 
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the excess amine furnished a white solid, which was identified by 
1
H-NMR as 2-methyl-N-
propylpropanamide. Analytical data were consistent with the literature.
192, 220 
 1H-NMR (CDCl3, 400 MHz): δ = 5.81 (br s, 1 H), 3.13 (dt, J = 5.9, 7.1 Hz, 2 H), 2.29 
(spt, J = 6.9 Hz, 1 H), 1.45 (sxt, J = 7.4 Hz, 2 H), 1.08 (d, J = 7.1 Hz, 6 H), 0.85 (t, J = 
7.4 Hz, 3 H). 
 13C-NMR (CDCl3, 100MHz): δ = 177.0, 77.3, 76.7, 40.9, 35.5, 22.8, 19.6, 11.2, 0.9. 
Cyclopentyl methyl ketene (2-cyclopentylprop-1-en-1-one) (183) 
 
 To a sonicated slurry of Zn (2.42 g, 37 mmol, 3.5 eq) in THF (12 mL) at –78 °C was 
added a solution of 2-bromo-2-cyclopentylpropanoylbromide 181 (3 g, 10.56 mmol) in THF (5 
mL). THF (3 mL) was used to wash the walls of the Schlenk tube. The reaction mixture was 
sonicated for 30 min at rt. Then, the resulting solution of the ketene was vacuum transferred into 
a second Schlenk tube. To quantify the amount of ketene generated by this procedure, 0.5 mL of 
the yellow ketene solution was quenched with an excess of n-propylamine. Evaporation of the 
solvent and the excess amine furnished a white solid, which was identified as 2-cyclopentyl-N-
propylpropanamide.
 
Analytical data were consistent with the literature.
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 1H-NMR (CDCl3, 200 MHz): δ = 5.45 (br s, 1 H), 3.37 - 3.07 (m, 2 H), 2.09 - 1.85 
(m, 2 H), 1.85 - 1.66 (m, 2 H), 1.66 - 1.40 (m, 6 H), 1.30 - 1.02 (m, 5 H), 0.92 (t, J = 
1.0 Hz, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 176.4, 47.8, 43.9, 40.9, 31.3, 30.5, 25.1, 25.0, 23.0, 
17.0, 11.3. 
 Synthesis of Ketene 183 in Toluene
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 The ketene was prepared by dehydrochlorination of 2-cyclopentylpropanoyl chloride 
(2.73 g, 17 mmol) with DABCO (1.9 g 17 mmol) in toluene (20 mL) under a nitrogen 
atmosphere at 80 °C. After 3 h, the reaction mixture was allowed to cool down to rt and the 
ketene and toluene were vacuum transferred into another flask. To quantify the amount of 
ketene generated by this procedure, 0.5 mL of the yellow ketene solution was quenched with an 
excess of n-propylamine. Evaporation of the solvent and excess amine furnished 2-cyclopentyl-
N-propylpropanamide as a white solid (24.4 mg). The concentration of the ketene solution was 
0.3 M. Analytical data were consistent with the literature.
277, 192 
 Ketenes Synthesized from Acid Chloride 
General Procedure for the Preparation of Ketenes 
 
 An acid chloride (1 eq) in diethyl ether was treated with dimethylethyl amine (4 eq) at 0 
°C or rt for 2–6 h. The precipitate of N,N-dimethylethyl anaminium chloride was removed from 
the ketene solution by filtration. The crude ketene was distilled under reduced pressure to give 
the products in 45–73% yield. 
2-Phenylbut-1-en-1-one (178) 
 
 From 2-phenylbutanoyl chloride (7.65 g, 7 mL, 41.88 mmol, 1 eq) and N,N-
dimethylethylamine (DMEA) (18.15 mL, 167 mmol, 4 eq) in diethyl ether (100 mL) over 4 h at 
0 °C to 10 °C. The ketene was distilled under reduced pressure at 40 °C under 0.27 torr to give 
the product as a yellow oil in 70% yield (4.3 g, 29.31 mmol). Analytical data were consistent 
with the literature.
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2,2-Diphenylethenone (179) 
 
 From diphenylacetyl chloride (5 g, 21.7 mmol, 1 eq) and DMEA (3.17 g, 2.46 mL, 22.7 
mmol, 1.05 eq) in diethyl ether (50 mL) over 12 h at 0° C to give the product as an orange oil in 
73%, yield obtained after distillation under reduced pressure (1.5 torr) at 50° C. Analytical data 
were consistent with the literature.
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Cycloheptylidenemethanone (180)
 
 Cycloheptanecarbonyl chloride. From cycloheptane carboxylic acid (5 g, 35.1 mmol, 1 
eq) and oxalyl chloride (6.1 mL, 70.3 mmol, 2 eq) in CH2Cl2 (50 mL) as colourless oil (5.34 g, 
33.4 mmol, 95% yield) obtained after distillation under reduced pressure (3 mbar) at 39–45° C. 
Analytical data were consistent with the literature.
220
 
 1H-NMR (CDCl3, 200MHz) δ = 2.92 (ddd, J = 4.0, 6.0, 12.0 Hz, 1 H), 2.23 - 1.96 (m, 
2 H), 1.88 - 1.63 (m, 5 H), 1.63 - 1.44 (m, 7 H) 
 13C-NMR (CDCl3, 50MHz) δ = 177.4, 56.8, 30.6, 28.1, 25.9 
 Cycloheptylidenemethanone. From cycloheptanecarbonyl chloride (5.25 g, 32.7 mmol, 
1 eq) and DMEA (3.9 mL, 35.9 mmol, 1.1 eq) in diethyl ether (100 mL) over 40 h at 0° to 10° C 
to provide the product as a light yellow oil (1.82 g, 14.71 mmol, 45%) after distillation under 
reduced pressure (1.5 mbar) at 35 °C. Analytical data were consistent with the literature.
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 3.11.3. Wynberg Reaction  
 3.11.3.1. Catalyzed by Hindered Brønsted Bases 
General Experimental Procedure 
 
 To a ketene solution of 183 (0.6 mmol, 2 mL toluene, 2 eq) was added benzaldehyde 
(30µL, 0.3 mmol) at −78 °C followed by the addition of MHMDS (0.5M solution in 
toluene), NaOTMS or KO
t
Bu (0.03 mmol). After the given times and temperatures 
mentioned in Table 11, the reaction mixture was subjected directly to column 
chromatography on silica gel and the diastereomers were eluted with a 1:19 diethyl 
ether/petrol ether mixture to give the desired compounds as an oil. For yields and 
diastereomeric ratios see Table 11. The spectral data were consistent with literature 
values.
277 
193: trans-diastereomer:  
 1H-NMR ((CD3)2O, 200 MHz) δ 7.31 - 7.505 (m, 5H), 5.56 (s, 1H), 2.41 - 2.24 (m, 
1H), 2.003-1.78 (m, 2H), 1.76 - 1.602 (m, 4H), 1.59-1.35 (m, 2H), 0.872 (s, 3H) 
 13C-NMR ((CD3)2O, 50 MHz) δ 207.1, 175.5, 138, 130.4, 127.4, 80.8, 64.9, 46.1, 
29.7, 27, 26.9, 16,8. 
cis-diastereomer: 
 1H-NMR ((CD3)2O, 200 MHz) δ 7.49 - 7.33 (m, 5H), 5.47 (s, 1H), 2.08 - 1.97 (m, 
1H), 1.54 (s, 3H), 1.26 - 1.49 (m, 5H), 1.24 - 0.83 (m, 3H) 
 13C-NMR ((CD3)2O, 50 MHz) δ 207.1, 175.7, 137.9, 130.2, 127.9, 84.7, 64.9, 41.6, 
28.2, 27.7, 27, 17.0.  
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General Experimental Procedure for 193b 
 
 To a ketene solution of 183b (0.42 mmol, 1,5 mL toluene, 1eq) was added 
benzaldehyde (29µL, 0.28 mmol, 1eq) at −78 °C followed by the addition of MHMDS (10 
mol%, 0.5 M solution in toluene), NaOTMS or KOtBu (0.03 mmol). After the given times 
and temperatures mentioned in Table 12, the reaction mixture was subjected directly to 
column chromatography on silica gel and the diastereomers were eluted with a 1:19 diethyl 
ether/petrol ether mixture to give the desired oily compounds. For yields and diastereomeric 
ratios see Table 12. 
cis/trans-diastereomer:  
 1H-NMR (CDCl3, 200 MHz): δ = 7.46 - 7.26 (m, 10 H), 5.37 (s, 1 H), 5.34 (s, 1 
H), 2.05 - 1.82 (m, 4 H), 1.51 - 1.31 (m, 6 H), 1.30 - 1.17 (m, 5 H), 1.12 (t, J = 7.5 
Hz, 5 H), 1.04 - 0.91 (m, 6 H), 0.82 - 0.65 (m, 6 H). 
 13C-NMR (CDCl3, 50MHz) : 174.2, 135.3, 135.2, 128.5, 128.3, 125.6, 125.6, 81.1, 
80.8, 64.2, 63.9, 31.4, 28.4, 26.3, 25.3, 23.0, 22.8, 22,1, 13.9, 13.5, 8.7. 
General Experimental Procedure for 194 
 
  Ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and an aldehyde (30µL, 0.3 mmol, 1eq) were 
placed into a dry Schlenk flask in dry toluene (2 mL) at −78 °C. KHMDS (0.5M solution in 
toluene) (0.03 mmol, 10 mol%) was slowly added. The reaction mixture was stirred for 10 
min. The solvent was removed under reduced pressure giving the crude product 194, which 
was purified by column chromatography (2/98 diethyl ether/hexane) to give the desired 
lactones. For yields see Table 13. 
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3-Phenyl-2-oxaspiro[3.6]decan-1-one (194a) 
 
  The general procedure was followed with ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and 
benzaldehyde (31.2 mg, 30µl, 0.3 mmol, 1 eq) to produce 194a as an oil. Spectral data were 
consistent with literature values.
277 
 1H-NMR (CDCl3, 400 MHz): δ = 7.25 - 7.46 (m, 5 H), 5.30 (s, 1 H), 2.14 - 2.25 (m, 2 
H), 1.851.90 (m, 2 H), 1.55 - 1.64 (m, 4 H), 1.25 - 1.42 (m, 4 H). 
 13C-NMR (CDCl3, 100 MHz): δ = 175.5. 135.5, 128.7, 125.9, 84.2, 64.0, 35.4, 30.4, 
29.2, 29.1, 23.8, 22.9. 
3-(4-Chlorophenyl)-2-oxaspiro[3.6]decan-1-one (194b) 
 
  Following the general procedure with ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and 4-
chlorobenzaldehyde (42,2 mg, 0.3 mmol, 1 eq) gave an oily product. Spectral data were 
consistent with literature values.
277 
 IR (NaCl) 1827, 1460, 1092, 940 cm−1. 
 1H-NMR (CDCl3, 400 MHz): δ = 7.45 (d, J = 8.0 Hz, 2 H), 7.30 (d, J = 8.0 Hz, 2 
H), 5.31 (s, 1 H), 2.27 - 2.31 (m, 1 H), 2.13-2.19 (m, 1 H). 1.85-1.90 (m, 1 H), 
1.60-1.69 (m, 4 H), 1.26-1.37 (m, 5 H). 
 13C-NMR (CDCl3, 100 MHz): δ = 175.0, 134.4, 134.0, 128.9, 127.2, 83.4, 64.1, 
35.2, 30.3, 29.03, 28.98, 23.7, 22.7. 
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3-(o-Tolyl)-2-oxaspiro[3.6]decan-1-one (194c) 
 
  Following the general procedure with ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and 2-
methylbenzaldehyde (36.04 mg, 0.3 mmol, 1 eq) gave an oil. Spectral data were consistent 
with literature values.
277 
 IR (NaCl) 1827, 1458, 1460, 1102, 937 cm−1. 
 1H-NMR (CDCl3, 400 MHz): δ = 7.49 - 7.47 (m, 1 H), 7.35 - 7.27 (m, 2 H), 7.19 (d, J 
= 8.0 Hz), 5.40 (s, 1 H), 2.48 - 2.42 (m, 1 H). 2.30 (s, 3 H), 2.22 - 2.16 (m, 1 H), 1.94 
- 1.90 (m, 1 H), 1.76 - 1.74 (m, 1 H), 1.57 - 1.44 (m, 9 H). 
 13C-NMR (CDCl3, 100 MHz): δ = 174.2, 133.1, 132.9, 129.2, 128.9, 127.1, 125.3, 
124.4, 81.7, 62.7, 34.9, 30.9, 28.7, 28.4, 22.7, 22.0, 18.4. 
3-(p-Tolyl)-2-oxaspiro[3.6]decan-1-one (194d) 
 
  Following the general procedure with ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and 4-
methylbenzaldehyde (36.04 mg, 0.3 mmol, 1 eq) gave an oil. Spectral data were consistent 
with literature values.
277 
 IR (NaCl) 1823, 1459, 1260, 1106, 938 cm−1. 
 1H-NMR (CDCl3, 200 MHz): δ = 7.18 - 7.05 (m, 4 H), 5.20 (s, 1 H), 2.30 (s, 3 H), 
2.25 - 2.05 (m, 2 H), 1.94 - 1.90 (m, 1 H), 1.90 - 1.70 (m, 1 H), 1.25 - 1.22 (m, 5 H), 
1.57 - 1.50- (m, 4 H). 
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 13C-NMR (CDCl3, 50 MHz): δ = 175.7, 138.5, 132.5, 129.4, 125.9, 84.3, 63.8, 35.4, 
30.3, 29.8, 29.2, 23.8, 22.9, 21.4. 
3-(4-(Trifluoromethyl)phenyl)-2-oxaspiro[3.6]decan-1-one (194e)
 
  Following the general procedure with ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and 4-
(trifluoromethyl)benzaldehyde (52.21 mg, 0.3 mmol, 1 eq) give an oil. Spectral data were 
consistent with literature values.
277 
 IR (NaCl) 1827, 1512, 1264, 1108, 939 cm−1. 
 1H-NMR (CDCl3, 200 MHz): δ = 7.71 (d, J = 8.0 Hz, 2 H), 7.44 (d, J = 8.0 Hz, 2 
H), 5.34 (s, 1 H), 2.09 - 2.37 (m, 2 H), 1.84 - 1.97 (m, 1 H), 1.63 - 1.20 (m, 9 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 174.6, 139.5, 131.1, 130.4, 126.1, 125.8, 125.6, 
121.2, 83.2, 64.5, 35.3, 30.4, 29.0, 28.9, 23.6, 22.7. 
3-(4-Fluorophenyl)-2-oxaspiro[3.6]decan-1-one (194f) 
 
  Following the general procedure with ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and 4-
fluorobenzaldehyde (37.23 mg, 0.3 mmol, 1 eq) give an oil. Spectral data were consistent 
with literature values.
277 
 IR (NaCl) 1826, 1512, 1459, 1261, 1109, 939 cm−1. 
 1H-NMR (CDCl3, 200 MHz) : δ = 7.31 - 7.24 (m, 2 H), 7.15 - 7.07 (m, 2 H), 5.28 
(s, 1 H), 2.30 (s, 3 H), 2.32 - 2.06 (m, 2 H), 1.82 - 1.92 (m, 2 H), 1.68-1.63 (m, 4 
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H), 1.45-1.25 (m, 4 H). 
 13C-NMR (CDCl3, 50 MHz) : δ = 174.6. 162.2 (d, J = 245 Hz), 131.1, 127.1 (d, J 
= 8 Hz), 115.2 (d, J = 22 Hz), 83.0, 63.5, 34.8, 29.6, 28.5, 27.8, 23.2, 22.3. 
3-(2,4-Dichlorophenyl)-2-oxaspiro[3.6]decan-1-one (194g) 
 
  Following the general procedure with ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and 4-
fluorobenzaldehyde (37.23 mg, 0.3 mmol, 1 eq) give an oil. 
 IR (NaCl) 3056, 2932, 1862, 1734, 1702, 1592, 1473, 1265, 1108, 943, 740, 705.cm−1. 
 1H-NMR (CDCl3,
 
400 MHz) δ = 7.37 - 7.34 (m, 2 H), 7.28 (dd, J = 2.0, 8.3 Hz, 1 
H), 5.38 (s, 1 H), 2.30 (qd, J = 2.3, 3.0 Hz, 1 H), 2.19 (quin, J = 2.5 Hz, 1 H), 1.62 
- 1.53 (m, 3 H), 1.53 - 1.47 (m, 4 H), 1.47 - 1.42 (m, 2 H).
 
 13C-NMR (CDCl3, 100 MHz) δ = 174.5, 134.8, 132.6, 132.1, 129.3, 128.2, 127.6, 
81.4, 64.7, 35.4, 30.0, 29.2, 29.1, 23.5, 22.9. 
3-Phenyl-3-(trifluoromethyl)-2-oxaspiro[3.6]decan-1-one (195c) 
 
  Following the general procedure with ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and 
2,2,2-trifluoro-1-phenylethanone (52,2 mg, 0.3 mmol, 1 eq) give an oil. Analytical data were 
consistent with the literature.
277 
 IR (NaCl)  3055, 2987, 1845, 1422, 1266, 1179, 748 cm−1. 
 1H-NMR (CDCl3, 200 MHz): δ = 7.55 - 7.24 (m, 5 H), 2.40 - 2.15 (m, 2 H), 1.20 - 
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1.91 (m, 10 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 172.2, 131.2, 129.4, 128.2, 129.2, 126.5, 125.3 
(q, J = 2.2 Hz), 124.1 (q, J = 281.6 Hz), 84.7 (q, J = 30.2 Hz), 34.3, 66.7, 29.3 (q, 
J = 2.8 Hz), 29.7, 29.5, 23.1, 22.7. 
General Experimental Procedure for Reaction with Ketene (182) 
 
  Ketene 182 (0.6 mmol, 1.62 mL, 0.37M solution in THF, 2 eq) and an aldehyde (0.3 
mmol, 1eq) were added at −78 °C to toluene (2 mL) followed by the addition of KHMDS 
(0.03 mmol, 0.5M solution in toluene). The reaction was monitored by TLC. After 15 min 
the reaction was completed. The reaction was worked up with sat. NH4Cl(aq) (5 mL) and the 
aqueous phase was extracted with CH2Cl2 (3 x 5 mL). The combined organic phases were 
dried (Na2CO3) and the solvent was removed. The resulting product was dissolved in THF (5 
mL) and LiAlH4 (1.2 mmol) was added. After 1 h stirring the reaction was carefully 
quenched with 1M NaOH (5 mL) and H2O (5 mL). The aqueous solution was extracted with 
EtOAc (3 x 5 mL) and the combined phases were dried (Na2SO4) and the solvent was 
removed. The crude product was purified on silica gel and the products were eluted with 1:2 
diethyl ether/petrol ether mixture to give the desired compounds as white solids. 
2,2-Dimethyl-1-phenylpropane-1,3-diol (195a) 
 
  Prepared from ketene 182 (0.6 mmol, 1.62 mL, 0.37 M solution in THF, 2 eq) and 
benzaldehyde (31,83 mg, 0.3 mmol, 1 eq) as solid by the general procedure. Analytical data 
were consistent with the literature.
277 
 1H-NMR (200 MHz): δ =  7.44 - 7.28 (m, 5 H). 5.30 (s, 1 H), 2.08 - 1.97 (m, 1 H), 
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1.55 (s, 3 H), 1.53 - 1.30 (m, 5 H), 1.29 - 0.89 (m, 3 H). 
 13C-NMR (50 MHz): δ =  138.4. 137.1, 128.4, 127.4, 83.7, 63.3, 39.8, 28.2, 26.7, 
25.8, 25.6, 17.0. 
2,2-Dimethyl-1-(p-tolyl)propane-1,3-diol (195b) 
 
  Prepared from ketene 182 (0.6 mmol, 1.62 mL, 0.37 M solution in THF, 2 eq) and 4-
methylbenzaldehyde (36.05 mg, 0.3 mmol, 1 eq) as solid by the general procedure. 
Analytical data were consistent with the literature.
277 
 1H-NMR (200 MHz): δ = 7.59 - 7.11 (m, 4 H), 4.59 (s, 1 H), 3.58 (d, J = 10.5 Hz, 
1 H), 3.48 (d, J = 10.2 Hz, 1 H), 3.15 (s, 2 H), 2.34 (s, 3 H), 0.86 (s, 3 H), 0.81 (s, 
3 H). 
 13C-NMR (50 MHz): δ =  138.4, 137.1, 128.4, 127.5, 127.4, 82.1, 72.0, 39.0, 22.7, 
21.7, 18.9. 
  3.11.3.2. Wynberg Reaction Catalyzed by Carbenes 
General Procedure  
 
 Salt 153a (38 mg, 0.06 mmol, 10 mol%) was placed into a dry Schlenk flask and dry 
toluene (2 mL) was added. The suspension was cooled to −60 °C and KHMDS (48 µL, 0.024 
mmol, 8 mol%) was slowly added. The mixture was stirred for 1.5 h at −60 °C or 30 min at rt. 
Then an aldehyde 10 (0.03 mmol) and a ketene (0.6 mmol, 2 eq) were added. The reaction 
mixture was stirred for 10 min (for differences in reaction times and temperatures see Table 15) 
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and the solvent was removed under reduced pressure giving the crude product, which was 
purified by FCC (diethyl ether/hexane, 2/98) to give the corresponding lactone. 
3-Phenyl-2-oxaspiro[3.6]decan-1-one (194a) 
 
 Prepared from benzaldehyde (30 µL, 0.3 mmol, 1 eq) and ketene 180 (75 mg, 0.6 mmol, 
2 eq), catalyzed by the carbene, generated from salt 153a, as an oil (76% yield, 92% ee). 
Enantiomeric ratio was determined by HPLC (AD-H, 1.0 mL / min; 1% 
i
PrOH/hexane: (R) t1 = 
11.1 min, (S) t2 = 16.3 min. Analytical data were consistent with the literature.
192 
 = +20.0 (c = 0.5, CH2Cl2) 
3-(4-Chlorophenyl)-2-oxaspiro[3.6]decan-1-one (200e) 
 
 Prepared from 4-chlorobenzaldehyde (42.17 mg, 0.3 mmol, 1 eq) and ketene 180 (75 
mg, 0.6 mmol, 2 eq) catalyzed by the carbene, generated from salt 153a, as an oil (80% yield, 
86% ee). Enantiomeric ratio was determined by HPLC (AD-H, 1.0 mL/min; 1% 
i
PrOH/hexane: 
(R) t1 = 11.8 min, (S) t2 = 16.0 min. Analytical data were consistent with the literature.
192 
 = +7.2 (c = 0.50, CH2Cl2) 
3-(o-Tolyl)-2-oxaspiro[3.6]decan-1-one (200d) 
 
[ ]22Dα
[ ]22Dα
3. Experimental 
 
 
209 
 Prepared from 2-methylbenzaldehyde (36.05 mg, 0.3 mmol, 1 eq) and ketene 180 (75 
mg, 0.6 mmol, 2 eq), catalyzed by the carbene, generated from salt 153a, as an oil. (73% yield, 
80% ee). Enantiomeric ratio was determined by HPLC (AD-H, 1.0 mL / min; 0.5% 
i
PrOH/hexane: (R) t1 = 12.5 min, (S) t2 = 13.5 min. Analytical data were consistent with the 
literature.
192 
 = +8.6 (c = 1.0, CH2Cl2).  
3-(p-Tolyl)-2-oxaspiro[3.6]decan-1-one (200c) 
 
 Prepared from 4-methylbenzaldehyde (36.05 mg, 0.3 mmol, 1 eq) and ketene 180 (75 
mg, 0.6 mmol, 2 eq), catalyzed by the carbene, generated from salt 153a, as an oil. (82% yield, 
91% ee). Enantiomeric ratio was determined by HPLC (AD-H, 1.0 mL/min; 1% 
i
PrOH/hexane: 
(R) t1 = 10.4 min, (S) t2 = 14.1 min. Analytical data were consistent with the literature.
192 
 = +9.6 (c = 1.0, CH2Cl2). 
3-(4-Fluorophenyl)-2-oxaspiro[3.6]decan-1-one (200b) 
 
 Prepared from 4-fluorobenzaldehyde (37.23 mg, 0.3 mmol, 1 eq) and ketene 180 (75 mg, 
0.6 mmol, 2 eq), catalyzed by the carbene, generated from salt 153a, as an oil. (72% yield, 91% 
ee). Enantiomeric ratio was determined by HPLC (AD-H, 1.0 mL/min; 1% 
i
PrOH/hexane: (R) t1 
= 13.4 min, (S) t2 = 19.2 min. Analytical data were consistent with the literature.
192 
 = +8.0 (c = 1.0, CH2Cl2). 
[ ]22Dα
[ ]22Dα
[ ]22Dα
3. Experimental 
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3-(2,4-Dichlorophenyl)-2-oxaspiro[3.6]decan-1-one (200f) 
 
 Prepared from the aromatic aldehyde (30 µL, 0.3 mmol, 1 eq) and ketene 180 (75 mg, 
0.6 mmol, 2 eq), catalyzed by a carbene, generated from 2,4-bis(anthracen-9-ylmethyl)-5,8,8-
trimethyl-4-aza-2-azonia-bicyclo[3.2.1]oct-2-ene chloride (153c), as an oil (70% yield, 53% ee). 
Enantiomeric ratio was determined by HPLC (AD-H, 1.0 mL/min; 1% 
i
PrOH/hexane: (R) t1 = 
14.1 min, (S) t2 = 17.3 min. 
 = +26.5 (c = 1.7, CH2Cl2). 
2,2-Dimethyl-1-phenylpropane-1,3-diol (200g) 
 
 Prepared from benzaldehyde (30 µL, 0.3 mmol, 1 eq) and ketene 182 (0.6 mmol, 1.62 
mL, 0.37 M solution in THF, 2 eq), catalyzed by the carbene, generated from salt 153a, as an 
oil. (75% yield, 54% ee). Enantiomeric ratio was determined by HPLC (AD-H, 1.0 mL/min; 5% 
i
PrOH/hexane: (R) t1 = 14.5 min, (S) t2 = 15.8 min. Analytical data were consistent with the 
literature.
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2,2-Dimethyl-1-(p-tolyl)propane-1,3-diol (200h)
 
[ ]22Dα
3. Experimental 
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 Prepared from 4-methylbenzaldehyde (30 µL, 0.3 mmol, 1 eq) and ketene 182 (0.6 
mmol, 1.62 mL, 0.37 M solution in THF, 2 eq) catalyzed by the carbene, generated from salt 
153a, as an oil (65% yield, 57% ee). Enantiomeric ratio was determined by HPLC (OD-H, 5.0 
mL/min; 5% 
i
PrOH/hexane: (R) t1 = 14.2 min, (S) t2 = 16.5 min. Analytical data were consistent 
with the literature.
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3-Cyclopentyl-3-methyl-4-phenyloxetan-2-one (200i) 
 
 Prepared from benzaldehyde (30 µL, 0.3 mmol, 1 eq) and ketene 183 (0.6 mmol, 2 mL 
toluene, 2 eq) catalyzed by the carbene, generated from salt 153a, as an oil (99% yield, trans:cis 
1:2. trans: 82% ee). Enantiomeric ratio was determined by HPLC (AD-H, 1.0 mL/min; 1% 
i
PrOH/hexane: (R) t1 = 7.4 min, (S) t2 = 9.2 min cis: 79% ee. Enantiomeric ratio was determined 
by HPLC (AD-H, 1.0 mL/min; 1% 
i
PrOH/hexane: (R) t1 = 7.6 min, (S) t2 = 8.5 min. The 
spectral data were consistent with literature values.
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193: trans-diastereomer: 
 1H-NMR (CDCl3, 200 MHz): δ = 7.22-7.46 (m, 5 H), 5.39 (s, 1 H), 2.21-2.38 (m, 
1 H), 1.79-2.06 (m, 2 H), 1.62-1.78 (m, 4 H), 1.26-1.58 (m, 2 H), 0.91 (s, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 174.5, 135.6, 128.6, 128.3, 125.4, 79.5, 63.3, 
44.3, 28.3, 27.8, 25.6, 25.5, 15.5. 
cis-diastereomer: 
 1H-NMR (CDCl3, 200 MHz): δ  =  7.28-7.44 (m, 5 H), 5.30 (s, 1 H), 1.97-2.08 (m, 
1 H), 1.55 (s, 3 H), 1.30-1.53 (m, 5 H), 0.89-1.29 (m, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ =  174.7, 135.6, 128.6, 128.5, 126.1, 83.7, 63.3, 
39.8, 28.2, 26.7, 25.8, 25.6, 17.0. 
3. Experimental 
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3-Phenyl-3-(trifluoromethyl)-2-oxaspiro[3.6]decan-1-one (204a) 
 
 Following the general procedure with ketene 180 (93 mg, 0.75 mmol, 2.5 eq) and 2,2,2-
trifluoro-1-phenylethanone (52,2 mg, 0.3 mmol, 1 eq), as an oil (45% yield). 204a was reduced 
with LAH and the product was purified by FCC (ethyl acetate/petrol ether 12:88) and the 
product was obtained as a white solid. (90 yield, 34% ee). Enantiomeric ratio was determined by 
HPLC (AD-H, 1.0 mL/min; 1% 
i
PrOH/hexane: (R) t1 = 19.5 min, (S) t2 = 22.5 min.
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 mp: 124 °C (DSC) 
 IR (KBr): 3382, 2964, 2926, 2360, 1493, 1462, 1257, 1205, 1158, 1146, 1068, 1022, 
796, 715, 664, 568 cm
−1
. 
 MS (EI): m/z 303 (M++H, 25%), 267 (30), 253 (10), 157 (10), 156 (25), 111 (25), 109 
(100), 67 (60), 55 (50). 
 HRMS (ESI): Calcd. for C16H21F3O2Na: 325.1391, found: 325.1391. 
 1H-NMR (CDCl3, 400 MHz): δ = 7.82 (br s, 1 H, OH), 7.67 - 7.24 (m, 5 H, ArCH), 
5.77 (s, 1 H, OH), 4.05 (dd, J = 4.9, 11.3 Hz, 1 H, OH-CH2), 3.76 (dd, J = 3.2, 11.2 
Hz, 1 H, OH-CH2), 2.23 (dd, J = 3.8, 5.2 Hz, 1 H, CH2), 2.11 (dd, J = 8.9, 15.4 Hz, 1 
H, CH2), 1.94 (dd, J = 9.4, 15.1 Hz, 1 H, CH2), 1.65 (dd, J = 9.6, 15.3 Hz, 1 H, CH2), 
1.41 - 1.12 (m, 7 H, CH2), 1.09 - 0.96 (m, 1 H, CH2). 
 13C-NMR (CDCl3, 100 MHz): δ = 136.9 (ArC), 128.1(ArCH), 69.6 (ArOHC-CF3), 
46.8, 31.4 (CH2-HC-CH2), 31.3 (CH2), 31.2 (CH2), 30.3 (CH2), 23.9(CH2), 
23.1(CH2). 
  
3. Experimental 
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 3.11.3.3. Wynberg Reaction Catalyzed with Chiral Amides 
(R)-1-Tert-butyl-1,1-diphenyl-N-(1-phenylethyl)silanamine 
 
 In a stirred solution of (R)-1-phenylethanamine 207 (1,72 g, 1.81 mL, 14.2 mmol 1,5 eq) 
and triethylamine (2.87 g, 3.94 mL, 28.4 mmol, 3 eq) was added tert-butylchlorodiphenylsilane 
(2.6 g, 2.5 mL, 9.4 mmol, 1 eq). The reaction was stirred for 16 h and the product was purified 
by distillation (180 °C, 0.5 torr) as a colourless viscous liquid (2.9 g, 8 mmol, 85% yield). 
Analytical data were consistent with the literature.
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 1H-NMR (CDCl3, 400 MHz) δ = 7.76 - 7.70 (m, 2 H), 7.53 (d, J = 7.8 Hz, 2 H), 7.41 - 
7.26 (m, 4 H), 7.26 - 7.11 (m, 7 H), 3.93 (br s, 1 H), 1.35 (s, 1 H), 1.31 (d, J = 6.5 Hz, 
3 H), 1.01 (s, 9 H) 
 13C-NMR (CDCl3, 100 MHz): δ = 148.9, 136.1, 136.0, 135.8, 134.9, 129.1, 129.0, 
128.1, 127.4, 127.2, 126.1, 125.7, 51.9, 28.2, 27.5, 18.6. 
General Procedure 
 
 Amine 209a (37 mg, 0.073 mmol, 10 mol%) was placed into a dry Schlenk flask and dry 
toluene (2 mL) was added. The KH (2.65 mg, 0.066 mmol, 8 mol%) was slowly added. The 
mixture was stirred for 2.5 h at −40 °C. Benzaldehyde 10 (75 µL, 0.736 mmol, 1 eq) and 
hexamethyleneketene 180 (102 mg, 0.736 mmol, 1 eq) were added. The reaction mixture was 
stirred for 16 h and the solvent was removed under reduced pressure giving the crude product, 
which was purified by FCC (diethyl ether/hexane, 2/98) to give the corresponding lactone 200 
(Table 18). Analytical data were consistent with the literature.
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3. Experimental 
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 3.11.3.4. Wynberg Reaction with 2-Oxaldehyde 
General Procedure 
 
 To a dried Schlenk 153a (10 mol%) and toluene (2 mL) were added. The temperature 
was lowered to −60° C and 8 mol% KHMDS was added. The reaction mixture was stirred for 
1.5 h at this temperature and at – 78°C. The ketene (1.5 mmol) was added via a syringe followed 
by the addition of 2-oxaldehyde (1.0 mmol) and the reaction mixture was stirred for a specific 
time as mentioned in Table 16. The mixture was purified directly with petroleum ether/ethyl 
acetate (20:1). 
4-Benzoyl-3,3-diphenyloxetan-2-one (201a) 
 
 Synthesized from diphenyl ketene (116.5 mg, 0.6 mmol, 2 eq) and 2-oxaldehyde (40.2 
mg, 0.3 mmol, 1 eq) catalyzed by salt 153a. The reaction mixture was stirred for a specific time 
as mentioned in Table 16. The mixture was purified directly with petroleum ether/ethyl acetate 
(20:1) as a white solid (50% yield, 0% ee). Spectral data were consistent with literature 
values.
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 1H-NMR (CDCl3, 200 MHz): δ = 7.70-7.48 (m, 5H), 7.48-7.29(m, 5H), 7.16-7.00 (m, 
3H), 7.00-6.86 (m, 2H), 6.34 (s, 1H). 
 13C-NMR (CDCl3, 50 MHz): δ = 193.8, 169.4, 136.9, 135.7, 134.5, 133.9, 129.2, 
128.7, 128.5, 128.4, 128.3, 128.2, 127.9, 127.4, 127.1, 80.9, 75.5. 
  
3. Experimental 
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4-Benzoyl-3,3-dimethyloxetan-2-one (201b) 
 
 Synthesized from dimethyl ketene (31.14 mg in 1.16 mL THF, 0.45 mmol, 2 eq) and 2-
oxaldehyde (30 mg, 0.224 mmol, 1 eq) catalyzed by salt 153a. The reaction mixture was stirred 
for a specific time as mentioned in Table 16. The mixture was purified directly with petroleum 
ether/ethyl acetate (10:1.5) as a white solid (62% yield, 0 % ee). 
 1H-NMR (CDCl3, 200 MHz): δ = 7.74 - 7.45 (m, 5 H), 5.53 (s, 1 H), 1.71 (s, 3 H), 1.13 
(s, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 192.6, 172.7, 134.5, 129.2, 129.0, 128.9, 127.9, 81.4, 
21.8, 17.7. 
 3.11.4. Preparation of Imines 
General Procedure 
 
 A flask was charged with benzenesulfonamide (1 eq), benzaldehyde (1 eq), and 
tetraethoxysilane (1.25 eq) under an atmosphere of nitrogen. The flask was sealed and the 
mixture was heated at 160 °C for 4-16 h. After that, the reaction mixture was cooled down to rt. 
Warm ethyl acetate and pentane were added subsequently. The protected imine crystallized on 
standing.
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N-Benzylidene-4-nitrobenzenesulfonamide (212b) 
 
3. Experimental 
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 From 4-nitrobenzenesulfonamide (1.01 g, 5.0 mmol, 1 eq), benzaldehyde (0.531 g, 5.0 
mmol, 1eq) and Si(OEt)4 (1.172 g, 5.625 mmol, 1.1 eq) upon heating at 160 °C for 6 h 
according to method A to provide the imine as a light yellow solid (1.14 g, 3.95 mmol, 79% 
yield). Spectral data were consistent with literature values.
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 mp = 150 °C. 
 1H-NMR (CDCl3, 200 MHz): δ = 7.49-7.56 (m, 2 H), 7.64-7.71 (m, 1 H), 7.96(d, J = 9.6 
Hz, 2 H), 8.21 (d, J = 9.0 Hz, 2 H,), 8.38 (d, J = 9.0 Hz, 2 H), 9.13 (s, 1 H). 
13
C-NMR ((CD3)2CO, 50 MHz): δ = 150.6, 144.2, 135.8, 131.9, 131.7, 129.3, 124.3. 
N-Benzylidene-4-methylbenzenesulfonamide (212c) 
 
 From 4-toluenebenzenesulfonamide (3 g, 17.5 mmol, 1 eq), benzaldehyde (1.86 g, 17.5 
mmol, 1eq) and Si(OEt)4 (4.12 g, 19.7 mmol, 1.1 eq) upon heating at 160 °C for 6 h according 
to the general method to provide the imine as a white solid (3.2 g, 12.25 mmol, 70% yield). 
Spectral data were consistent with literature values.
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 1H-NMR (CDCl3, 400 MHz): δ = 9.03 (s, 1 H), 7.95 - 7.87 (m, 4 H), 7.62 (tt, J = 1.4, 
7.5 Hz, 1 H), 7.56 - 7.45 (m, 2 H), 7.40 - 7.30 (m, 2 H), 2.44 (s, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 170.1, 144.6, 135.1, 134.9, 132.4, 131.3, 129.8, 
129.1, 128.1, 21.6. 
General Procedure for the Synthesis of Benzimidoyl Chloride (217) 
 
 N-Benzamide (216): Benzenesulfonamide (1 eq) and K2CO3 (2.5 eq) were dissolved in 
THF and stirred for 20 min at rt followed by cooling to 0 °C with an ice-bath. Benzene carbonic 
chloride (1.3 eq) in THF was syringed into the reaction mixture. After stirring for 48 h, a white 
3. Experimental 
 
 
217 
precipitate formed, and the reaction mixture was refluxed for 12 h. The reaction was quenched 
by 50% H2SO4 and was extracted with ethyl acetate 2x, washed with water and brine, dried over 
Na2SO4, evaporated in vacuo, and crystallized to give crystals of N-benzamide (up to 94 
yield).
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 N-Benzimidoyl chloride (217): A mixture of N-benzamide (1 eq) and PCl5 (1.05 eq) 
was dissolved in benzene at rt and stirred at this temperature for 0.5 h. Then, the reaction 
mixture was refluxed for 6 h. The solvent was removed in vacuo and the crude product was 
recrystallized from diethyl ether to afford 217 (up to 91%) as a solid.
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N-Tosylbenzimidoyl chloride (217a)
 
 N-Benzamide (216a): Prepared from benzenesulfonamide (TsNH2) (3.42 g, 20 mmol, 1 
eq), K2CO3 (6.9 g, 50 mmol, 2.5 eq) and benzene carbonic chloride (36. g, 26 mmol) in THF. 
The reaction was performed according to the procedure mentioned above and white crystals of 
N-tosylbenzamide (5.17 g, 18.8 mol, 94% yield) were obtained. Spectral data were consistent 
with literature values.
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 1H-NMR (CDCl3, 200 MHz): δ = 9.23 (s, 1 H), 8.11 - 8.00 (m, 2 H), 7.87 - 7.76 (m, 2 
H), 7.58 - 7.50 (m, 1 H), 7.48 - 7.45 (m, 1 H), 7.44 - 7.40 (m, 1 H), 7.39 - 7.36 (m, 1 H), 
7.36 - 7.30 (m, 1 H), 2.44 (s, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 164.3, 145.3, 135.4, 133.5, 131.1, 129.6, 128.9, 128.7, 
127.8, 21.7. 
 N-Tosylbenzimidoyl chloride (217a): Synthesized from N-tosylbenzamide (2 g, 7.26 
mmol, 1 eq) and PCl5 (1.59 g, 2.37 mmol, 1.05 eq) in benzene (25 mL). The crude product was 
recrystallized from diethyl ether to afford 217a (1.94 g, 6.6 mmol, 91% yield) as a white solid. 
Spectral data were consistent with literature values.
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 1H-NMR (CDCl3, 200 MHz): δ = 8.05 - 7.94 (m, 2 H), 7.91 - 7.79 (m, 2 H), 7.59 - 
7.44 (m, 1 H), 7.42 - 7.19 (m, 4 H), 2.37 (s, 3 H). 
3. Experimental 
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 13C-NMR (CDCl3, 50 MHz): δ = 144.5, 137.2, 134.7, 134.0, 130.2, 129.6, 128.7, 
127.7, 21.7. 
N-((4-Nitrophenyl)sulfonyl)benzimidoyl chloride (217b) 
p
p
p
2 3 5
2
 
 N-Benzamide (216b): Prepared from benzenesulfonamide (pNsNH2) (1 g, 4.94 mmol, 1 
eq), K2CO3 (1.707 g, 12.35 mmol, 2.5 eq) and benzene carbonic chloride (902.67 mg, 6.42 
mmol, 1.3 eq) in THF. The reaction was performed according to the procedure mentioned above 
and yellow crystals of N-tosylbenzamide (1.61 g, 5.25 mmol, 94% yield) were obtained. 
 mp: 203 °C  
 IR (KBr): 3291, 3213, 1937, 1704, 1530, 1452, 1352, 1238, 1173 1059, 1026, 836, 
794, 736, 712, 682, 606, 558, 467.cm
−1
. 
 MS ESI: m/z 307 (M++H, 100%), 303 (10), 245 (15), 237 (20), 164 (40), 141 (45), 
117 (60), 74 (40), 57 (45). 
 HRMS (ESI): Calcd. for C13H11N2O2S: 307.3018, found: 307.3016. 
 1H-NMR (CDCl3, 200 MHz): δ = 8.85 (s, 1 H, Ar-CONH-SO2), 8.39 - 8.26 (m, 4 H, 
ArH), 7.75 - 7.67 (m, 2 H, ArH), 7.61 - 7.49 (m, 1 H, ArH), 7.47 - 7.33 (m, 2 H, 
ArH). 
 13C-NMR (CDCl3, 50 MHz): δ = 164.1 (Ar-CONH-SO2), 150.8 (ArC), 143.8 (ArC), 
134.1 (ArC), 130.2 (ArCH), 129.2 (ArCH), 127.8 (ArCH), 124.2 (ArCH). 
 N-Nosylbenzimidoyl chloride (217b): Synthesized from N-nosylbenzamide (920 mg, 
3.01 mmol, 1 eq) and PCl5 (657 mg, 3.154 mmol, 1.05 eq) in benzene (15 mL). The crude 
product was recrystallized from diethyl ether to afford 217b (890 mg, 2.74 mmol, 91% yield) as 
a slight yellow solid. The compound was used in the next step. 
 1H-NMR (CDCl3, 200 MHz): δ = 8.39 - 8.29 (m, 2 H, ArH), 8.22 - 8.11 (m, 2 H, 
ArH), 8.05 - 7.93 (m, 2 H, ArH), 7.64 - 7.49 (m, 1 H, ArH), 7.45 - 7.30 (m, 2 H, 
ArH). 
3. Experimental 
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 13C-NMR (CDCl3, 50 MHz): δ = 159.0 (Ar-C-Cl), 145.7 (ArC), 135.4 (ArC), 133.5 
(ArC), 130.3 (ArCH), 129.0 (ArC), 128.9 (ArCH), 124.3. (ArCH) 
General Procedure for the Synthesis of N-Sulfonyl Ketimine (219) 
 
 N-Benzimidoyl chloride (217) (1 eq), phenylboronic acid (1.2 eq), Na2CO3 (2.1 eq), 
Ag2O (1.1 eq), PdCl2(PPh3)2 (1 mol%) and toluene (1.0 mol% solvent (water:toluene = 1:1000, 
v/v) were combined and stirred at 30 °C. The reaction was monitored by TLC. The reaction 
mixture was filtered and evaporated in vacuo and the residue was purified by FCC 
(pentane:EtOAc, 15:1) to give the solid product 219 (up to 61% yield). 
N-((4-Methoxyphenyl)(phenyl)methylene)-4-methylbenzenesulfonamide (219a) 
 
 N-Tosylbenzimidoyl chloride (217a) (293 mg, 1.0 mmol, 1 eq), phenylboronic acid (184 
mg, 1.2 mmol, 1.2 eq), Na2CO3 (223 mg, 2.1 mmol, 2.1 eq), Ag2O (254 mg, 1.1 mmol, 1.1 eq), 
PdCl2(PPh3)2 (7 mg, 1 mol%) and toluene (10 mL) were used to synthesize 219a as a white solid 
(182 mg, 0.5 mmol, 50% yield). Spectral data were consistent with literature values.
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 1H-NMR (CDCl3, 200 MHz): δ = 7.80 - 7.66 (m, 2 H), 7.57 - 7.47 (m, 2 H), 7.46 - 7.12 
(m, 7 H), 6.86 - 6.75 (m, 2 H), 3.78 (s, 3 H), 2.35 (s, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 143.1, 138.9, 132.8, 129.3, 127.9, 127.2, 113.6, 55.5, 
21.5. 
  
3. Experimental 
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N-((4-Methoxyphenyl)(phenyl)methylene)-4-nitrobenzenesulfonamide (219b) 
 
 N-Nosylbenzimidoyl chloride 217b (250 mg, 0.77 mmol, 1 eq), phenylboronic acid (140 
mg, 0.924 mmol, 1.2 eq), Na2CO3 (171 mg, 1.62 mmol, 2.1 eq), Ag2O (196 mg, 0.846 mmol, 
1.1 eq), PdCl2(PPh3)2 (5.4 mg, 0.0077 mmol, 1 mol%) and toluene (10 mL) were used to 
synthesize 219a as light yellw solid (186 mg, 0.47 mmol, 61% yield). 
 mp: 135 °C  
 IR (KBr): 3106, 2935, 2843, 2581, 1606, 1530, 1446, 1306, 1262, 1180, 921, 825, 
732, 572, 471, 417 cm
−1
.  
 MS ESI: m/z : 397 (M++H,100%), 237 (5), 167 (8), 163 (10), 135 (22). 
 HRMS (ESI): Calcd. for C20H17N2O5S [M+H]: 397.0858, found 397.0864. 
 1H-NMR (CDCl3, 400 MHz): δ = 8.35 - 8.30 (m, 2 H, ArH), 8.16 - 8.11 (m, 2 H, 
ArH), 7.64 - 7.59 (m, 2 H, ArH), 7.58 - 7.43 (m, 5 H, ArH), 6.94 - 6.87 (m, J = 8.8 
Hz, 2 H, ArH), 3.87 (s, 3 H, Ar-OCH3). 
 13C-NMR (CDCl3, 100 MHz): δ = 180.0 (ArC), 149.9 (ArC), 147.5 (ArC), 133.3 
(ArC), 132.6 (ArCH), 129.0 (ArCH), 128.5 (ArCH), 128.2 (ArCH), 128.2 (ArCH), 
127.9 (ArCH), 124.3 (ArC), 124.1 (ArCH), 114.0 (ArCH), 113.6 (ArCH), 55.7 (Ar-
OCH3). 
 3.11.5. Staudinger Reaction 
General Procedure for the Synthesis of β-Lactams 
 
3. Experimental 
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 A zwitterion (10 mol%) was placed into a dry Schlenk flask and a dry organic solvent (2 
mL) was added (Table 19-20). The suspension was cooled to −60 °C and a base (8-9 mol%) was 
slowly added. The mixture was stirred for 1.5 h at −60 °C or 30 min at rt. Then, an imine (0.1 
mmol) and a ketene (0.25 mmol) were added. The reaction was monitored by TLC. The reaction 
mixture was applied to column chromatography on silica gel and the products were eluted with 
1:8 ethyl acetate/petrol ether mixture to give the desired compounds as white solids (up to 99% 
yield)
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3-Ethyl-1-(4-nitrophenylsulfonyl)-3-phenyl-4-(thiophen-2-yl)azetidin-2-one (213a) 
 
 From ketene 178 (38 µL, 0.25 mmol, 2.5 eq) and imine 212a (29.6 mg, 0.1 mmol, 1 eq) 
in THF (1.5 mL) with 10 mol% 136a (4.76 mg, 0.01 mmol, 10 mol%) and base KHMDS (16µl, 
0.008 mmol, 8 mol%) after stirring at –78 °C - −40 °C for 16 h as a white solid in 99% yield 
(cis:trans 12:88) (entry 2, Table 19). Spectral data were consistent with literature values.
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trans-Isomer  
 1H-NMR (CDCl3, 200 MHz): δ = 8.34 (d, J = 9.2 Hz, 4 H).8.10 (d, J = 9.0 Hz, 2 H), 
0.64 (t, J = 7.6 Hz, 3 H),5.53 (s, 1 H), 7.24-7.37 (m, 6 H), 7.04-7.11 (m, 2 H), 1.50-
1.68 (m, 1 H), 1.85-2.03 (m, 1 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 168.2, 144.0, 137.1, 136.5, 129.2, 129.2, 128.2, 
127.9, 127.5, 126.7, 126.2, 124.5, 68.3, 65.8, 27.6, 8.7. 
cis-Isomer 
 1H-NMR (CDCl3, 200 MHz): δ = 8.25 (d, J = 9.04 Hz, 2 H),7.93 (d, J = 9.04 Hz, 2 H), 
.25 (q, J = 8.0 Hz, 2 H),0.97 (t, J = 7.2 Hz, 3 H), 5.49 (s, 1 H), 6.73-6.75 (m, 2 H), 6.97-
7.04 (m, 3 H), 7.11-7.18 (m, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 167.2, 150.8, 144.4, 137.2, 134.5, 129.1, 128.9, 128.5, 
127.9, 127.2, 126.4, 124.3, 70.5, 64.9, 32.3,9.3. 
 
3. Experimental 
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3-Ethyl-3,4-diphenyl-1-tosylazetidin-2-one (213b) 
 
 From ketene 178 (38 µL, 0.25 mmol, 2.5 eq) and imine 212a (26 mg, 0.1 mmol, 1 eq) in 
THF (1.5 mL) with 10 mol% 136a (4.8 mg, 0.01 mmol, 10 mol%) and base KHMDS (18 µL, 
0.009 mmol, 9 mol%) after stirring at −40 °C for 20 h as a white solid in 86% yield (cis:trans 
8:92) (entry 5, Table 19). Spectral data were consistent with literature values.
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trans-Isomer 
 1H-NMR (CDCl3, 200 MHz): δ = 7.93 - 7.76 (m, 2 H), 7.43 - 7.38 (m, 4 H), 7.38 - 
7.24 (m, 7 H), 7.24 - 7.20 (m, 1 H), 5.18 (s, 1 H), 2.47 (s, 3 H), 1.83 - 1.61 (m, 1 H), 
1.43 - 1.26 (m, 1 H), 0.61 (t, J = 1.0 Hz, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 167.7, 144.3, 136.8, 134.4, 128.8, 127.9, 127.7, 
127.6, 126.7, 126.6, 126.1, 125.2, 68.4, 66.3, 25.8, 20.7, 7.6. 
cis-Isomer 
 1H-NMR (CDCl3, 200 MHz): δ = 7.80 - 7.69 (m, 2 H), 7.32 (tt, J = 1.1, 1.6 Hz, 1 H), 
7.15 - 6.99 (m, 6 H), 6.95 - 6.80 (m, 4 H), 5.08 (s, 1 H), 2.46 (s, 3 H), 2.21 - 2.07 (m, 
2 H), 0.91 (t, J = 7.4 Hz, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 168.0, 145.1, 135.7, 129.7, 128.9, 128.3, 128.0, 
127.9, 127.8, 127.7, 127.6, 127.3, 127.0, 69.8, 68.5, 31.9, 21.7, 9.1. 
  
3. Experimental 
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3-Ethyl-1-(4-nitrophenylsulfonyl)-3,4-diphenylazetidin-2-one ) (213c) 
 
 From ketene 178 (38 µL, 0.25 mmol, 2.5 eq) and imine 212b (29.6 mg, 0.1 mmol, 1 eq) 
in toluene (1.5 mL) with 10 mol% 139c (5.4 mg, 0.01 mmol, 10 mol%) and base LiHMDS 
(10µl, 0.009 mmol, 9 mol%) after stirring at −40 °C for 24 h as a white solid in 30% yield 
(cis:trans 20:80) (entry 7, Table 19). Spectral data were consistent with literature values.
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trans-Isomer:  
 1H-NMR (CDCl3, 200 MHz): δ = 8.34 (d, J = 8.98 Hz, 2 H), 8.12 (d, J = 8.9 Hz, 2 
H), 7.44 - 7.21 (m, 10 H), 5.24 (s, 1 H), 1.89 - 1.64 (m, 1 H). 1.43 - 1.25 (m, 1 H), 
0.57 (t, J = 7.4 Hz, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 168.6, 151.0, 143.9, 137.4, 133.4, 129.3, 129.2, 
128.9, 128.1, 127.2, 126.2, 124.6, 69.9, 68.1, 27.1, 8.6. 
cis-Isomer:  
 1H-NMR (CDCl3, 200 MHz): δ = 8.26 (d, J = 8.9 Hz, 2 H). 7.95 (d, J = 8.9 Hz, 2 H), 
2.20 (q, J = 7.4 Hz, 2 H), 0.94 (t, J = 7.4 Hz, 3 H), 5.15 (s, 1 H), 7.16-6.94 (m, 6 H), 
6.76 - 6.70 (m, 2 H), 6.91 – 6.82 (m, 2 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 167.8, 150.8, 144.4, 134.5, 133.7, 129.0, 128.9, 
128.3, 128.2, 128.2, 127.4, 127.2, 124.4, 70.2, 69.1, 32.6, 9.3. 
1-(4-Nitrophenylsulfonyl)-3,3,4-triphenylazetidin-2-one (214b) 
 
3. Experimental 
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 From ketene 179 (39 µL, 0.2 mmol, 2 eq) and imine 212b (29.63 mg, 0.1 mmol, 1 eq) in 
Et2O (1.5 mL) with 10 mol% 136b (5.4 mg, 0.01 mmol, 10 mol%) and base KHMDS (16 µL, 
0.008 mmol, 8 mol%) after stirring at rt for 24 h as a white solid in 36% yield and 20% ee (entry 
2, Table 20). HPLC (Chiralpack AD-H, 10% 
i
PrOH/hexane, 1 mL/min): 20% ee, Rt 27.11 min 
(major), 35.46 min (minor). Spectral data were consistent with literature values.
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 = +4.5 (c = 0.53, CH2Cl2). 
 1H-NMR (CDCl3, 200 MHz): δ = 5.86 (s, 1 H), 7.21 - 6.87 (m, 10 H), 7.48 – 7.28 
(m, 5 H), 8.00 (d, J = 9.0 Hz, 2 H), 8.26 (d, J = 9.0 Hz, 2 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 69.6, 73.3, 124.4, 126.9, 127.6, 127.8, 128.0, 
128.3, 128.3, 129.0, 129.1, 129.2, 133.4, 135.6, 138.7, 143.9, 150.9, 166.7. 
(S)-3,3,4-Triphenyl-1-tosylazetidin-2-one (214a)
 
 From ketene 179 (25.25 mg, 0.13 mmol,1.3 eq) and imine 212c (26 mg, 0.1 mmol, 1 eq) 
in Et2O (1.5 mL) with 10 mol% 136b (5.4 mg, 0.01 mmol, 10 mol%) and base KHMDS (18 µL, 
0.009 mmol, 9 mol%) after stirring at rt for 24 h as a white solid in 51% yield and 85% ee (entry 
1, Table 20). HPLC (Chiralpak AD-H, 10% 
i
PrOH/hexane, 1 mL/min): 85% ee, Rt 8.63 min 
(major), 15.43 min (minor). Spectral data were consistent with literature values.
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 = +24 (c = 0.35, CH2Cl2) 
 1H-NMR (CDCl3, 200 MHz): δ = 7.73 (d, J = 8.2 Hz, 2 H), 7.42 – 7.22 (m, 7 H), 
7.14 - 6.88 (m, 10 H), 5.78 (s, 1 H), 2.42 (s, 3 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 166.8, 143.3, 139.0, 135.8, 135.4, 133.9, 129.8, 
128.9, 128.5, 128.0, 128.0, 127.9, 127.7, 127.2, 127.0, 72.8, 69.2, 21.7. 
  
[ ]22Dα
[ ]22Dα
3. Experimental 
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2-(4-Nitrophenylsulfonyl)-3-phenyl-2-azaspiro[3.6]decan-1-one (214c) 
 
 Chiral amine 209 (10 mol%) was placed into a dry Schlenk flask and dry THF (2 mL) 
was added. Then the base (9 mol%) was slowly added. The temperature was raised to 40 °C and 
the mixture was stirred for 2.5 h. Thereafter it was cooled to –78 °C. Ketene (35 µL, 0.25 mmol, 
2.5 eq) and imine (29 mg, 0.1 mmol, 1 eq) were added. The reaction mixture was stirred for 24 h 
and the crude product was purified by FCC (diethyl ether/hexane, 1/8) giving the corresponding 
lactone as a white solid (Table 21). Spectral data were consistent with literature values.
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 1H-NMR (CDCl3, 200 MHz): δ = 8.38 (d, J = 8.8 Hz, 2 H), 8.12 (d, J = 8.8 Hz, 2 H), 
7.33 – 7.11 (m, 5 H), 4.85 (s, 1 H), 1.72-2.02 (m, 2 H), 1.66 – 1.46 (m, 6 H), 1.38 – 
1.06 (m, 4 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 171.3, 151.0, 144.19, 134.1, 129.1, 129.0, 129.0, 
127.1, 124.6, 70.5, 64.3, 35.4, 30.0, 29.1, 29.0, 23.7, 22.8. 
 3.11.6. TMSCN Addition to Aldehydes 
 3.11.6.1. TMSCN Addition to Aldehydes with Chiral Zwitterions 
2-Phenyl-2-((trimethylsilyl)oxy)acetonitrile (225) 
 
 An aldehyde (50 µL, 0.49 mmol, 1 eq), TMSCN (123 µL, 0.98 mmol, 2 eq) and a 
zwitterion (10 mol%) in a solvent (1 mL) were stirred under a flow of nitrogen. After 
completion the product was purified by column chromatography (petrol ether/ethyl acetate, 9:1) 
to give a slight yellow oil (Table 23). The spectral data were consistent with the literature.
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 1H-NMR (CDCl3, 200 MHz): δ = 7.55 - 7.40 (m, 5 H), 5.53 (s, 1 H), 0.26 (s, 9 H). 
3. Experimental 
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 3.11.6.2. Derivatization of Cyanohydrins for HPLC 
Cyano(phenyl)methyl acetate (225a) 
 
 To a solution of O-silylated cyanohydrin (1 mmol, 1 eq) in acetonitrile (1 mL) was 
added acetic anhydride (2 mmol, 2 eq) and Sc(OTf)3 (1 mol%). The resulting solution was 
stirred for 15 min at rt. The solvent was evaporated and the residue was purified by column 
chromatography. Isolated yields were almost quantitative. Enantiomeric excess was measured 
by chiral HPLC (Chiralcel OD-H, 10% 
i
PrOH/hexane, 1 mL/min). Rt 13.8 min 15.7 min. The 
spectral data were consistent with the literature.
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 1H-NMR (CDCl3, 200 MHz): δ = 7.58 - 7.43 (m, 5 H), 6.42 (s, 1 H), 2.17 (s, 3 H). 
 3.11.6.3. TMSCN Addition to Aldehydes with Carbenes 
2-Phenyl-2-((trimethylsilyl)oxy)acetonitrile (225) 
 
 A base (9 mol%) was added to the zwitterion 136a (23 mg, 0.049 mmol, 0.1 eq) in a dry 
solvent (1 mL). After 1.5 h, benzaldehyde (50 µL, 0.49 mmol, 1 eq) and TMSCN (123 µL, 0.98 
mmol, 2 eq) were added. After 48 h the crude product was columned (petrol ether/AcOEt, 9:1) 
to give the expected product in quantitative yield (Table 25). The spectral data were consistent 
with the literature.
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3. Experimental 
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 3.11.7. TMSCF3 Addition to Aldehydes 
 
 To a solution of zwitterion (10 mol%) in (1.5 mL) of a solvent base (9 mol%) was added 
and the solution was stirred for 5-16 h. After that, aldehyde (1 eq) and TMSCF3 (2 eq) were 
added. The reaction was performed for 16 h at rt. Then, 2 N HCl (5 mL) was added and the 
combined solution was stirred at rt until all the TMS protected intermediate converted to the 
product. Water (30 mL) was added and the aqueous layer was extracted with CH2Cl2 (3x10 mL). 
The combined organic layers were washed with brine (20 mL) and dried over anhydrous 
Na2SO4. The solvent was removed under vacuum to give the crude product, which was purified 
by FCC on silica gel (PE/EtOAc 20:1). 
2,2,2-Trifluoro-1-phenylethanol (229a) 
 
 Synthesized from zwitterion 136a (23.4 mg, 0.049 mmol, 10 mol%), THF (1.5 mL), base 
NaH (1.76 mg, 0.044 mmol, 9 mol%), benzaldehyde (52.6 mg, 0.49 mmol, 1 eq) and TMSCF3 
(195.5 mg, 212 µL, 1.37 mmol, 2.8 eq). The reaction was stirred for 24 h at rt. Then, HCl (2N, 5 
mL) was added and the combined solution was stirred at rt for 1 h. After workup, the crude 
residue was purified by FCC on silica gel (PE/EtOAc 30:70) (86 mg, 0.38 mmol, 99.9% yield). 
HPLC (Chiralcel OD-H, n-hexane/isopropanol 99:1, 1 mL/min). Rt  35.76 min and 41.43 min. 
The spectral data were consistent with the literature.
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 1H-NMR (CDCl3, 200 MHz): δ = 7.54 - 7.45 (m, 2 H), 7.45 - 7.38 (m, 4 H), 5.03 (q, J = 
6.7 Hz, 1 H), 2.50 (br s, 2 H). 
  
3. Experimental 
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2,2,2-Trifluoro-1-(naphthalen-2-yl)ethanol (229b) 
 
 Synthesized with zwitterion 136a (18,31 mg, 0.038 mmol, 10 mol%), THF (1.5 mL), the 
base NaH (1.32 mg, 0.0346 mmol, 9 mol%), 2-naphthaldehyde (60 mg, 0.384 mmol, 1 eq) and 
TMSCF3 ( 98.32 mg, 103 µL, 0,69 mmol, 1.8 eq). The reaction was stirred for 24 h at rt. Then 
2N HCl (5 mL) was added and the combined solution was stirred at rt for 1 h. After workup the 
crude residue was purified by FCC on silica gel (PE/EtOAc 20:1) (86 mg, 0.38 mmol, 99.9% 
yield). HPLC (Chiralcel OD-H, n-hexane/isopropanol 90:10, 1 mL/min). Rt 10.54 min and 15.52 
min. The spectral data were consistent with literature values.
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 1H-NMR (CDCl3, 200 MHz): δ = 7.97 - 7.77 (m, 4 H), 7.60 - 7.41 (m, 3 H), 5.15 (dq, 
J = 3.1, 6.6 Hz, 1 H), 2.73 (d, J = 4.0 Hz, 1 H). 
 13C-NMR (CDCl3, 50 MHz): δ = 133.8, 132.9, 131.2, 128.5, 128.2, 127.8, 127.4, 
127.1, 126.9, 126.6, 124.3, 124.3, 121.5, 74.0, 73.3, 72.7, 72.1. 
 3.12.  Zwitterion as Chiral Shift Reagents: 
    NMR Experiments with the Racemic compounds 
The racemic compound (1 eq) and the corresponding zwitterion (2eq) were dissolved in 
deuterated organic solvent and the 
1
H-NMR and 
19
F-NMR spectra were recorded at rt. For 
results see Table 26-29. 
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